[["index.html", "SCOPE &amp; STOP Hormones Analysis Overview", " SCOPE &amp; STOP Hormones Analysis 23 October 2022 Overview This page contains analysis results for SCOPE and STOP Hormones. Absorbance Concentrations: Standard curves "],["part-raw-data.html", "(PART*) Raw Data", " (PART*) Raw Data "],["standard-curves.html", "1 Standard Curves", " 1 Standard Curves This section contains standard curves fitted for Prolactin, HPL, and GH2. GH2 Plate 22 (28-2-22) omitted due to invalid standard curve. Inter-assay CV for Prolactin and HPL higher than recommended 15%. According to the protocols, the following methods were used for curve fitting: - Prolactin: Quadratic - HPL: 4-parameter Logistic - GH2: non-linear splines "],["prolactin.html", "1.1 Prolactin", " 1.1 Prolactin 1.1.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;Prolactin_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL Combined Abs standards only&quot;) std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates # samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;Prolactin_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL SCOPE and STOP combined Abs &quot;) samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates 1.1.1.1 Standard concentration by plate Click for more details Concentration 0 5 15 50 100 200 Assay 1 1 1 1 1 1 1 Assay 2 1 1 1 1 1 1 Assay 3 1 1 1 1 1 1 Assay 4 1 1 1 1 1 1 Assay 5 1 1 1 1 1 1 Assay 6 1 1 1 1 1 1 Assay 7 1 1 1 1 1 1 Assay 8 1 1 1 1 1 1 Assay 9 1 1 1 1 1 1 Assay 10 1 1 1 1 1 1 Assay 11 1 1 1 1 1 1 Assay 12 1 1 1 1 1 1 Assay 13 1 1 1 1 1 1 Assay 14 1 1 1 1 1 1 Assay 15 1 1 1 1 1 1 Assay 16 1 1 1 1 1 1 Assay 17 1 1 1 1 1 1 Assay 18 1 1 1 1 1 1 Assay 19 1 1 1 1 1 1 Assay 20 1 1 1 1 1 1 Assay 21 1 1 1 1 1 1 Assay 22 1 1 1 1 1 1 Assay 23 1 1 1 1 1 1 Assay 24 1 1 1 1 1 1 Assay 25 1 1 1 1 1 1 Assay 26 1 1 1 1 1 1 Assay 27 1 1 1 1 1 1 Assay 28 1 1 1 1 1 1 Assay 29 1 1 1 1 1 1 Assay 30 1 1 1 1 1 1 Assay 31 1 1 1 1 1 1 Assay 32 1 1 1 1 1 1 Assay 33 1 1 1 1 1 1 Assay 34 1 1 1 1 1 1 Assay 35 1 1 1 1 1 1 Assay 36 1 1 1 1 1 1 Assay 37 1 1 1 1 1 1 Assay 38 1 1 1 1 1 1 Assay 39 1 1 1 1 1 1 Assay 40 1 1 1 1 1 1 Assay 41 1 1 1 1 1 1 Assay 42 1 1 1 1 1 1 Assay 43 1 1 1 1 1 1 Assay 44 1 1 1 1 1 1 Assay 45 1 1 1 1 1 1 Assay 46 1 1 1 1 1 1 Assay 47 1 1 1 1 1 1 Assay 48 1 1 1 1 1 1 Assay 49 1 1 1 1 1 1 Assay 50 1 1 1 1 1 1 Assay 51 1 1 1 1 1 1 Assay 52 1 1 1 1 1 1 Assay 53 1 1 1 1 1 1 Assay 54 1 1 1 1 1 1 Assay 55 1 1 1 1 1 1 Assay 56 1 1 1 1 1 1 Assay 57 1 1 1 1 1 1 1.1.1.2 Samples by plate Click for more details Study SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 22 18 40 Assay 19 15 1 16 Assay 20 12 29 41 Assay 21 5 35 40 Assay 22 22 18 40 Assay 23 15 25 40 Assay 24 15 25 40 Assay 25 26 14 40 Assay 26 23 17 40 Assay 27 23 17 40 Assay 28 18 22 40 Assay 29 21 19 40 Assay 30 20 20 40 Assay 31 17 23 40 Assay 32 30 10 40 Assay 33 18 22 40 Assay 34 25 15 40 Assay 35 25 15 40 Assay 36 23 17 40 Assay 37 24 16 40 Assay 38 22 18 40 Assay 39 20 20 40 Assay 40 25 15 40 Assay 41 21 19 40 Assay 42 20 20 40 Assay 43 14 26 40 Assay 44 24 16 40 Assay 45 17 23 40 Assay 46 21 19 40 Assay 47 18 22 40 Assay 48 23 17 40 Assay 49 22 18 40 Assay 50 21 19 40 Assay 51 20 20 40 Assay 52 21 19 40 Assay 53 28 12 40 Assay 54 26 14 40 Assay 55 23 17 40 Assay 56 18 22 40 Assay 57 19 14 33 1.1.2 CV ## Inter-assay CV cv_dat &lt;- std_raw #cv_dat &lt;- std_raw[with(std_raw,get(conc_name)&lt;=50),] #cv_dat &lt;- std_raw[!std_raw$Assay%in%c(2,6,7,11,18,19),] cv_dat$Group &lt;- as.factor(with(cv_dat,get(conc_name))) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$&quot;Abs Ave&quot;,x$Group,mean,na.tm=T))) cv_mean_dat[cv_mean_dat&lt;0.0000001] &lt;- 0 cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_gps[is.nan(cv_gps)] &lt;- 0 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) cv_intra &lt;- mean(samp_cv) Inter-assay CV = 25.25% from 57 assays. Intra-assay CV = 3.85% from 2247 sample measurements. 1.1.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ poly(Conc,2,raw=T),data=std_ls[[k]])}) #fit quadratic #std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ Conc + I(Conc^2),data=std_ls[[k]])}) #fit model std_fit2 &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit splines Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 57 1.1.4 Session info Results generated on: 2022-10-23 14:38:06 Click for more details sessionInfo() ## R version 4.2.1 (2022-06-23) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.1 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils datasets ## [9] methods base ## ## other attached packages: ## [1] geepack_1.3.3 ggpubr_0.4.0 car_3.0-13 carData_3.0-5 ## [5] minpack.lm_1.2-2 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] plotly_4.10.0 investr_1.4.2 readxl_1.4.0 nlme_3.1-159 ## [13] lmerTest_3.1-3 lme4_1.1-29 Matrix_1.5-1 emmeans_1.7.3 ## [17] fontawesome_0.2.2 widgetframe_0.3.1 htmlwidgets_1.5.4 kableExtra_1.3.4 ## [21] knitr_1.39 rmarkdown_2.14 ggplot2_3.3.6 devtools_2.4.1 ## [25] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [29] bookdown_0.28 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-1 minqa_1.2.4 colorspace_2.0-3 ggsignif_0.6.3 ## [5] ellipsis_0.3.2 rprojroot_2.0.3 estimability_1.3 fs_1.5.2 ## [9] rstudioapi_0.13 remotes_2.4.2 fansi_1.0.3 mvtnorm_1.1-3 ## [13] xml2_1.3.3 codetools_0.2-18 cachem_1.0.4 pkgload_1.2.4 ## [17] jsonlite_1.8.0 nloptr_2.0.1 broom_0.8.0 compiler_4.2.1 ## [21] httr_1.4.4 backports_1.4.1 assertthat_0.2.1 fastmap_1.1.0 ## [25] lazyeval_0.2.2 cli_3.3.0 htmltools_0.5.2 prettyunits_1.1.1 ## [29] tools_4.2.1 coda_0.19-4 gtable_0.3.0 glue_1.6.2 ## [33] dplyr_1.0.9 Rcpp_1.0.8.3 cellranger_1.1.0 jquerylib_0.1.4 ## [37] vctrs_0.4.1 svglite_2.1.0 crosstalk_1.2.0 xfun_0.30 ## [41] stringr_1.4.0 ps_1.7.0 brio_1.1.3 testthat_3.1.4 ## [45] rvest_1.0.2 lifecycle_1.0.1 rstatix_0.7.0 MASS_7.3-58 ## [49] zoo_1.8-10 scales_1.2.0 sandwich_3.0-1 yaml_2.3.5 ## [53] memoise_2.0.0 sass_0.4.1 stringi_1.7.6 highr_0.9 ## [57] desc_1.4.1 boot_1.3-28 pkgbuild_1.3.1 rlang_1.0.4 ## [61] pkgconfig_2.0.3 systemfonts_1.0.4 evaluate_0.15 lattice_0.20-45 ## [65] purrr_0.3.4 processx_3.5.3 tidyselect_1.1.2 R6_2.5.1 ## [69] generics_0.1.3 multcomp_1.4-19 DBI_1.1.2 pillar_1.8.1 ## [73] withr_2.5.0 survival_3.4-0 abind_1.4-5 tibble_3.1.8 ## [77] crayon_1.5.1 utf8_1.2.2 data.table_1.14.2 callr_3.7.0 ## [81] digest_0.6.29 webshot_0.5.3 xtable_1.8-4 tidyr_1.2.0 ## [85] numDeriv_2016.8-1.1 munsell_0.5.0 viridisLite_0.4.0 bslib_0.3.1 ## [89] sessioninfo_1.2.2 "],["hpl.html", "1.2 HPL", " 1.2 HPL 1.2.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;HPL_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs standards&quot;) std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates #std_raw$Abs.ave &lt;- std_raw$&quot;Abs Ave&quot; std_qc &lt;- read.csv(file.path(&quot;..&quot;,&quot;data&quot;,&quot;HPL_QC.csv&quot;),header=T) #standards QC std_qc$Abs.ave &lt;- apply(std_qc[,c(&quot;Abs.1&quot;,&quot;Abs.2&quot;)],1,mean,na.rm=T) #average replicates # samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;HPL_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs samples&quot;) #samples samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates samp_raw$Abs.ave[samp_raw$Abs.ave&lt;0] &lt;- 0 #restrict to &gt;=0 Standard concentration by plate Click for more details Concentration St 0 St 1.25 St 10 St 20 St 5 Assay 1 1 1 1 1 1 Assay 2 1 1 1 1 1 Assay 3 1 1 1 1 1 Assay 4 1 1 1 1 1 Assay 5 1 1 1 1 1 Assay 6 1 1 1 1 1 Assay 7 1 1 1 1 1 Assay 8 1 1 1 1 1 Assay 9 1 1 1 1 1 Assay 10 1 1 1 1 1 Assay 11 1 1 1 1 1 Assay 12 1 1 1 1 1 Assay 13 1 1 1 1 1 Assay 14 1 1 1 1 1 Assay 15 1 1 1 1 1 Assay 16 1 1 1 1 1 Assay 17 1 1 1 1 1 Assay 18 1 1 1 1 1 Assay 19 1 1 1 1 1 Assay 20 1 1 1 1 1 Assay 21 1 1 1 1 1 Assay 22 1 1 1 1 1 Assay 23 1 1 1 1 1 Assay 24 1 1 1 1 1 Assay 25 1 1 1 1 1 Assay 26 1 1 1 1 1 Assay 27 1 1 1 1 1 Assay 28 1 1 1 1 1 Assay 29 1 1 1 1 1 Assay 30 1 1 1 1 1 Assay 31 1 1 1 1 1 Assay 32 1 1 1 1 1 Assay 33 1 1 1 1 1 Assay 34 1 1 1 1 1 Assay 35 1 1 1 1 1 Assay 36 1 1 1 1 1 Assay 37 1 1 1 1 1 Assay 38 1 1 1 1 1 Assay 39 1 1 1 1 1 Assay 40 1 1 1 1 1 Assay 41 1 1 1 1 1 Assay 42 1 1 1 1 1 Assay 43 1 1 1 1 1 Assay 44 1 1 1 1 1 Assay 45 1 1 1 1 1 Assay 46 1 1 1 1 1 Assay 47 1 1 1 1 1 Assay 48 1 1 1 1 1 Assay 49 1 1 1 1 1 Assay 50 1 1 1 1 1 Assay 51 1 1 1 1 1 Assay 52 1 1 1 1 1 Assay 53 1 1 1 1 1 Assay 54 1 1 1 1 1 Assay 55 1 1 1 1 1 Assay 56 1 1 1 1 1 Assay 57 1 1 1 1 1 Samples by plate Click for more details Concentration SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 23 18 41 Assay 19 12 0 12 Assay 20 27 13 40 Assay 21 22 18 40 Assay 22 22 18 40 Assay 23 15 25 40 Assay 24 15 25 40 Assay 25 26 14 40 Assay 26 23 17 40 Assay 27 23 17 40 Assay 28 18 22 40 Assay 29 21 19 40 Assay 30 20 20 40 Assay 31 17 23 40 Assay 32 30 10 40 Assay 33 18 22 40 Assay 34 25 15 40 Assay 35 25 15 40 Assay 36 23 17 40 Assay 37 24 16 40 Assay 38 22 18 40 Assay 39 20 20 40 Assay 40 25 15 40 Assay 41 21 19 40 Assay 42 20 20 40 Assay 43 14 26 40 Assay 44 24 16 40 Assay 45 17 23 40 Assay 46 21 19 40 Assay 47 18 22 40 Assay 48 23 17 40 Assay 49 22 18 40 Assay 50 21 19 40 Assay 51 20 20 40 Assay 52 21 19 40 Assay 53 28 12 40 Assay 54 26 14 40 Assay 55 23 17 40 Assay 56 18 22 40 Assay 57 19 14 33 1.2.2 CV ## Inter-assay CV cv_dat &lt;- std_qc cv_dat$Group &lt;- as.factor(with(cv_dat,Standard.conc..pg.ml.)) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$Abs.Ave,x$Group,mean,na.tm=T))) cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) cv_intra &lt;- mean(samp_cv) Inter-assay CV = 20% from 57 assays. Intra-assay CV = 7.81% from 2243 sample measurements. 1.2.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate fit.4PL &lt;- function(x,a,b,g,d){return(d + ((a-d)/(1+((x/g)^b))))} #f1 &lt;- nls(Abs.ave ~ d + ((a-d)/(1+((Conc/g)^b))),data=std_ls[[1]],start=list(a=-1,b=1,g=5,d=2)) #std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit splines std_fit &lt;- lapply(1:length(std_ls),function(k){ #fit 4PL start_ls &lt;- list(a=floor(min(std_ls[[k]][,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)])), b=1,g=5, d=ceiling(max(std_ls[[k]][,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)]))) fit &lt;- NULL try(fit &lt;- nls(Abs.ave ~ fit.4PL(Conc,a,b,g,d),data=std_ls[[k]],start=start_ls),silent=T) if(is.null(fit)){fit &lt;- nlsLM(Abs.ave ~ fit.4PL(Conc,a,b,g,d),data=std_ls[[k]],start=start_ls)} return(fit)}) Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 57 1.2.4 Session info Results generated on: 2022-10-23 14:38:49 Click for more details sessionInfo() ## R version 4.2.1 (2022-06-23) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.1 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils datasets ## [9] methods base ## ## other attached packages: ## [1] geepack_1.3.3 ggpubr_0.4.0 car_3.0-13 carData_3.0-5 ## [5] minpack.lm_1.2-2 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] plotly_4.10.0 investr_1.4.2 readxl_1.4.0 nlme_3.1-159 ## [13] lmerTest_3.1-3 lme4_1.1-29 Matrix_1.5-1 emmeans_1.7.3 ## [17] fontawesome_0.2.2 widgetframe_0.3.1 htmlwidgets_1.5.4 kableExtra_1.3.4 ## [21] knitr_1.39 rmarkdown_2.14 ggplot2_3.3.6 devtools_2.4.1 ## [25] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [29] bookdown_0.28 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-1 minqa_1.2.4 colorspace_2.0-3 ggsignif_0.6.3 ## [5] ellipsis_0.3.2 rprojroot_2.0.3 estimability_1.3 fs_1.5.2 ## [9] rstudioapi_0.13 remotes_2.4.2 fansi_1.0.3 mvtnorm_1.1-3 ## [13] xml2_1.3.3 codetools_0.2-18 cachem_1.0.4 pkgload_1.2.4 ## [17] jsonlite_1.8.0 nloptr_2.0.1 broom_0.8.0 compiler_4.2.1 ## [21] httr_1.4.4 backports_1.4.1 assertthat_0.2.1 fastmap_1.1.0 ## [25] lazyeval_0.2.2 cli_3.3.0 htmltools_0.5.2 prettyunits_1.1.1 ## [29] tools_4.2.1 coda_0.19-4 gtable_0.3.0 glue_1.6.2 ## [33] dplyr_1.0.9 Rcpp_1.0.8.3 cellranger_1.1.0 jquerylib_0.1.4 ## [37] vctrs_0.4.1 svglite_2.1.0 crosstalk_1.2.0 xfun_0.30 ## [41] stringr_1.4.0 ps_1.7.0 brio_1.1.3 testthat_3.1.4 ## [45] rvest_1.0.2 lifecycle_1.0.1 rstatix_0.7.0 MASS_7.3-58 ## [49] zoo_1.8-10 scales_1.2.0 sandwich_3.0-1 yaml_2.3.5 ## [53] memoise_2.0.0 sass_0.4.1 stringi_1.7.6 highr_0.9 ## [57] desc_1.4.1 boot_1.3-28 pkgbuild_1.3.1 rlang_1.0.4 ## [61] pkgconfig_2.0.3 systemfonts_1.0.4 evaluate_0.15 lattice_0.20-45 ## [65] purrr_0.3.4 processx_3.5.3 tidyselect_1.1.2 R6_2.5.1 ## [69] generics_0.1.3 multcomp_1.4-19 DBI_1.1.2 pillar_1.8.1 ## [73] withr_2.5.0 survival_3.4-0 abind_1.4-5 tibble_3.1.8 ## [77] crayon_1.5.1 utf8_1.2.2 data.table_1.14.2 callr_3.7.0 ## [81] digest_0.6.29 webshot_0.5.3 xtable_1.8-4 tidyr_1.2.0 ## [85] numDeriv_2016.8-1.1 munsell_0.5.0 viridisLite_0.4.0 bslib_0.3.1 ## [89] sessioninfo_1.2.2 "],["gh2.html", "1.3 GH2", " 1.3 GH2 1.3.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;GH2_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs standards only&quot;) #standards std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates std_raw$Abs.ave[std_raw$Abs.ave&lt; 1e-10] &lt;- 0 ## samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;GH2_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs samples&quot;) #samples samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates Standard concentration by plate Click for more details Concentration 0 78.125 156.25 312.5 625 1250 2500 5000 Assay 1 1 1 1 1 1 1 1 1 Assay 2 1 1 1 1 1 1 1 1 Assay 3 1 1 1 1 1 1 1 1 Assay 4 1 1 1 1 1 1 1 1 Assay 5 1 1 1 1 1 1 1 1 Assay 6 1 1 1 1 1 1 1 1 Assay 7 1 1 1 1 1 1 1 1 Assay 8 1 1 1 1 1 1 1 1 Assay 9 1 1 1 1 1 1 1 1 Assay 10 1 1 1 1 1 1 1 1 Assay 11 1 1 1 1 1 1 1 1 Assay 12 1 1 1 1 1 1 1 1 Assay 13 1 1 1 1 1 1 1 1 Assay 14 1 1 1 1 1 1 1 1 Assay 15 1 1 1 1 1 1 1 1 Assay 16 1 1 1 1 1 1 1 1 Assay 17 1 1 1 1 1 1 1 1 Assay 18 1 1 1 1 1 1 1 1 Assay 19 1 1 1 1 1 1 1 1 Assay 20 1 1 1 1 1 1 1 1 Assay 21 1 1 1 1 1 1 1 1 Assay 22 1 1 1 1 1 1 1 1 Assay 23 1 1 1 1 1 1 1 1 Assay 24 1 1 1 1 1 1 1 1 Assay 25 1 1 1 1 1 1 1 1 Assay 26 1 1 1 1 1 1 1 1 Assay 27 1 1 1 1 1 1 1 1 Assay 28 1 1 1 1 1 1 1 1 Assay 29 1 1 1 1 1 1 1 1 Assay 30 1 1 1 1 1 1 1 1 Assay 31 1 1 1 1 1 1 1 1 Assay 32 1 1 1 1 1 1 1 1 Assay 33 1 1 1 1 1 1 1 1 Assay 34 1 1 1 1 1 1 1 1 Assay 35 1 1 1 1 1 1 1 1 Assay 36 1 1 1 1 1 1 1 1 Assay 37 1 1 1 1 1 1 1 1 Assay 38 1 1 1 1 1 1 1 1 Assay 39 1 1 1 1 1 1 1 1 Assay 40 1 1 1 1 1 1 1 1 Assay 41 1 1 1 1 1 1 1 1 Assay 42 1 1 1 1 1 1 1 1 Assay 43 1 1 1 1 1 1 1 1 Assay 44 1 1 1 1 1 1 1 1 Assay 45 1 1 1 1 1 1 1 1 Assay 46 1 1 1 1 1 1 1 1 Assay 47 1 1 1 1 1 1 1 1 Assay 48 1 1 1 1 1 1 1 1 Assay 49 1 1 1 1 1 1 1 1 Assay 50 1 1 1 1 1 1 1 1 Assay 51 1 1 1 1 1 1 1 1 Assay 52 1 1 1 1 1 1 1 1 Assay 53 1 1 1 1 1 1 1 1 Assay 54 1 1 1 1 1 1 1 1 Assay 55 1 1 1 1 1 1 1 1 Assay 56 1 1 1 1 1 1 1 1 Assay 57 1 1 1 1 1 1 1 1 Assay 58 1 1 1 1 1 1 1 1 Assay 59 1 1 1 1 1 1 1 1 Samples by plate Click for more details Concentration SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 0 16 16 Assay 19 38 2 40 Assay 20 22 18 40 Assay 21 20 20 40 Assay 22 27 13 40 Assay 23 22 18 40 Assay 24 22 18 40 Assay 25 15 25 40 Assay 26 15 25 40 Assay 27 26 14 40 Assay 28 23 17 40 Assay 29 23 17 40 Assay 30 18 22 40 Assay 31 21 19 40 Assay 32 20 20 40 Assay 33 17 23 40 Assay 34 30 10 40 Assay 35 18 22 40 Assay 36 25 15 40 Assay 37 25 15 40 Assay 38 23 17 40 Assay 39 24 16 40 Assay 40 22 18 40 Assay 41 20 20 40 Assay 42 25 15 40 Assay 43 21 19 40 Assay 44 20 20 40 Assay 45 14 26 40 Assay 46 24 16 40 Assay 47 17 23 40 Assay 48 21 19 40 Assay 49 18 22 40 Assay 50 23 17 40 Assay 51 22 18 40 Assay 52 21 19 40 Assay 53 20 20 40 Assay 54 21 19 40 Assay 55 28 12 40 Assay 56 26 14 40 Assay 57 23 17 40 Assay 58 18 22 40 Assay 59 19 14 33 1.3.2 CV ## Inter-assay CV cv_dat &lt;- std_raw[!std_raw$Assay%in%exc_plate,] cv_dat &lt;- std_raw cv_dat$Group &lt;- as.factor(with(cv_dat,get(conc_name))) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$&quot;Abs Ave&quot;,x$Group,mean,na.tm=T))) cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_gps[is.nan(cv_gps)] &lt;- 0 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) samp_cv[is.infinite(samp_cv)|samp_cv&lt;0] &lt;- NA cv_intra &lt;- mean(samp_cv,na.rm=T) Inter-assay CV = 15.24% from 59 assays. Intra-assay CV = 3.78% from 2326 sample measurements. Plate 22 (28-2-22) omitted due to invalid standard curve. 1.3.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit model Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 59 1.3.4 Session info Results generated on: 2022-10-23 14:44:52 Click for more details sessionInfo() ## R version 4.2.1 (2022-06-23) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.1 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils datasets ## [9] methods base ## ## other attached packages: ## [1] geepack_1.3.3 ggpubr_0.4.0 car_3.0-13 carData_3.0-5 ## [5] minpack.lm_1.2-2 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] plotly_4.10.0 investr_1.4.2 readxl_1.4.0 nlme_3.1-159 ## [13] lmerTest_3.1-3 lme4_1.1-29 Matrix_1.5-1 emmeans_1.7.3 ## [17] fontawesome_0.2.2 widgetframe_0.3.1 htmlwidgets_1.5.4 kableExtra_1.3.4 ## [21] knitr_1.39 rmarkdown_2.14 ggplot2_3.3.6 devtools_2.4.1 ## [25] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [29] bookdown_0.28 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-1 minqa_1.2.4 colorspace_2.0-3 ggsignif_0.6.3 ## [5] ellipsis_0.3.2 rprojroot_2.0.3 estimability_1.3 fs_1.5.2 ## [9] rstudioapi_0.13 remotes_2.4.2 fansi_1.0.3 mvtnorm_1.1-3 ## [13] xml2_1.3.3 codetools_0.2-18 cachem_1.0.4 pkgload_1.2.4 ## [17] jsonlite_1.8.0 nloptr_2.0.1 broom_0.8.0 compiler_4.2.1 ## [21] httr_1.4.4 backports_1.4.1 assertthat_0.2.1 fastmap_1.1.0 ## [25] lazyeval_0.2.2 cli_3.3.0 htmltools_0.5.2 prettyunits_1.1.1 ## [29] tools_4.2.1 coda_0.19-4 gtable_0.3.0 glue_1.6.2 ## [33] dplyr_1.0.9 Rcpp_1.0.8.3 cellranger_1.1.0 jquerylib_0.1.4 ## [37] vctrs_0.4.1 svglite_2.1.0 crosstalk_1.2.0 xfun_0.30 ## [41] stringr_1.4.0 ps_1.7.0 brio_1.1.3 testthat_3.1.4 ## [45] rvest_1.0.2 lifecycle_1.0.1 rstatix_0.7.0 MASS_7.3-58 ## [49] zoo_1.8-10 scales_1.2.0 sandwich_3.0-1 yaml_2.3.5 ## [53] memoise_2.0.0 sass_0.4.1 stringi_1.7.6 highr_0.9 ## [57] desc_1.4.1 boot_1.3-28 pkgbuild_1.3.1 rlang_1.0.4 ## [61] pkgconfig_2.0.3 systemfonts_1.0.4 evaluate_0.15 lattice_0.20-45 ## [65] purrr_0.3.4 processx_3.5.3 tidyselect_1.1.2 R6_2.5.1 ## [69] generics_0.1.3 multcomp_1.4-19 DBI_1.1.2 pillar_1.8.1 ## [73] withr_2.5.0 survival_3.4-0 abind_1.4-5 tibble_3.1.8 ## [77] crayon_1.5.1 utf8_1.2.2 data.table_1.14.2 callr_3.7.0 ## [81] digest_0.6.29 webshot_0.5.3 xtable_1.8-4 tidyr_1.2.0 ## [85] numDeriv_2016.8-1.1 munsell_0.5.0 viridisLite_0.4.0 bslib_0.3.1 ## [89] sessioninfo_1.2.2 "],["plate-effect.html", "2 Plate Effect", " 2 Plate Effect This section explores the Plate effect on hormone levels. Outcomes: Prolactin, hPL, GH2 (all outcomes log-transformed) Independent variables: Plate + Study, BMI, GA at sampling Model fitted: LME model       log(hormones) ~ Plate + Study + BMI + GA at sampling       Random intercepts for Study ID There is evidence of a Plate effect and it will be adjusted for (as a random effect) in the analyses. "],["prolactin-1.html", "2.1 Prolactin", " 2.1 Prolactin Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 199.6614114 1 &lt;0.0001 *** Assay.Prolactin 3242.3208728 56 &lt;0.0001 *** Study 0.3979199 1 0.5 ns BMI 20.3495997 1 &lt;0.0001 *** GA_samp 243.3457402 1 &lt;0.0001 *** 2.1.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 2.7029744 0.1912911 2699.475 14.1301596 &lt;0.0001 *** Assay.Prolactin1 0.1212429 0.1059894 2432.004 1.1439154 0.3 ns Assay.Prolactin2 -0.1778566 0.1164062 2644.382 -1.5278971 0.1 ns Assay.Prolactin3 0.0276810 0.1298168 2712.887 0.2132314 0.8 ns Assay.Prolactin4 0.6684824 0.1336746 2711.326 5.0008191 &lt;0.0001 *** Assay.Prolactin5 -2.7409455 0.1179895 2243.227 -23.2304135 &lt;0.0001 *** Assay.Prolactin6 0.6409714 0.1270956 2623.258 5.0432213 &lt;0.0001 *** Assay.Prolactin7 -0.1247035 0.1242381 2559.986 -1.0037455 0.3 ns Assay.Prolactin8 -0.0314570 0.1266782 2528.487 -0.2483226 0.8 ns Assay.Prolactin9 -0.0105195 0.1232303 2503.349 -0.0853644 0.9 ns Assay.Prolactin10 0.1684885 0.1273688 2629.966 1.3228395 0.2 ns Assay.Prolactin11 -0.1515119 0.1276569 2639.532 -1.1868683 0.2 ns Assay.Prolactin12 0.0851213 0.1324984 2702.232 0.6424328 0.5 ns Assay.Prolactin13 0.1201180 0.1242125 2510.966 0.9670367 0.3 ns Assay.Prolactin14 0.3695932 0.1201204 2438.010 3.0768569 0.002 ** Assay.Prolactin15 0.0363681 0.1199989 2386.639 0.3030706 0.8 ns Assay.Prolactin16 -0.1975498 0.1205968 2441.830 -1.6381007 0.1 ns Assay.Prolactin17 0.2384564 0.1186976 2352.060 2.0089402 0.04 * Assay.Prolactin18 -0.0096860 0.1191918 2397.717 -0.0812641 0.9 ns Assay.Prolactin19 -0.2778632 0.1327844 1795.499 -2.0925895 0.04 * Assay.Prolactin20 1.3669181 0.1168697 2375.834 11.6960822 &lt;0.0001 *** Assay.Prolactin21 0.2718832 0.1032018 2404.313 2.6344795 0.008 ** Assay.Prolactin22 -0.0736811 0.1147746 2665.747 -0.6419630 0.5 ns Assay.Prolactin23 0.6455956 0.1278116 2602.500 5.0511520 &lt;0.0001 *** Assay.Prolactin24 0.4746078 0.1293510 2658.915 3.6691463 0.0002 *** Assay.Prolactin25 0.2473075 0.1337241 2702.103 1.8493856 0.06 ns Assay.Prolactin26 -0.4426617 0.1308254 2707.453 -3.3836077 0.0007 *** Assay.Prolactin27 0.0793262 0.1311297 2706.948 0.6049449 0.5 ns Assay.Prolactin28 -0.0203714 0.1311472 2707.661 -0.1553322 0.9 ns Assay.Prolactin29 0.5754633 0.1308084 2698.094 4.3992841 &lt;0.0001 *** Assay.Prolactin30 0.1374354 0.1336598 2708.164 1.0282480 0.3 ns Assay.Prolactin31 0.7510784 0.1292684 2677.630 5.8102227 &lt;0.0001 *** Assay.Prolactin32 0.2829795 0.1298106 2693.328 2.1799416 0.03 * Assay.Prolactin33 0.2428402 0.1314159 2709.509 1.8478750 0.06 ns Assay.Prolactin34 -0.0032740 0.1281654 2623.648 -0.0255455 1.0 ns Assay.Prolactin35 0.0472200 0.1252984 2583.389 0.3768606 0.7 ns Assay.Prolactin36 -0.0709905 0.1336269 2702.845 -0.5312586 0.6 ns Assay.Prolactin37 -0.0405481 0.1316884 2710.312 -0.3079097 0.8 ns Assay.Prolactin38 0.2676561 0.1297542 2680.044 2.0627942 0.04 * Assay.Prolactin39 -0.1316890 0.1319063 2703.547 -0.9983530 0.3 ns Assay.Prolactin40 0.0215482 0.1290479 2701.244 0.1669784 0.9 ns Assay.Prolactin41 0.1862089 0.1337114 2703.047 1.3926173 0.2 ns Assay.Prolactin42 0.2115212 0.1270103 2640.916 1.6653858 0.10 ns Assay.Prolactin43 0.3240612 0.1332052 2712.017 2.4327969 0.02 * Assay.Prolactin44 0.0393886 0.1289286 2653.486 0.3055074 0.8 ns Assay.Prolactin45 0.1143590 0.1313129 2704.973 0.8708892 0.4 ns Assay.Prolactin46 0.0123467 0.1283756 2631.277 0.0961763 0.9 ns Assay.Prolactin47 -0.2727913 0.1324885 2711.041 -2.0589806 0.04 * Assay.Prolactin48 0.0159011 0.1312939 2699.744 0.1211110 0.9 ns Assay.Prolactin49 0.2076152 0.1333566 2710.643 1.5568427 0.1 ns Assay.Prolactin50 0.1781637 0.1281007 2644.721 1.3908103 0.2 ns Assay.Prolactin51 0.2760667 0.1314998 2708.357 2.0993700 0.04 * Assay.Prolactin52 -0.0623079 0.1305366 2691.379 -0.4773213 0.6 ns Assay.Prolactin54 0.2941893 0.1280834 2674.690 2.2968567 0.02 * Assay.Prolactin55 0.2087797 0.1280497 2674.447 1.6304584 0.1 ns Assay.Prolactin56 0.2677806 0.1346602 2684.107 1.9885659 0.05 ns Assay.Prolactin57 1.2168334 0.1401107 2695.656 8.6848014 &lt;0.0001 *** StudySTOP 0.0301960 0.0478687 2710.543 0.6308090 0.5 ns BMI -0.0089192 0.0019772 2628.076 -4.5110531 &lt;0.0001 *** GA_samp 0.1511183 0.0096874 2707.712 15.5995429 &lt;0.0001 *** 2.1.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Female Male Plate 1 (n=206) 0 (0.0) 206 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 206 (100.0) 0 (0.0) 114 (55.3) 92 (44.7) Plate 2 (n=86) 0 (0.0) 8 (9.3) 78 (90.7) 0 (0.0) 0 (0.0) 86 (100.0) 0 (0.0) 23 (26.7) 63 (73.3) Plate 3 (n=49) 0 (0.0) 5 (10.2) 44 (89.8) 0 (0.0) 0 (0.0) 49 (100.0) 0 (0.0) 20 (40.8) 29 (59.2) Plate 4 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 20 (46.5) 23 (53.5) Plate 5 (n=45) 0 (0.0) 5 (11.1) 40 (88.9) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 20 (44.4) 25 (55.6) Plate 6 (n=45) 0 (0.0) 5 (11.1) 40 (88.9) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 29 (64.4) 16 (35.6) Plate 7 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 1 (2.1) 14 (29.2) 33 (68.8) Plate 8 (n=40) 0 (0.0) 5 (12.5) 35 (87.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 9 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 21 (43.8) 27 (56.2) Plate 10 (n=44) 0 (0.0) 6 (13.6) 38 (86.4) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 11 (n=44) 0 (0.0) 4 (9.1) 40 (90.9) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 30 (68.2) 14 (31.8) Plate 12 (n=41) 0 (0.0) 4 (9.8) 37 (90.2) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 23 (56.1) 18 (43.9) Plate 13 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 23 (50.0) 23 (50.0) Plate 14 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 24 (48.0) 26 (52.0) Plate 15 (n=48) 0 (0.0) 4 (8.3) 44 (91.7) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 18 (37.5) 30 (62.5) Plate 16 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 1 (2.0) 23 (46.0) 26 (52.0) Plate 17 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 35 (70.0) 15 (30.0) Plate 18 (n=51) 0 (0.0) 27 (52.9) 24 (47.1) 0 (0.0) 17 (33.3) 34 (66.7) 0 (0.0) 27 (52.9) 24 (47.1) Plate 19 (n=24) 0 (0.0) 23 (95.8) 1 (4.2) 0 (0.0) 14 (58.3) 10 (41.7) 0 (0.0) 17 (70.8) 7 (29.2) Plate 20 (n=53) 0 (0.0) 15 (28.3) 38 (71.7) 0 (0.0) 0 (0.0) 53 (100.0) 0 (0.0) 19 (35.8) 34 (64.2) Plate 21 (n=130) 0 (0.0) 29 (22.3) 101 (77.7) 0 (0.0) 0 (0.0) 130 (100.0) 0 (0.0) 74 (56.9) 56 (43.1) Plate 22 (n=112) 0 (0.0) 44 (39.3) 68 (60.7) 0 (0.0) 0 (0.0) 112 (100.0) 0 (0.0) 40 (35.7) 72 (64.3) Plate 23 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 24 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 25 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 26 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 27 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 28 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 29 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 27 (67.5) 13 (32.5) Plate 30 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 24 (52.2) 22 (47.8) Plate 31 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 15 (37.5) 25 (62.5) Plate 32 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 33 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 34 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 35 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 36 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 37 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 38 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 39 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 40 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 26 (60.5) 17 (39.5) Plate 41 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 42 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 26 (60.5) 17 (39.5) Plate 43 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 44 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 45 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 46 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 16 (40.0) 23 (57.5) Plate 47 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 48 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 49 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 18 (39.1) 28 (60.9) Plate 50 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 27 (67.5) 13 (32.5) Plate 51 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 53 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 54 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 21 (48.8) 22 (51.2) Plate 55 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 15 (34.9) 28 (65.1) Plate 56 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 57 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 13 (39.4) 17 (51.5) Plate Total (n=2776) 0 (0.0) 1201 (43.3) 1575 (56.7) 0 (0.0) 31 (1.1) 2745 (98.9) 6 (0.2) 1353 (48.7) 1417 (51.0) "],["hpl-1.html", "2.2 HPL", " 2.2 HPL Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 89.04744 1 &lt;0.0001 *** Assay.HPL 738.44227 56 &lt;0.0001 *** Study 12.65682 1 0.0004 *** BMI 281.91493 1 &lt;0.0001 *** GA_samp 3001.83025 1 &lt;0.0001 *** 2.2.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 0.9918178 0.1051045 2533.466 9.4364953 &lt;0.0001 *** Assay.HPL1 0.0921711 0.0606656 2625.550 1.5193305 0.1 ns Assay.HPL2 0.2305057 0.0664929 2693.257 3.4666206 0.0005 *** Assay.HPL3 0.0324389 0.0715481 2652.110 0.4533860 0.7 ns Assay.HPL4 0.0768561 0.0735279 2622.508 1.0452644 0.3 ns Assay.HPL5 0.1891226 0.0678734 2497.891 2.7864029 0.005 ** Assay.HPL6 0.2354691 0.0716632 2692.436 3.2857748 0.001 ** Assay.HPL7 -0.0648563 0.0703540 2693.768 -0.9218564 0.4 ns Assay.HPL8 0.2909962 0.0722893 2693.732 4.0254407 &lt;0.0001 *** Assay.HPL9 0.0574963 0.0703906 2690.741 0.8168175 0.4 ns Assay.HPL10 0.0977651 0.0719626 2689.477 1.3585548 0.2 ns Assay.HPL11 0.1245978 0.0718970 2684.512 1.7330032 0.08 ns Assay.HPL12 0.2577725 0.0734449 2646.439 3.5097395 0.0005 *** Assay.HPL13 0.3311287 0.0709268 2692.442 4.6685975 &lt;0.0001 *** Assay.HPL14 0.1470589 0.0691096 2677.510 2.1279094 0.03 * Assay.HPL15 0.1324150 0.0693577 2673.205 1.9091614 0.06 ns Assay.HPL16 0.2984871 0.0693148 2677.391 4.3062555 &lt;0.0001 *** Assay.HPL17 -0.0358695 0.0686740 2651.758 -0.5223152 0.6 ns Assay.HPL18 0.0544943 0.0644116 2626.621 0.8460317 0.4 ns Assay.HPL19 0.2686786 0.0990292 2143.426 2.7131257 0.007 ** Assay.HPL20 -0.2121390 0.0631995 2582.169 -3.3566574 0.0008 *** Assay.HPL21 -0.1312074 0.0586272 2671.829 -2.2379947 0.03 * Assay.HPL22 -0.0543114 0.0643441 2617.563 -0.8440767 0.4 ns Assay.HPL23 0.7437893 0.0723670 2692.466 10.2780225 &lt;0.0001 *** Assay.HPL24 0.0334058 0.0726732 2681.475 0.4596709 0.6 ns Assay.HPL25 0.6560953 0.0738694 2604.776 8.8818215 &lt;0.0001 *** Assay.HPL26 0.0799927 0.0740999 2660.203 1.0795247 0.3 ns Assay.HPL27 0.1095021 0.0728614 2653.404 1.5028829 0.1 ns Assay.HPL28 0.0196264 0.0728741 2653.324 0.2693193 0.8 ns Assay.HPL29 0.1805839 0.0728864 2659.331 2.4776074 0.01 * Assay.HPL30 -0.0553226 0.0734201 2586.721 -0.7535075 0.5 ns Assay.HPL31 0.1580722 0.0724168 2677.426 2.1828106 0.03 * Assay.HPL32 0.3118338 0.0724805 2669.127 4.3023152 &lt;0.0001 *** Assay.HPL33 0.1090237 0.0729327 2649.276 1.4948532 0.1 ns Assay.HPL34 0.1072198 0.0723386 2688.378 1.4821926 0.1 ns Assay.HPL35 -0.1816678 0.0711618 2693.932 -2.5528833 0.01 * Assay.HPL36 0.0570492 0.0733728 2604.436 0.7775243 0.4 ns Assay.HPL37 0.1132805 0.0730191 2643.142 1.5513835 0.1 ns Assay.HPL38 0.3106045 0.0726500 2674.769 4.2753557 &lt;0.0001 *** Assay.HPL39 0.1459116 0.0729377 2653.643 2.0004958 0.05 ns Assay.HPL40 0.0566781 0.0718851 2661.086 0.7884536 0.4 ns Assay.HPL41 0.1994536 0.0734263 2605.205 2.7163791 0.007 ** Assay.HPL42 -0.0677224 0.0715788 2687.222 -0.9461240 0.3 ns Assay.HPL43 0.2401154 0.0736095 2602.954 3.2620161 0.001 ** Assay.HPL44 0.1141842 0.0724814 2682.267 1.5753580 0.1 ns Assay.HPL45 0.1800752 0.0730007 2653.527 2.4667617 0.01 * Assay.HPL46 0.1009820 0.0725317 2681.930 1.3922466 0.2 ns Assay.HPL47 0.2556517 0.0734007 2635.412 3.4829610 0.0005 *** Assay.HPL48 0.1066926 0.0730994 2653.596 1.4595558 0.1 ns Assay.HPL49 -0.0254198 0.0733466 2592.945 -0.3465716 0.7 ns Assay.HPL50 0.1892451 0.0721640 2687.798 2.6224304 0.009 ** Assay.HPL51 0.1394344 0.0731642 2634.829 1.9057741 0.06 ns Assay.HPL52 0.1119099 0.0728747 2665.948 1.5356468 0.1 ns Assay.HPL54 0.3039624 0.0717702 2675.625 4.2352185 &lt;0.0001 *** Assay.HPL55 0.2546358 0.0717667 2676.413 3.5481031 0.0004 *** Assay.HPL56 0.0147899 0.0736068 2584.311 0.2009311 0.8 ns Assay.HPL57 0.0507690 0.0768536 2607.965 0.6605935 0.5 ns StudySTOP 0.0926816 0.0260514 2576.298 3.5576422 0.0004 *** BMI -0.0178690 0.0010642 2367.090 -16.7903227 &lt;0.0001 *** GA_samp 0.2925421 0.0053394 2549.329 54.7889611 &lt;0.0001 *** 2.2.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Female Male Plate 1 (n=106) 0 (0.0) 106 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 106 (100.0) 0 (0.0) 60 (56.6) 46 (43.4) Plate 2 (n=86) 0 (0.0) 8 (9.3) 78 (90.7) 0 (0.0) 0 (0.0) 86 (100.0) 0 (0.0) 23 (26.7) 63 (73.3) Plate 3 (n=48) 0 (0.0) 5 (10.4) 43 (89.6) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 20 (41.7) 28 (58.3) Plate 4 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 20 (46.5) 23 (53.5) Plate 5 (n=81) 0 (0.0) 8 (9.9) 73 (90.1) 0 (0.0) 0 (0.0) 81 (100.0) 0 (0.0) 34 (42.0) 47 (58.0) Plate 6 (n=44) 0 (0.0) 5 (11.4) 39 (88.6) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 29 (65.9) 15 (34.1) Plate 7 (n=47) 0 (0.0) 6 (12.8) 41 (87.2) 0 (0.0) 0 (0.0) 47 (100.0) 1 (2.1) 15 (31.9) 31 (66.0) Plate 8 (n=41) 0 (0.0) 6 (14.6) 35 (85.4) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 22 (53.7) 19 (46.3) Plate 9 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 21 (43.8) 27 (56.2) Plate 10 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 23 (53.5) 20 (46.5) Plate 11 (n=44) 0 (0.0) 4 (9.1) 40 (90.9) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 30 (68.2) 14 (31.8) Plate 12 (n=42) 0 (0.0) 5 (11.9) 37 (88.1) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 23 (54.8) 19 (45.2) Plate 13 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 23 (50.0) 23 (50.0) Plate 14 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 24 (48.0) 26 (52.0) Plate 15 (n=49) 0 (0.0) 5 (10.2) 44 (89.8) 0 (0.0) 0 (0.0) 49 (100.0) 0 (0.0) 19 (38.8) 30 (61.2) Plate 16 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 1 (2.0) 23 (46.0) 26 (52.0) Plate 17 (n=51) 0 (0.0) 4 (7.8) 47 (92.2) 0 (0.0) 0 (0.0) 51 (100.0) 0 (0.0) 36 (70.6) 15 (29.4) Plate 18 (n=71) 0 (0.0) 46 (64.8) 25 (35.2) 0 (0.0) 14 (19.7) 57 (80.3) 0 (0.0) 46 (64.8) 25 (35.2) Plate 19 (n=13) 0 (0.0) 13 (100.0) 0 (0.0) 0 (0.0) 13 (100.0) 0 (0.0) 0 (0.0) 9 (69.2) 4 (30.8) Plate 20 (n=72) 0 (0.0) 50 (69.4) 22 (30.6) 0 (0.0) 0 (0.0) 72 (100.0) 0 (0.0) 30 (41.7) 42 (58.3) Plate 21 (n=162) 0 (0.0) 78 (48.1) 84 (51.9) 0 (0.0) 0 (0.0) 162 (100.0) 0 (0.0) 88 (54.3) 74 (45.7) Plate 22 (n=112) 0 (0.0) 44 (39.3) 68 (60.7) 0 (0.0) 0 (0.0) 112 (100.0) 0 (0.0) 40 (35.7) 72 (64.3) Plate 23 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 24 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 25 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 26 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 27 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 28 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 29 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 27 (67.5) 13 (32.5) Plate 30 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 24 (52.2) 22 (47.8) Plate 31 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 15 (37.5) 25 (62.5) Plate 32 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 33 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 34 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 35 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 36 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 37 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 38 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 39 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 40 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 26 (60.5) 17 (39.5) Plate 41 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 42 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 26 (60.5) 17 (39.5) Plate 43 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 44 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 45 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 46 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 16 (40.0) 23 (57.5) Plate 47 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 48 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 49 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 18 (39.1) 28 (60.9) Plate 50 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 27 (67.5) 13 (32.5) Plate 51 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 53 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 54 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 21 (48.8) 22 (51.2) Plate 55 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 15 (34.9) 28 (65.1) Plate 56 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 57 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 13 (39.4) 17 (51.5) Plate Total (n=2772) 0 (0.0) 1197 (43.2) 1575 (56.8) 0 (0.0) 27 (1.0) 2745 (99.0) 6 (0.2) 1351 (48.7) 1415 (51.0) "],["gh2-1.html", "2.3 GH2", " 2.3 GH2 Plate 22 omitted due to invalid standard curve. Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 1136.934469 1 &lt;0.0001 *** Assay.GH2 228.193477 57 &lt;0.0001 *** Study 4.354346 1 0.04 * BMI 109.759740 1 &lt;0.0001 *** GA_samp 1154.337251 1 &lt;0.0001 *** 2.3.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 4.8224805 0.1430220 2582.495 33.7184589 &lt;0.0001 *** Assay.GH21 -0.0791846 0.0837897 2525.783 -0.9450398 0.3 ns Assay.GH22 0.1754518 0.0903899 2634.047 1.9410538 0.05 ns Assay.GH23 0.2868065 0.0986797 2611.877 2.9064371 0.004 ** Assay.GH24 -0.0048460 0.1050752 2438.502 -0.0461189 1.0 ns Assay.GH25 0.1980649 0.0943090 2610.141 2.1001708 0.04 * Assay.GH26 0.2803362 0.0976512 2634.714 2.8707907 0.004 ** Assay.GH27 0.0989152 0.0950059 2602.155 1.0411480 0.3 ns Assay.GH28 -0.0810342 0.0973165 2610.800 -0.8326878 0.4 ns Assay.GH29 0.0634070 0.0945526 2587.036 0.6706003 0.5 ns Assay.GH210 -0.1162066 0.0994339 2636.863 -1.1686820 0.2 ns Assay.GH211 -0.1601729 0.0975028 2635.430 -1.6427510 0.1 ns Assay.GH212 -0.0603924 0.1011241 2609.689 -0.5972102 0.6 ns Assay.GH213 0.1146427 0.0958679 2610.351 1.1958399 0.2 ns Assay.GH214 0.2642879 0.0932988 2565.500 2.8327037 0.005 ** Assay.GH215 0.1451245 0.0937086 2575.083 1.5486792 0.1 ns Assay.GH216 0.1255673 0.0931174 2556.264 1.3484842 0.2 ns Assay.GH217 0.3126568 0.0924637 2539.728 3.3814022 0.0007 *** Assay.GH218 0.3073315 0.1247045 2637.952 2.4644781 0.01 * Assay.GH219 0.0798359 0.0908369 2308.265 0.8788927 0.4 ns Assay.GH220 -0.0715429 0.0892041 2582.031 -0.8020143 0.4 ns Assay.GH221 0.1159995 0.0818348 2553.780 1.4174827 0.2 ns Assay.GH223 0.1156668 0.0814530 2562.999 1.4200437 0.2 ns Assay.GH224 -0.0715429 0.0892041 2582.031 -0.8020143 0.4 ns Assay.GH225 0.3472763 0.0978500 2627.980 3.5490665 0.0004 *** Assay.GH226 0.0567823 0.0990734 2639.989 0.5731334 0.6 ns Assay.GH227 0.0386721 0.1019304 2567.883 0.3793975 0.7 ns Assay.GH228 0.0803651 0.1012572 2594.081 0.7936724 0.4 ns Assay.GH229 0.0381013 0.1005929 2630.209 0.3787673 0.7 ns Assay.GH230 -0.1241027 0.1001082 2626.523 -1.2396856 0.2 ns Assay.GH231 -0.0019059 0.0999963 2631.126 -0.0190602 1.0 ns Assay.GH232 0.2835346 0.1018710 2571.564 2.7832699 0.005 ** Assay.GH233 -0.0613889 0.1005350 2618.603 -0.6106217 0.5 ns Assay.GH234 0.0560195 0.1009235 2612.151 0.5550687 0.6 ns Assay.GH235 -0.0076636 0.0989012 2638.810 -0.0774879 0.9 ns Assay.GH236 0.2298988 0.0997097 2639.804 2.3056812 0.02 * Assay.GH237 0.1735538 0.0961543 2619.356 1.8049509 0.07 ns Assay.GH238 -0.0645211 0.1017993 2566.048 -0.6338064 0.5 ns Assay.GH239 -0.0706903 0.1007704 2613.399 -0.7014987 0.5 ns Assay.GH240 0.0480588 0.0993875 2638.649 0.4835499 0.6 ns Assay.GH241 -0.0688661 0.0987487 2639.995 -0.6973873 0.5 ns Assay.GH242 -0.0583906 0.0987406 2633.463 -0.5913532 0.6 ns Assay.GH243 -0.1163097 0.1017559 2568.225 -1.1430258 0.3 ns Assay.GH244 0.1624526 0.0972865 2637.584 1.6698366 0.10 ns Assay.GH245 0.2267436 0.1012045 2596.830 2.2404505 0.03 * Assay.GH246 -0.0126099 0.0989556 2639.895 -0.1274296 0.9 ns Assay.GH247 -0.0684904 0.1001997 2628.589 -0.6835389 0.5 ns Assay.GH248 0.0704647 0.0985888 2636.871 0.7147330 0.5 ns Assay.GH249 0.1156909 0.1011720 2614.499 1.1435066 0.3 ns Assay.GH250 0.0953516 0.1005831 2629.596 0.9479887 0.3 ns Assay.GH251 0.1946719 0.1015888 2587.761 1.9162727 0.06 ns Assay.GH252 -0.0969296 0.0997871 2634.971 -0.9713637 0.3 ns Assay.GH254 -0.0028326 0.0997500 2635.834 -0.0283965 1.0 ns Assay.GH255 -0.0164475 0.0987908 2638.169 -0.1664878 0.9 ns Assay.GH256 0.0426585 0.0980730 2639.719 0.4349666 0.7 ns Assay.GH257 0.2281709 0.0978808 2639.943 2.3311089 0.02 * Assay.GH258 0.0975326 0.1022645 2535.274 0.9537292 0.3 ns Assay.GH259 0.1453408 0.1081603 2495.146 1.3437527 0.2 ns StudySTOP -0.0754529 0.0361588 2632.840 -2.0867070 0.04 * BMI -0.0155536 0.0014846 2542.218 -10.4766283 &lt;0.0001 *** GA_samp 0.2526113 0.0074351 2610.748 33.9755390 &lt;0.0001 *** 2.3.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Female Male Plate 1 (n=91) 0 (0.0) 91 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 91 (100.0) 0 (0.0) 53 (58.2) 38 (41.8) Plate 2 (n=70) 0 (0.0) 8 (11.4) 62 (88.6) 0 (0.0) 0 (0.0) 70 (100.0) 0 (0.0) 21 (30.0) 49 (70.0) Plate 3 (n=47) 0 (0.0) 5 (10.6) 42 (89.4) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 18 (38.3) 29 (61.7) Plate 4 (n=42) 0 (0.0) 5 (11.9) 37 (88.1) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 19 (45.2) 23 (54.8) Plate 5 (n=79) 0 (0.0) 8 (10.1) 71 (89.9) 0 (0.0) 0 (0.0) 79 (100.0) 0 (0.0) 32 (40.5) 47 (59.5) Plate 6 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 27 (62.8) 16 (37.2) Plate 7 (n=45) 0 (0.0) 6 (13.3) 39 (86.7) 0 (0.0) 0 (0.0) 45 (100.0) 1 (2.2) 15 (33.3) 29 (64.4) Plate 8 (n=41) 0 (0.0) 6 (14.6) 35 (85.4) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 22 (53.7) 19 (46.3) Plate 9 (n=46) 0 (0.0) 8 (17.4) 38 (82.6) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 21 (45.7) 25 (54.3) Plate 10 (n=44) 0 (0.0) 6 (13.6) 38 (86.4) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 11 (n=43) 0 (0.0) 4 (9.3) 39 (90.7) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 29 (67.4) 14 (32.6) Plate 12 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 24 (55.8) 19 (44.2) Plate 13 (n=45) 0 (0.0) 4 (8.9) 41 (91.1) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 21 (46.7) 24 (53.3) Plate 14 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 24 (52.2) 22 (47.8) Plate 15 (n=47) 0 (0.0) 5 (10.6) 42 (89.4) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 19 (40.4) 28 (59.6) Plate 16 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 1 (2.2) 21 (45.7) 24 (52.2) Plate 17 (n=47) 0 (0.0) 4 (8.5) 43 (91.5) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 32 (68.1) 15 (31.9) Plate 18 (n=20) 0 (0.0) 0 (0.0) 20 (100.0) 0 (0.0) 0 (0.0) 20 (100.0) 0 (0.0) 9 (45.0) 11 (55.0) Plate 19 (n=48) 0 (0.0) 43 (89.6) 5 (10.4) 0 (0.0) 35 (72.9) 13 (27.1) 0 (0.0) 27 (56.2) 21 (43.8) Plate 20 (n=64) 0 (0.0) 22 (34.4) 42 (65.6) 0 (0.0) 0 (0.0) 64 (100.0) 0 (0.0) 21 (32.8) 43 (67.2) Plate 21 (n=109) 0 (0.0) 55 (50.5) 54 (49.5) 0 (0.0) 0 (0.0) 109 (100.0) 0 (0.0) 65 (59.6) 44 (40.4) Plate 22 (n=72) 0 (0.0) 50 (69.4) 22 (30.6) 0 (0.0) 0 (0.0) 72 (100.0) 0 (0.0) 33 (45.8) 39 (54.2) Plate 23 (n=115) 0 (0.0) 61 (53.0) 54 (47.0) 0 (0.0) 0 (0.0) 115 (100.0) 0 (0.0) 65 (56.5) 50 (43.5) Plate 24 (n=64) 0 (0.0) 22 (34.4) 42 (65.6) 0 (0.0) 0 (0.0) 64 (100.0) 0 (0.0) 21 (32.8) 43 (67.2) Plate 25 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 26 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 27 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 28 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 29 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 30 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 31 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 27 (67.5) 13 (32.5) Plate 32 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 24 (52.2) 22 (47.8) Plate 33 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 15 (37.5) 25 (62.5) Plate 34 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 35 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 36 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 37 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 38 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 39 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 40 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 41 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 42 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 26 (60.5) 17 (39.5) Plate 43 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 44 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 26 (60.5) 17 (39.5) Plate 45 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 46 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 47 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 48 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 16 (40.0) 23 (57.5) Plate 49 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 50 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 16 (40.0) 24 (60.0) Plate 51 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 18 (39.1) 28 (60.9) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 27 (67.5) 13 (32.5) Plate 53 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 54 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 55 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 56 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 21 (48.8) 22 (51.2) Plate 57 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 15 (34.9) 28 (65.1) Plate 58 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 59 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 13 (39.4) 17 (51.5) Plate Total (n=2780) 0 (0.0) 1205 (43.3) 1575 (56.7) 0 (0.0) 35 (1.3) 2745 (98.7) 6 (0.2) 1356 (48.8) 1418 (51.0) "],["session-info-3.html", "2.4 Session info", " 2.4 Session info Results generated on: 2022-10-23 14:45:14 Click for more details sessionInfo() ## R version 4.2.1 (2022-06-23) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.1 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils datasets ## [9] methods base ## ## other attached packages: ## [1] geepack_1.3.3 ggpubr_0.4.0 car_3.0-13 carData_3.0-5 ## [5] minpack.lm_1.2-2 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] plotly_4.10.0 investr_1.4.2 readxl_1.4.0 nlme_3.1-159 ## [13] lmerTest_3.1-3 lme4_1.1-29 Matrix_1.5-1 emmeans_1.7.3 ## [17] fontawesome_0.2.2 widgetframe_0.3.1 htmlwidgets_1.5.4 kableExtra_1.3.4 ## [21] knitr_1.39 rmarkdown_2.14 ggplot2_3.3.6 devtools_2.4.1 ## [25] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [29] bookdown_0.28 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-1 minqa_1.2.4 colorspace_2.0-3 ggsignif_0.6.3 ## [5] ellipsis_0.3.2 rprojroot_2.0.3 estimability_1.3 fs_1.5.2 ## [9] rstudioapi_0.13 farver_2.1.0 remotes_2.4.2 fansi_1.0.3 ## [13] mvtnorm_1.1-3 xml2_1.3.3 codetools_0.2-18 cachem_1.0.4 ## [17] pkgload_1.2.4 jsonlite_1.8.0 nloptr_2.0.1 broom_0.8.0 ## [21] compiler_4.2.1 httr_1.4.4 backports_1.4.1 assertthat_0.2.1 ## [25] fastmap_1.1.0 lazyeval_0.2.2 cli_3.3.0 htmltools_0.5.2 ## [29] prettyunits_1.1.1 tools_4.2.1 coda_0.19-4 gtable_0.3.0 ## [33] glue_1.6.2 dplyr_1.0.9 Rcpp_1.0.8.3 cellranger_1.1.0 ## [37] jquerylib_0.1.4 vctrs_0.4.1 svglite_2.1.0 crosstalk_1.2.0 ## [41] xfun_0.30 stringr_1.4.0 ps_1.7.0 brio_1.1.3 ## [45] testthat_3.1.4 rvest_1.0.2 lifecycle_1.0.1 rstatix_0.7.0 ## [49] MASS_7.3-58 zoo_1.8-10 scales_1.2.0 sandwich_3.0-1 ## [53] yaml_2.3.5 memoise_2.0.0 sass_0.4.1 stringi_1.7.6 ## [57] highr_0.9 desc_1.4.1 boot_1.3-28 pkgbuild_1.3.1 ## [61] rlang_1.0.4 pkgconfig_2.0.3 systemfonts_1.0.4 evaluate_0.15 ## [65] lattice_0.20-45 purrr_0.3.4 labeling_0.4.2 processx_3.5.3 ## [69] tidyselect_1.1.2 R6_2.5.1 generics_0.1.3 multcomp_1.4-19 ## [73] DBI_1.1.2 pillar_1.8.1 withr_2.5.0 survival_3.4-0 ## [77] abind_1.4-5 tibble_3.1.8 crayon_1.5.1 utf8_1.2.2 ## [81] data.table_1.14.2 callr_3.7.0 digest_0.6.29 webshot_0.5.3 ## [85] xtable_1.8-4 tidyr_1.2.0 numDeriv_2016.8-1.1 munsell_0.5.0 ## [89] viridisLite_0.4.0 bslib_0.3.1 sessioninfo_1.2.2 "],["part-association-with-factors.html", "(PART*) Association with Factors", " (PART*) Association with Factors "],["descriptives.html", "3 Descriptives", " 3 Descriptives Descriptives on raw data. Tables in this page are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value PRL (pg/ml): Mean (SD) 187.2 (190.0) 108.8 (129.7) 141.3 (162.2) &lt;0.0001 hPL (mg/l): Mean (SD) 183.2 (54.4) 73.5 (49.0) 119.0 (74.5) &lt;0.0001 GH2 (pg/ml): Mean (SD) 4731.8 (2805.3) 1922.1 (1675.7) 3084.2 (2610.4) &lt;0.0001 "],["by-study.html", "3.1 By Study", " 3.1 By Study 3.1.1 Demographics Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 26.0 (22.0-29.0) 25.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.02 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1140 (97.9) 1252 (96.3) 2392 (97.1) &gt;=35 24 (2.1) 48 (3.7) 72 (2.9) Maternal BMI: Median (IQ range) 25.6 (22.2-30.8) 26.3 (22.7-31.8) 25.9 (22.5-31.3) 0.006 Maternal BMI (category): N(%) 0.02 Missing 0 (0.0) 1 (0.1) 1 (0.0) &lt;20 122 (10.5) 95 (7.3) 217 (8.8) &gt;=20 to &lt;25 398 (34.2) 442 (34.0) 840 (34.1) &gt;=25 to &lt;30 322 (27.7) 361 (27.8) 683 (27.7) &gt;=30 to &lt;40 267 (22.9) 315 (24.2) 582 (23.6) &gt;=40 55 (4.7) 86 (6.6) 141 (5.7) SEI: Median (IQ range) 25.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-34.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Aboriginal 23 (2.0) 24 (1.8) 47 (1.9) African 4 (0.3) 23 (1.8) 27 (1.1) Caucasian 1067 (91.7) 1073 (82.5) 2140 (86.9) China and Japan 0 (0.0) 16 (1.2) 16 (0.6) Hispanic 0 (0.0) 5 (0.4) 5 (0.2) Indian 4 (0.3) 60 (4.6) 64 (2.6) Maori 5 (0.4) 2 (0.2) 7 (0.3) Middle-eastern 6 (0.5) 25 (1.9) 31 (1.3) Other 12 (1.0) 2 (0.2) 14 (0.6) Pacific Islander 1 (0.1) 4 (0.3) 5 (0.2) South East and Far East 42 (3.6) 66 (5.1) 108 (4.4) Smoking: N(%) 0.63 Missing 0 (0.0) 510 (39.2) 510 (20.7) No 886 (76.1) 593 (45.6) 1479 (60.0) Yes 278 (23.9) 197 (15.2) 475 (19.3) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 152 (11.7) 152 (6.2) None 251 (21.6) 97 (7.5) 348 (14.1) &lt;800 611 (52.5) 271 (20.8) 882 (35.8) &gt;=800 302 (25.9) 780 (60.0) 1082 (43.9) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 152 (11.7) 152 (6.2) None 251 (21.6) 97 (7.5) 348 (14.1) &lt;=400 116 (10.0) 15 (1.2) 131 (5.3) &gt;400 to &lt;800 495 (42.5) 256 (19.7) 751 (30.5) &gt;=800 302 (25.9) 780 (60.0) 1082 (43.9) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 16 (1.2) 16 (0.6) &lt;1-3x/month 117 (10.1) 95 (7.3) 212 (8.6) 1-6x/week 454 (39.0) 388 (29.8) 842 (34.2) &gt;=1-&lt;3x/day 410 (35.2) 639 (49.2) 1049 (42.6) &gt;=3x/day 183 (15.7) 162 (12.5) 345 (14.0) Leafy vege (1st trim): N(%) 0.004 Missing 0 (0.0) 17 (1.3) 17 (0.7) &lt;1-3x/month 113 (9.7) 143 (11.0) 256 (10.4) 1-2x/week 265 (22.8) 291 (22.4) 556 (22.6) 3-6x/week 474 (40.7) 440 (33.8) 914 (37.1) &gt;=1x/day 312 (26.8) 409 (31.5) 721 (29.3) Fast food (1st trim): N(%) &lt;0.0001 Missing 233 (20.0) 176 (13.5) 409 (16.6) Never 16 (1.4) 58 (4.5) 74 (3.0) &gt;0-&lt;2x/week 109 (9.4) 216 (16.6) 325 (13.2) &gt;=2-&lt;4x/week 479 (41.2) 501 (38.5) 980 (39.8) &gt;=4x/week 327 (28.1) 349 (26.8) 676 (27.4) Vigorous exercise: N(%) 0.45 Missing 3 (0.3) 12 (0.9) 15 (0.6) 2-3/wk 87 (7.5) 119 (9.2) 206 (8.4) 4-6/wk 14 (1.2) 22 (1.7) 36 (1.5) Daily 12 (1.0) 18 (1.4) 30 (1.2) More than once a day 3 (0.3) 2 (0.2) 5 (0.2) Never 755 (64.9) 809 (62.2) 1564 (63.5) Once a week 290 (24.9) 318 (24.5) 608 (24.7) Moderate exercise: N(%) 0.46 Missing 3 (0.3) 14 (1.1) 17 (0.7) 2-3/wk 231 (19.8) 286 (22.0) 517 (21.0) 4-6/wk 53 (4.6) 64 (4.9) 117 (4.7) Daily 67 (5.8) 71 (5.5) 138 (5.6) More than once a day 8 (0.7) 15 (1.2) 23 (0.9) Never 500 (43.0) 516 (39.7) 1016 (41.2) Once a week 302 (25.9) 334 (25.7) 636 (25.8) Recreational walking: N(%) 0.08 Missing 3 (0.3) 14 (1.1) 17 (0.7) 2-3/wk 309 (26.5) 313 (24.1) 622 (25.2) 4-6/wk 84 (7.2) 95 (7.3) 179 (7.3) Daily 113 (9.7) 126 (9.7) 239 (9.7) More than once a day 26 (2.2) 16 (1.2) 42 (1.7) Never 266 (22.9) 272 (20.9) 538 (21.8) Once a week 363 (31.2) 464 (35.7) 827 (33.6) Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.8) 40.5 (36.3-45.3) 39.1 (33.3-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.2) &lt;0.0001 B12 concentration (pM): Median (IQ range) 245.5 (195.0-309.0) 278.0 (218.0-356.0) 262.0 (206.0-337.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 143.1 (102.9-208.5) 152.6 (114.8-222.1) 148.8 (108.7-217.2) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.5 (24.1) 69.3 (25.5) 64.9 (25.2) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 603.3 (437.9-895.6) 628.1 (461.3-920.6) 620.6 (448.9-901.5) 0.05 Vitamin D: Median (IQ range) 57.6 (42.1-76.0) 61.0 (46.0-77.0) 59.6 (44.0-76.2) 0.009 UIC (ug/L): Median (IQ range) 107.2 (66.4-163.3) 202.5 (125.5-331.4) 159.3 (92.8-269.0) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.5) 0.14 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.4) 1.0 (0.7-1.4) 0.08 Haemoglobin (g/L): Mean (SD) 129.2 (9.3) 131.5 (9.6) 130.4 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 3.1.2 MetS Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value MetS: N(%) &lt;0.0001 Missing 11 (0.9) 92 (7.1) 103 (4.2) No 952 (81.8) 1100 (84.6) 2052 (83.3) Yes 201 (17.3) 108 (8.3) 309 (12.5) MetS: number of criteria: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-98.0) 82.0 (75.0-94.0) 85.0 (76.5-96.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.6 (0.8) 5.0 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.8) 1.1 (0.9-1.4) 1.2 (1.0-1.6) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.5 (0.8) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.1 (0.8) 2.5 (0.7) 2.7 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 109.3 (10.3) 115.9 (10.6) 112.7 (11.0) &lt;0.0001 diastolic BP (mmHg): Mean (SD) 64.5 (8.0) 70.7 (8.7) 67.7 (9.0) &lt;0.0001 Mean arterial pressure (mmHg): Mean (SD) 79.4 (7.8) 85.8 (8.4) 82.7 (8.7) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 3 (0.3) 28 (2.2) 31 (1.3) &lt;80 cm 307 (26.4) 528 (40.6) 835 (33.9) &gt;=80 cm 854 (73.4) 744 (57.2) 1598 (64.9) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 15 (1.2) 15 (0.6) &lt;1.7 mmol/L 828 (71.1) 1108 (85.2) 1936 (78.6) &gt;=1.7 mmol/L 336 (28.9) 177 (13.6) 513 (20.8) MetS criteria: HDL: N(%) 0.001 Missing 0 (0.0) 15 (1.2) 15 (0.6) &lt;1.3 mmol/L 128 (11.0) 200 (15.4) 328 (13.3) &gt;=1.3 mmol/L 1036 (89.0) 1085 (83.5) 2121 (86.1) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 10 (0.9) 15 (1.2) 25 (1.0) &lt;5.6 mmol/L 661 (56.8) 1184 (91.1) 1845 (74.9) &gt;=5.6 mmol/L 493 (42.4) 101 (7.8) 594 (24.1) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;130 mmHg 1127 (96.8) 1112 (85.5) 2239 (90.9) &gt;=130 mmHg 37 (3.2) 132 (10.2) 169 (6.9) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;85 mmHg 1156 (99.3) 1169 (89.9) 2325 (94.4) &gt;=85 mmHg 8 (0.7) 75 (5.8) 83 (3.4) MetS criteria: BP: Mean (SD) 0.0 (0.2) 0.1 (0.3) 0.1 (0.3) &lt;0.0001 CRP (mg/L): Median (IQ range) 4.9 (2.5-9.1) 3.4 (1.4-6.6) 4.0 (1.9-7.6) &lt;0.0001 3.1.3 Outcomes Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value Birthweight (g): Median (IQ range) 3390.0 (3050.0-3730.0) 3390.0 (3039.0-3704.5) 3390.0 (3045.0-3720.0) 0.78 Birthweight customised centile: Median (IQ range) 44.5 (20.8-71.0) 46.2 (23.3-73.6) 45.2 (22.0-72.4) 0.10 Baby sex: N(%) 0.19 Missing 6 (0.5) 18 (1.4) 24 (1.0) Female 591 (50.8) 619 (47.6) 1210 (49.1) Male 567 (48.7) 663 (51.0) 1230 (49.9) Delivery mode: N(%) 0.02 Missing 6 (0.5) 16 (1.2) 22 (0.9) LSCS in labour 278 (23.9) 284 (21.8) 562 (22.8) Operative vaginal 186 (16.0) 268 (20.6) 454 (18.4) Pre-labour LSCS 77 (6.6) 89 (6.8) 166 (6.7) Unassisted vaginal 617 (53.0) 643 (49.5) 1260 (51.1) PE vs Uncomplicated: N(%) 0.59 Missing 467 (40.1) 469 (36.1) 936 (38.0) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 93 (8.0) 120 (9.2) 213 (8.6) SPTB vs Uncomplicated: N(%) 0.14 Missing 491 (42.2) 528 (40.6) 1019 (41.4) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 69 (5.9) 61 (4.7) 130 (5.3) SGA vs Uncomplicted: N(%) 0.65 Missing 419 (36.0) 435 (33.5) 854 (34.7) No 604 (51.9) 710 (54.6) 1314 (53.3) Yes 141 (12.1) 155 (11.9) 296 (12.0) GDM vs Uncomplicated: N(%) &lt;0.0001 Missing 502 (43.1) 391 (30.1) 893 (36.2) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 58 (5.0) 198 (15.2) 256 (10.4) GHT vs Uncomplicated: N(%) 0.001 Missing 442 (38.0) 505 (38.8) 947 (38.4) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 118 (10.1) 84 (6.5) 202 (8.2) PE vs non-PE: N(%) 0.27 Missing 5 (0.4) 20 (1.5) 25 (1.0) No 1066 (91.6) 1160 (89.2) 2226 (90.3) Yes 93 (8.0) 120 (9.2) 213 (8.6) SPTB vs non-SPTB: N(%) 0.22 Missing 5 (0.4) 16 (1.2) 21 (0.9) No 1090 (93.6) 1223 (94.1) 2313 (93.9) Yes 69 (5.9) 61 (4.7) 130 (5.3) SGA vs non-SGA: N(%) 0.99 Missing 6 (0.5) 17 (1.3) 23 (0.9) No 1017 (87.4) 1128 (86.8) 2145 (87.1) Yes 141 (12.1) 155 (11.9) 296 (12.0) GDM vs non-GDM: N(%) &lt;0.0001 Missing 33 (2.8) 54 (4.2) 87 (3.5) No 1073 (92.2) 1048 (80.6) 2121 (86.1) Yes 58 (5.0) 198 (15.2) 256 (10.4) GHT vs non-GHT: N(%) 0.002 Missing 6 (0.5) 20 (1.5) 26 (1.1) No 1040 (89.3) 1196 (92.0) 2236 (90.7) Yes 118 (10.1) 84 (6.5) 202 (8.2) "],["folate-vs-fa-supplement.html", "3.2 Folate vs FA supplement", " 3.2 Folate vs FA supplement 3.2.1 FA supp (3 categories) Characteristic None (n=348) &lt;800 (n=882) &gt;=800 (n=1082) Total (n=2312) P-value Serum folate concentration (nM): Median (IQ range) 29.5 (20.4-36.4) 38.4 (32.2-43.8) 41.2 (36.9-56.8) 39.3 (33.3-44.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.7 (1.2) 4.7 (1.0) 4.7 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 246.0 (192.0-302.5) 254.0 (200.0-326.8) 275.0 (217.0-355.0) 262.0 (205.0-337.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.2 (24.2) 63.1 (25.7) 68.5 (24.8) 65.1 (25.3) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 117.0 (78.4-165.1) 150.8 (112.0-219.6) 158.8 (117.9-237.3) 149.8 (109.0-218.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 478.0 (331.8-675.2) 628.6 (471.7-924.4) 653.3 (481.0-1012.1) 619.3 (447.8-913.0) &lt;0.0001 Vitamin D: Median (IQ range) 52.6 (39.3-69.0) 58.0 (42.5-75.7) 63.5 (47.9-79.0) 60.0 (44.0-76.7) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=251) &lt;800 (n=611) &gt;=800 (n=302) Total (n=1164) P-value Serum folate concentration (nM): Median (IQ range) 25.6 (17.5-33.3) 37.3 (30.2-43.2) 40.0 (34.8-48.7) 36.0 (28.2-42.8) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (179.0-291.0) 250.0 (198.0-319.0) 249.5 (198.8-310.2) 245.5 (195.0-309.0) 0.002 Active B12 concentration (pM): Mean (SD) 55.9 (22.2) 60.0 (24.3) 65.4 (24.6) 60.5 (24.1) 0.002 Folate:B12 ratio: Median (IQ range) 108.4 (72.7-157.7) 143.2 (108.4-208.8) 167.7 (119.7-253.8) 143.1 (102.9-208.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (332.7-708.0) 632.8 (476.9-923.9) 650.8 (489.9-1074.3) 603.3 (437.9-895.6) &lt;0.0001 Vitamin D: Median (IQ range) 51.7 (38.9-68.5) 55.3 (40.2-74.2) 67.7 (50.9-83.4) 57.6 (42.1-76.0) &lt;0.0001 Click here for table within STOP Characteristic None (n=97) &lt;800 (n=271) &gt;=800 (n=780) Total (n=1148) P-value Serum folate concentration (nM): Median (IQ range) 36.6 (30.5-41.2) 40.4 (35.5-54.4) 41.5 (37.6-58.0) 40.9 (36.7-54.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.3 (1.4) 5.1 (1.3) 4.8 (1.0) 4.9 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 279.0 (217.0-339.0) 266.0 (205.0-345.0) 282.0 (226.0-370.0) 279.0 (220.0-361.5) 0.007 Active B12 concentration (pM): Mean (SD) 74.2 (25.3) 70.8 (27.8) 69.8 (24.8) 70.4 (25.6) 0.55 Folate:B12 ratio: Median (IQ range) 132.7 (101.4-193.7) 166.7 (121.1-234.6) 155.4 (116.7-227.8) 154.9 (116.2-227.9) 0.003 Folate:Active B12 ratio: Median (IQ range) 518.7 (336.7-647.2) 622.1 (460.9-916.9) 658.3 (472.2-979.9) 627.4 (460.1-939.8) 0.001 Vitamin D: Median (IQ range) 57.0 (43.0-69.5) 64.0 (48.0-80.0) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.04 3.2.2 FA supp (4 categories) Characteristic None (n=348) &lt;=400 (n=131) &gt;400 to &lt;800 (n=751) &gt;=800 (n=1082) Total (n=2312) P-value Serum folate concentration (nM): Median (IQ range) 29.5 (20.4-36.4) 36.3 (28.6-42.7) 38.8 (33.0-44.0) 41.2 (36.9-56.8) 39.3 (33.3-44.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.6 (1.0) 4.7 (1.2) 4.7 (1.0) 4.7 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 246.0 (192.0-302.5) 260.0 (200.8-347.5) 254.0 (200.0-322.0) 275.0 (217.0-355.0) 262.0 (205.0-337.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.2 (24.2) 62.3 (27.2) 63.2 (25.5) 68.5 (24.8) 65.1 (25.3) 0.0002 Folate:B12 ratio: Median (IQ range) 117.0 (78.4-165.1) 135.4 (106.9-185.3) 154.9 (113.5-225.5) 158.8 (117.9-237.3) 149.8 (109.0-218.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 478.0 (331.8-675.2) 540.9 (429.0-882.4) 638.0 (476.3-938.6) 653.3 (481.0-1012.1) 619.3 (447.8-913.0) &lt;0.0001 Vitamin D: Median (IQ range) 52.6 (39.3-69.0) 50.1 (37.1-69.1) 58.9 (43.7-77.0) 63.5 (47.9-79.0) 60.0 (44.0-76.7) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=251) &lt;=400 (n=116) &gt;400 to &lt;800 (n=495) &gt;=800 (n=302) Total (n=1164) P-value Serum folate concentration (nM): Median (IQ range) 25.6 (17.5-33.3) 35.5 (27.8-41.6) 37.5 (30.9-43.5) 40.0 (34.8-48.7) 36.0 (28.2-42.8) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (179.0-291.0) 251.0 (201.0-339.0) 248.5 (198.0-311.5) 249.5 (198.8-310.2) 245.5 (195.0-309.0) 0.002 Active B12 concentration (pM): Mean (SD) 55.9 (22.2) 62.1 (28.3) 59.6 (23.4) 65.4 (24.6) 60.5 (24.1) 0.005 Folate:B12 ratio: Median (IQ range) 108.4 (72.7-157.7) 132.4 (105.5-179.9) 146.7 (111.8-219.3) 167.7 (119.7-253.8) 143.1 (102.9-208.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (332.7-708.0) 537.9 (410.4-891.6) 641.2 (484.9-967.9) 650.8 (489.9-1074.3) 603.3 (437.9-895.6) &lt;0.0001 Vitamin D: Median (IQ range) 51.7 (38.9-68.5) 49.0 (35.5-65.2) 56.6 (41.6-75.6) 67.7 (50.9-83.4) 57.6 (42.1-76.0) &lt;0.0001 Click here for table within STOP Characteristic None (n=97) &lt;=400 (n=15) &gt;400 to &lt;800 (n=256) &gt;=800 (n=780) Total (n=1148) P-value Serum folate concentration (nM): Median (IQ range) 36.6 (30.5-41.2) 43.0 (39.8-57.2) 40.1 (35.5-49.5) 41.5 (37.6-58.0) 40.9 (36.7-54.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.3 (1.4) 5.0 (0.9) 5.1 (1.3) 4.8 (1.0) 4.9 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 279.0 (217.0-339.0) 276.0 (203.5-360.5) 265.0 (205.8-343.2) 282.0 (226.0-370.0) 279.0 (220.0-361.5) 0.02 Active B12 concentration (pM): Mean (SD) 74.2 (25.3) 63.7 (17.7) 71.2 (28.3) 69.8 (24.8) 70.4 (25.6) 0.62 Folate:B12 ratio: Median (IQ range) 132.7 (101.4-193.7) 180.2 (141.2-214.2) 166.1 (119.0-236.7) 155.4 (116.7-227.8) 154.9 (116.2-227.9) 0.007 Folate:Active B12 ratio: Median (IQ range) 518.7 (336.7-647.2) 794.6 (550.8-848.5) 620.0 (455.9-931.1) 658.3 (472.2-979.9) 627.4 (460.1-939.8) 0.003 Vitamin D: Median (IQ range) 57.0 (43.0-69.5) 68.0 (53.5-94.0) 63.0 (48.0-79.8) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.06 "],["fa-supp-3-categories-1.html", "4 FA supp: 3 categories", " 4 FA supp: 3 categories Characteristic None (n=348) &lt;800 (n=882) &gt;=800 (n=1082) Total (n=2312) P-value Prolactin: Median (IQ range) 131.1 (81.5-208.5) 118.6 (72.3-183.2) 82.7 (50.5-138.6) 101.1 (58.7-168.7) &lt;0.0001 HPL: Median (IQ range) 158.2 (108.6-200.3) 153.3 (76.8-195.6) 73.4 (44.1-137.5) 113.3 (55.1-179.1) &lt;0.0001 GH2: Median (IQ range) 3606.1 (2389.6-5188.3) 3310.7 (1799.3-4704.0) 1773.7 (972.4-3413.2) 2624.5 (1266.6-4251.5) &lt;0.0001 LME for duplicated or repeated measures shown on next page. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(hormone_var,function(x){ mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run))) return(mod)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- hormone_var mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-2.html", "4.1 Prolactin", " 4.1 Prolactin Model summary Var Effect P (Intercept) 11.11 (7.93, 15.58) &lt;0.0001 folate_cat2&lt;800 1.09 (0.99, 1.20) 0.07 folate_cat2&gt;=800 1.15 (1.03, 1.29) 0.01 StudySTOP 1.26 (1.06, 1.49) 0.008 GA_samp 1.17 (1.15, 1.19) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.99 (0.83, 1.19) 0.95 folate_cat2&gt;=800:StudySTOP 0.74 (0.61, 0.88) 0.0009 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 89.48 7.29 110.51 76.14 105.17 &lt;800 SCOPE 97.43 7.47 86.74 83.66 113.46 &gt;=800 SCOPE 102.98 8.45 113.84 87.53 121.17 None STOP 112.59 10.87 213.14 93.08 136.19 &lt;800 STOP 121.89 9.70 100.69 104.09 142.72 &gt;=800 STOP 95.45 7.08 76.13 82.35 110.64 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.09 (0.97, 1.22) 0.2 &gt;=800 / None Study: SCOPE 1.15 (1.01, 1.32) 0.04 &gt;=800 / &lt;800 Study: SCOPE 1.06 (0.94, 1.19) 0.5 &lt;800 / None Study: STOP 1.08 (0.90, 1.30) 0.6 &gt;=800 / None Study: STOP 0.85 (0.72, 1.00) 0.05 &gt;=800 / &lt;800 Study: STOP 0.78 (0.71, 0.87) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): None 1.26 (1.06, 1.49) 0.008 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.25 (1.11, 1.41) 0.0003 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.82, 1.05) 0.2 "],["hpl-2.html", "4.2 HPL", " 4.2 HPL Model summary Var Effect P (Intercept) 1.84 (1.53, 2.22) &lt;0.0001 folate_cat2&lt;800 0.99 (0.93, 1.04) 0.61 folate_cat2&gt;=800 0.99 (0.93, 1.06) 0.88 StudySTOP 1.15 (1.04, 1.26) 0.004 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.98 (0.89, 1.08) 0.70 folate_cat2&gt;=800:StudySTOP 0.95 (0.86, 1.05) 0.29 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 94.15 3.23 297.02 88.01 100.72 &lt;800 SCOPE 92.78 2.73 165.19 87.55 98.32 &gt;=800 SCOPE 93.67 3.12 265.70 87.72 100.02 None STOP 108.14 4.67 641.78 99.35 117.71 &lt;800 STOP 104.45 3.35 229.04 98.06 111.25 &gt;=800 STOP 101.93 2.79 124.41 96.56 107.60 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.99 (0.92, 1.05) 0.9 &gt;=800 / None Study: SCOPE 0.99 (0.92, 1.07) 1.0 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.95, 1.08) 0.9 &lt;800 / None Study: STOP 0.97 (0.87, 1.07) 0.7 &gt;=800 / None Study: STOP 0.94 (0.86, 1.03) 0.3 &gt;=800 / &lt;800 Study: STOP 0.98 (0.92, 1.04) 0.6 STOP / SCOPE Folic acid supplement (μg): None 1.15 (1.04, 1.26) 0.004 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.13 (1.05, 1.21) 0.0009 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.09 (1.01, 1.17) 0.02 "],["gh2-2.html", "4.3 GH2", " 4.3 GH2 Model summary Var Effect P (Intercept) 91.76 (71.87, 117.09) &lt;0.0001 folate_cat2&lt;800 0.98 (0.91, 1.05) 0.59 folate_cat2&gt;=800 1.04 (0.95, 1.13) 0.39 StudySTOP 1.07 (0.94, 1.22) 0.28 GA_samp 1.28 (1.26, 1.30) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.86 (0.75, 0.98) 0.03 folate_cat2&gt;=800:StudySTOP 0.81 (0.71, 0.93) 0.003 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2508.13 96.19 861.43 2326.27 2704.21 &lt;800 SCOPE 2458.29 76.64 449.74 2312.19 2613.61 &gt;=800 SCOPE 2604.46 99.77 842.52 2415.81 2807.85 None STOP 2689.36 144.54 1569.18 2420.29 2988.35 &lt;800 STOP 2260.97 79.87 692.89 2109.48 2423.35 &gt;=800 STOP 2272.50 62.11 285.03 2153.47 2398.10 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.98 (0.90, 1.07) 0.8 &gt;=800 / None Study: SCOPE 1.04 (0.94, 1.15) 0.7 &gt;=800 / &lt;800 Study: SCOPE 1.06 (0.97, 1.16) 0.3 &lt;800 / None Study: STOP 0.84 (0.73, 0.96) 0.008 &gt;=800 / None Study: STOP 0.84 (0.75, 0.96) 0.005 &gt;=800 / &lt;800 Study: STOP 1.01 (0.93, 1.09) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.07 (0.94, 1.22) 0.3 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.92 (0.84, 1.01) 0.07 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.87 (0.80, 0.96) 0.004 "],["fa-supp-4-categories-1.html", "5 FA supp: 4 categories", " 5 FA supp: 4 categories Characteristic None (n=348) &lt;=400 (n=131) &gt;400 to &lt;800 (n=751) &gt;=800 (n=1082) Total (n=2312) P-value Prolactin: Median (IQ range) 131.1 (81.5-208.5) 127.2 (90.7-207.0) 112.4 (70.8-178.8) 82.7 (50.5-138.6) 101.1 (58.7-168.7) &lt;0.0001 HPL: Median (IQ range) 158.2 (108.6-200.3) 172.9 (130.1-202.8) 145.8 (70.3-195.1) 73.4 (44.1-137.5) 113.3 (55.1-179.1) &lt;0.0001 GH2: Median (IQ range) 3606.1 (2389.6-5188.3) 3997.1 (3043.8-5667.6) 3169.0 (1600.5-4546.7) 1773.7 (972.4-3413.2) 2624.5 (1266.6-4251.5) &lt;0.0001 LME for duplicated or repeated measures. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-3.html", "5.1 Prolactin", " 5.1 Prolactin Model summary Var Effect P (Intercept) 11.17 (7.97, 15.67) &lt;0.0001 folate_cat3&lt;=400 1.11 (0.98, 1.27) 0.10 folate_cat3&gt;400 to &lt;800 1.08 (0.98, 1.19) 0.13 folate_cat3&gt;=800 1.15 (1.03, 1.29) 0.01 StudySTOP 1.26 (1.06, 1.49) 0.008 GA_samp 1.17 (1.15, 1.19) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.90 (0.61, 1.31) 0.58 folate_cat3&gt;400 to &lt;800:StudySTOP 1.01 (0.84, 1.21) 0.94 folate_cat3&gt;=800:StudySTOP 0.74 (0.62, 0.88) 0.0010 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 89.60 7.31 110.59 76.23 105.31 &lt;=400 SCOPE 99.82 8.98 161.96 83.58 119.22 &gt;400 to &lt;800 SCOPE 96.76 7.56 93.61 82.85 113.00 &gt;=800 SCOPE 103.08 8.47 113.87 87.60 121.29 None STOP 112.51 10.87 213.10 93.00 136.10 &lt;=400 STOP 112.49 20.62 1335.21 78.52 161.18 &gt;400 to &lt;800 STOP 122.32 9.78 102.59 104.38 143.35 &gt;=800 STOP 95.48 7.08 76.19 82.37 110.68 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.11 (0.94, 1.32) 0.4 &gt;400 to &lt;800 / None Study: SCOPE 1.08 (0.95, 1.23) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.97 (0.83, 1.14) 1.0 &gt;=800 / None Study: SCOPE 1.15 (0.99, 1.33) 0.07 &gt;=800 / &lt;=400 Study: SCOPE 1.03 (0.87, 1.23) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.07 (0.93, 1.22) 0.6 &lt;=400 / None Study: STOP 1.00 (0.63, 1.59) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.09 (0.89, 1.33) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.09 (0.70, 1.70) 1.0 &gt;=800 / None Study: STOP 0.85 (0.71, 1.02) 0.10 &gt;=800 / &lt;=400 Study: STOP 0.85 (0.55, 1.31) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.78 (0.70, 0.88) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): None 1.26 (1.06, 1.49) 0.008 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.13 (0.79, 1.62) 0.5 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.26 (1.12, 1.43) 0.0002 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.93 (0.82, 1.05) 0.2 "],["hpl-3.html", "5.2 HPL", " 5.2 HPL Model summary Var Effect P (Intercept) 1.83 (1.51, 2.20) &lt;0.0001 folate_cat3&lt;=400 1.01 (0.94, 1.10) 0.74 folate_cat3&gt;400 to &lt;800 0.98 (0.92, 1.04) 0.44 folate_cat3&gt;=800 0.99 (0.93, 1.06) 0.88 StudySTOP 1.15 (1.05, 1.27) 0.004 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.09 (0.88, 1.34) 0.43 folate_cat3&gt;400 to &lt;800:StudySTOP 0.98 (0.88, 1.09) 0.71 folate_cat3&gt;=800:StudySTOP 0.95 (0.86, 1.05) 0.29 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 94.04 3.23 295.06 87.90 100.62 &lt;=400 SCOPE 95.33 3.92 550.13 87.94 103.34 &gt;400 to &lt;800 SCOPE 91.89 2.82 191.63 86.50 97.62 &gt;=800 SCOPE 93.57 3.12 264.02 87.61 99.93 None STOP 108.26 4.68 636.80 99.45 117.85 &lt;=400 STOP 119.24 11.23 1788.99 99.14 143.42 &gt;400 to &lt;800 STOP 103.73 3.36 236.36 97.32 110.57 &gt;=800 STOP 102.06 2.80 124.01 96.67 107.76 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.01 (0.91, 1.12) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.98 (0.91, 1.05) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.96 (0.88, 1.06) 0.8 &gt;=800 / None Study: SCOPE 0.99 (0.91, 1.08) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.89, 1.09) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.02 (0.95, 1.10) 0.9 &lt;=400 / None Study: STOP 1.10 (0.86, 1.42) 0.8 &gt;400 to &lt;800 / None Study: STOP 0.96 (0.86, 1.07) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.87 (0.68, 1.11) 0.4 &gt;=800 / None Study: STOP 0.94 (0.85, 1.04) 0.4 &gt;=800 / &lt;=400 Study: STOP 0.86 (0.68, 1.08) 0.3 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.98 (0.92, 1.05) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.15 (1.05, 1.27) 0.004 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.25 (1.03, 1.52) 0.03 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.13 (1.05, 1.21) 0.0010 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.09 (1.02, 1.17) 0.01 "],["gh2-3.html", "5.3 GH2", " 5.3 GH2 Model summary Var Effect P (Intercept) 92.26 (72.24, 117.75) &lt;0.0001 folate_cat3&lt;=400 1.03 (0.93, 1.14) 0.59 folate_cat3&gt;400 to &lt;800 0.96 (0.89, 1.04) 0.36 folate_cat3&gt;=800 1.04 (0.95, 1.13) 0.39 StudySTOP 1.07 (0.94, 1.22) 0.30 GA_samp 1.28 (1.26, 1.30) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.75 (0.56, 0.99) 0.04 folate_cat3&gt;400 to &lt;800:StudySTOP 0.88 (0.76, 1.01) 0.06 folate_cat3&gt;=800:StudySTOP 0.82 (0.71, 0.93) 0.003 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2511.28 96.31 867.07 2329.20 2707.60 &lt;=400 SCOPE 2582.54 124.32 1406.87 2349.84 2838.29 &gt;400 to &lt;800 SCOPE 2422.93 80.54 561.49 2269.80 2586.40 &gt;=800 SCOPE 2606.80 99.82 846.37 2418.05 2810.29 None STOP 2686.93 144.34 1570.93 2418.21 2985.51 &lt;=400 STOP 2064.57 262.21 1891.97 1609.37 2648.53 &gt;400 to &lt;800 STOP 2271.00 81.32 727.60 2116.82 2436.41 &gt;=800 STOP 2274.40 62.14 287.29 2155.32 2400.06 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.03 (0.90, 1.17) 0.9 &gt;400 to &lt;800 / None Study: SCOPE 0.96 (0.87, 1.07) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.94 (0.83, 1.06) 0.5 &gt;=800 / None Study: SCOPE 1.04 (0.93, 1.16) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 1.01 (0.88, 1.15) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.08 (0.97, 1.19) 0.2 &lt;=400 / None Study: STOP 0.77 (0.54, 1.09) 0.2 &gt;400 to &lt;800 / None Study: STOP 0.85 (0.73, 0.98) 0.02 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.10 (0.79, 1.53) 0.9 &gt;=800 / None Study: STOP 0.85 (0.74, 0.97) 0.010 &gt;=800 / &lt;=400 Study: STOP 1.10 (0.80, 1.52) 0.9 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.00 (0.92, 1.09) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.07 (0.94, 1.22) 0.3 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.80 (0.61, 1.05) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.94 (0.85, 1.03) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.87 (0.80, 0.96) 0.004 "],["age-groups.html", "6 Age groups", " 6 Age groups LME for duplicated or repeated measures. Characteristic &lt;35 yrs (n=2362) &gt;=35 yrs (n=102) Total (n=2464) P-value Prolactin: Median (IQ range) 99.6 (58.5-165.1) 82.6 (50.0-150.4) 99.0 (58.1-164.8) 0.09 HPL: Median (IQ range) 108.3 (54.6-177.0) 78.5 (40.3-147.2) 106.6 (54.1-176.2) 0.003 GH2: Median (IQ range) 2564.6 (1215.4-4210.2) 2082.3 (1112.7-3483.2) 2550.6 (1213.1-4193.3) 0.16 mod_ls &lt;- lapply(hormone_var,function(x){ #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) #mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID)&quot;)) #log mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run))) return(mod)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- hormone_var mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-4.html", "6.1 Prolactin", " 6.1 Prolactin Model summary Var Effect P (Intercept) 12.48 (9.02, 17.27) &lt;0.0001 Age_gp&gt;=35 yrs 1.02 (0.81, 1.29) 0.86 StudySTOP 1.05 (0.95, 1.15) 0.34 GA_samp 1.17 (1.15, 1.19) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.86 (0.65, 1.13) 0.27 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 96.38 7.08 78.06 83.27 111.55 &gt;=35 yrs SCOPE 98.44 13.48 782.55 75.24 128.79 &lt;35 yrs STOP 100.89 7.19 69.21 87.53 116.30 &gt;=35 yrs STOP 88.32 9.01 280.82 72.25 107.97 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.02 (0.81, 1.29) 0.9 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.88 (0.75, 1.02) 0.09 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.05 (0.95, 1.15) 0.3 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.90 (0.68, 1.19) 0.5 "],["hpl-4.html", "6.2 HPL", " 6.2 HPL Model summary Var Effect P (Intercept) 1.75 (1.47, 2.08) &lt;0.0001 Age_gp&gt;=35 yrs 0.93 (0.81, 1.06) 0.28 StudySTOP 1.12 (1.06, 1.19) &lt;0.0001 GA_samp 1.35 (1.33, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.95 (0.81, 1.11) 0.48 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 89.81 2.46 124.00 85.06 94.82 &gt;=35 yrs SCOPE 83.50 5.97 1960.48 72.57 96.08 &lt;35 yrs STOP 100.88 2.59 95.88 95.86 106.16 &gt;=35 yrs STOP 88.65 4.32 924.54 80.57 97.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.93 (0.81, 1.06) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.88 (0.81, 0.96) 0.003 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.12 (1.06, 1.19) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.06 (0.90, 1.25) 0.5 "],["gh2-4.html", "6.3 GH2", " 6.3 GH2 Model summary Var Effect P (Intercept) 82.55 (65.50, 104.07) &lt;0.0001 Age_gp&gt;=35 yrs 1.00 (0.83, 1.20) 1.00 StudySTOP 0.94 (0.88, 1.01) 0.09 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.01 (0.82, 1.25) 0.92 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 2414.87 66.66 338.98 2287.24 2549.61 &gt;=35 yrs SCOPE 2416.18 228.23 2637.59 2007.65 2907.85 &lt;35 yrs STOP 2270.77 54.36 207.39 2166.09 2380.50 &gt;=35 yrs STOP 2297.16 138.55 2161.22 2040.91 2585.59 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.00 (0.83, 1.20) 1.0 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.01 (0.90, 1.14) 0.8 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.94 (0.88, 1.01) 0.09 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.95 (0.76, 1.18) 0.6 "],["bmi-groups.html", "7 BMI groups", " 7 BMI groups LME for duplicated or repeated measures. Characteristic Underweight (n=63) Normal (n=994) Overweight (n=683) Obese (n=723) Total (n=2463) P-value Prolactin: Median (IQ range) 104.2 (52.4-216.8) 106.3 (62.5-174.0) 103.6 (61.4-179.3) 86.2 (50.7-144.9) 99.0 (58.1-164.8) &lt;0.0001 HPL: Median (IQ range) 155.5 (87.4-215.8) 126.2 (60.8-197.2) 111.3 (55.6-169.2) 76.3 (42.6-147.9) 106.6 (54.1-176.2) &lt;0.0001 GH2: Median (IQ range) 4254.9 (2327.1-6152.5) 3044.5 (1336.1-4881.6) 2555.4 (1207.5-3989.7) 2176.2 (1057.3-3350.7) 2550.6 (1213.1-4193.3) &lt;0.0001 "],["prolactin-5.html", "7.1 Prolactin", " 7.1 Prolactin Model summary Var Effect P (Intercept) 16.41 (11.05, 24.37) &lt;0.0001 BMI_gp3Normal 0.79 (0.63, 1.00) 0.05 BMI_gp3Overweight 0.87 (0.68, 1.10) 0.24 BMI_gp3Obese 0.70 (0.56, 0.89) 0.004 StudySTOP 0.90 (0.64, 1.26) 0.53 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.20 (0.86, 1.67) 0.30 BMI_gp3Overweight:StudySTOP 1.09 (0.78, 1.52) 0.63 BMI_gp3Obese:StudySTOP 1.15 (0.82, 1.61) 0.43 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 122.65 16.62 770.01 94.01 160.02 Normal SCOPE 97.48 7.46 94.00 83.74 113.47 Overweight SCOPE 106.45 8.44 108.21 90.97 124.57 Obese SCOPE 86.44 6.91 111.77 73.77 101.27 Underweight STOP 110.32 14.98 777.10 84.50 144.03 Normal STOP 104.81 7.71 80.48 90.54 121.33 Overweight STOP 103.90 7.89 91.30 89.35 120.81 Obese STOP 89.15 6.77 91.26 76.66 103.66 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.79 (0.58, 1.08) 0.2 Overweight / Underweight Study: SCOPE 0.87 (0.64, 1.19) 0.6 Overweight / Normal Study: SCOPE 1.09 (0.97, 1.23) 0.2 Obese / Underweight Study: SCOPE 0.70 (0.52, 0.96) 0.02 Obese / Normal Study: SCOPE 0.89 (0.78, 1.01) 0.07 Obese / Overweight Study: SCOPE 0.81 (0.71, 0.93) 0.0004 Normal / Underweight Study: STOP 0.95 (0.70, 1.29) 1.0 Overweight / Underweight Study: STOP 0.94 (0.69, 1.29) 1.0 Overweight / Normal Study: STOP 0.99 (0.89, 1.11) 1.0 Obese / Underweight Study: STOP 0.81 (0.59, 1.10) 0.3 Obese / Normal Study: STOP 0.85 (0.76, 0.95) 0.0008 Obese / Overweight Study: STOP 0.86 (0.76, 0.96) 0.004 STOP / SCOPE Maternal BMI: Underweight 0.90 (0.64, 1.26) 0.5 STOP / SCOPE Maternal BMI: Normal 1.08 (0.96, 1.20) 0.2 STOP / SCOPE Maternal BMI: Overweight 0.98 (0.86, 1.10) 0.7 STOP / SCOPE Maternal BMI: Obese 1.03 (0.91, 1.17) 0.6 "],["hpl-5.html", "7.2 HPL", " 7.2 HPL Model summary Var Effect P (Intercept) 1.94 (1.57, 2.39) &lt;0.0001 BMI_gp3Normal 1.04 (0.91, 1.18) 0.56 BMI_gp3Overweight 0.97 (0.86, 1.11) 0.69 BMI_gp3Obese 0.81 (0.71, 0.93) 0.002 StudySTOP 1.42 (1.18, 1.70) 0.0002 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.79 (0.66, 0.95) 0.01 BMI_gp3Overweight:StudySTOP 0.76 (0.64, 0.92) 0.004 BMI_gp3Obese:StudySTOP 0.74 (0.62, 0.89) 0.002 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 95.72 6.49 1905.36 83.80 109.35 Normal SCOPE 99.42 2.96 177.50 93.75 105.44 Overweight SCOPE 93.26 2.96 225.42 87.61 99.27 Obese SCOPE 77.85 2.48 229.86 73.11 82.89 Underweight STOP 135.54 9.27 1919.26 118.54 154.99 Normal STOP 111.74 3.07 130.07 105.83 117.98 Overweight STOP 100.95 2.95 165.04 95.29 106.95 Obese STOP 81.89 2.40 164.12 77.29 86.77 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.04 (0.88, 1.23) 0.9 Overweight / Underweight Study: SCOPE 0.97 (0.82, 1.15) 1.0 Overweight / Normal Study: SCOPE 0.94 (0.88, 1.00) 0.07 Obese / Underweight Study: SCOPE 0.81 (0.69, 0.96) 0.010 Obese / Normal Study: SCOPE 0.78 (0.73, 0.84) &lt;0.0001 Obese / Overweight Study: SCOPE 0.83 (0.78, 0.90) &lt;0.0001 Normal / Underweight Study: STOP 0.82 (0.70, 0.98) 0.02 Overweight / Underweight Study: STOP 0.74 (0.63, 0.88) &lt;0.0001 Overweight / Normal Study: STOP 0.90 (0.85, 0.96) &lt;0.0001 Obese / Underweight Study: STOP 0.60 (0.51, 0.72) &lt;0.0001 Obese / Normal Study: STOP 0.73 (0.69, 0.78) &lt;0.0001 Obese / Overweight Study: STOP 0.81 (0.76, 0.86) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.42 (1.18, 1.70) 0.0002 STOP / SCOPE Maternal BMI: Normal 1.12 (1.06, 1.19) 0.0001 STOP / SCOPE Maternal BMI: Overweight 1.08 (1.01, 1.16) 0.02 STOP / SCOPE Maternal BMI: Obese 1.05 (0.98, 1.13) 0.1 "],["gh2-5.html", "7.3 GH2", " 7.3 GH2 Model summary Var Effect P (Intercept) 98.56 (74.35, 130.71) &lt;0.0001 BMI_gp3Normal 0.98 (0.83, 1.17) 0.83 BMI_gp3Overweight 0.83 (0.70, 0.99) 0.04 BMI_gp3Obese 0.69 (0.58, 0.82) &lt;0.0001 StudySTOP 1.39 (1.08, 1.77) 0.010 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.62 (0.49, 0.80) 0.0002 BMI_gp3Overweight:StudySTOP 0.66 (0.52, 0.85) 0.001 BMI_gp3Obese:StudySTOP 0.77 (0.60, 0.99) 0.04 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 2854.06 253.43 2573.63 2397.97 3396.90 Normal SCOPE 2799.61 90.36 561.26 2627.63 2982.84 Overweight SCOPE 2376.63 84.76 772.46 2215.94 2548.97 Obese SCOPE 1961.24 71.43 810.06 1825.93 2106.59 Underweight STOP 3953.97 353.33 2609.11 3318.44 4711.21 Normal STOP 2416.65 67.86 362.91 2286.82 2553.85 Overweight STOP 2181.13 67.99 518.22 2051.57 2318.87 Obese STOP 2094.91 65.19 476.67 1970.66 2227.00 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.98 (0.78, 1.23) 1.0 Overweight / Underweight Study: SCOPE 0.83 (0.66, 1.05) 0.2 Overweight / Normal Study: SCOPE 0.85 (0.77, 0.93) &lt;0.0001 Obese / Underweight Study: SCOPE 0.69 (0.55, 0.87) 0.0002 Obese / Normal Study: SCOPE 0.70 (0.64, 0.77) &lt;0.0001 Obese / Overweight Study: SCOPE 0.83 (0.75, 0.91) &lt;0.0001 Normal / Underweight Study: STOP 0.61 (0.49, 0.77) &lt;0.0001 Overweight / Underweight Study: STOP 0.55 (0.44, 0.70) &lt;0.0001 Overweight / Normal Study: STOP 0.90 (0.83, 0.98) 0.007 Obese / Underweight Study: STOP 0.53 (0.42, 0.67) &lt;0.0001 Obese / Normal Study: STOP 0.87 (0.80, 0.94) &lt;0.0001 Obese / Overweight Study: STOP 0.96 (0.88, 1.05) 0.6 STOP / SCOPE Maternal BMI: Underweight 1.39 (1.08, 1.78) 0.01 STOP / SCOPE Maternal BMI: Normal 0.86 (0.80, 0.94) 0.0004 STOP / SCOPE Maternal BMI: Overweight 0.92 (0.84, 1.01) 0.06 STOP / SCOPE Maternal BMI: Obese 1.07 (0.97, 1.17) 0.2 "],["age-bmi-groups.html", "8 Age &amp; BMI groups", " 8 Age &amp; BMI groups LME for duplicated or repeated measures. Characteristic &lt;35 yrs, non-obese (n=1683) &lt;35 yrs, obese (n=678) &gt;=35 yrs, non-obese (n=57) &gt;=35 yrs, obese (n=45) Total (n=2463) P-value Prolactin: Median (IQ range) 105.3 (62.2-177.2) 88.7 (51.7-145.7) 95.6 (66.3-183.0) 59.2 (42.5-122.6) 99.0 (58.1-164.8) &lt;0.0001 HPL: Median (IQ range) 123.2 (59.3-187.7) 78.1 (44.2-148.4) 90.4 (58.6-156.9) 47.1 (26.5-113.8) 106.6 (54.1-176.2) &lt;0.0001 GH2: Median (IQ range) 2892.2 (1308.0-4577.3) 2204.3 (1059.8-3399.3) 2402.8 (1248.4-4597.2) 1773.8 (1016.9-2900.3) 2550.6 (1213.1-4193.3) &lt;0.0001 "],["prolactin-6.html", "8.1 Prolactin", " 8.1 Prolactin Model summary Var Effect P (Intercept) 13.44 (9.71, 18.58) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.85 (0.78, 0.93) 0.0005 Age_BMI_gp&gt;=35 yrs, non-obese 1.14 (0.85, 1.54) 0.37 Age_BMI_gp&gt;=35 yrs, obese 0.75 (0.51, 1.08) 0.12 StudySTOP 1.04 (0.94, 1.14) 0.46 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.00 (0.89, 1.13) 0.96 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.80 (0.56, 1.16) 0.24 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.00 (0.65, 1.54) 1.00 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 101.40 7.51 82.51 87.52 117.49 &lt;35 yrs, obese SCOPE 86.60 6.95 113.61 73.87 101.52 &gt;=35 yrs, non-obese SCOPE 116.04 19.18 1328.83 83.90 160.49 &gt;=35 yrs, obese SCOPE 75.75 15.22 1863.47 51.08 112.32 &lt;35 yrs, non-obese STOP 105.24 7.53 72.27 91.25 121.39 &lt;35 yrs, obese STOP 90.14 6.90 94.02 77.44 104.93 &gt;=35 yrs, non-obese STOP 96.69 12.05 586.99 75.70 123.51 &gt;=35 yrs, obese STOP 78.66 10.03 632.99 61.24 101.05 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.85 (0.76, 0.96) 0.003 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.14 (0.78, 1.69) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.34 (0.90, 2.00) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.75 (0.46, 1.22) 0.4 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.87 (0.53, 1.43) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.65 (0.35, 1.21) 0.3 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.86 (0.77, 0.95) 0.0005 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.92 (0.70, 1.21) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.07 (0.81, 1.42) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.75 (0.56, 0.99) 0.04 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.87 (0.65, 1.16) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.81 (0.55, 1.19) 0.5 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 1.04 (0.94, 1.14) 0.5 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.04 (0.91, 1.18) 0.5 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.83 (0.58, 1.20) 0.3 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.04 (0.67, 1.60) 0.9 "],["hpl-6.html", "8.2 HPL", " 8.2 HPL Model summary Var Effect P (Intercept) 1.95 (1.65, 2.31) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.81 (0.77, 0.85) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.94 (0.80, 1.12) 0.50 Age_BMI_gp&gt;=35 yrs, obese 0.77 (0.63, 0.94) 0.009 StudySTOP 1.12 (1.06, 1.18) &lt;0.0001 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.96 (0.90, 1.02) 0.17 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.04 (0.85, 1.27) 0.71 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.84 (0.67, 1.06) 0.14 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 96.71 2.67 136.81 91.58 102.14 &lt;35 yrs, obese SCOPE 77.95 2.50 244.36 73.17 83.04 &gt;=35 yrs, non-obese SCOPE 91.38 8.00 2456.90 76.96 108.50 &gt;=35 yrs, obese SCOPE 74.35 7.64 2021.35 60.78 90.95 &lt;35 yrs, non-obese STOP 108.06 2.78 103.75 102.69 113.71 &lt;35 yrs, obese STOP 83.27 2.47 177.80 78.54 88.28 &gt;=35 yrs, non-obese STOP 106.12 6.48 1575.55 94.14 119.63 &gt;=35 yrs, obese STOP 69.87 4.41 1712.26 61.73 79.08 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.81 (0.76, 0.86) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 0.94 (0.76, 1.18) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.17 (0.94, 1.47) 0.3 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.77 (0.59, 1.00) 0.05 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.95 (0.73, 1.24) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.81 (0.58, 1.14) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.77 (0.73, 0.81) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.98 (0.85, 1.14) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.27 (1.09, 1.48) 0.0003 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.65 (0.55, 0.75) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.84 (0.72, 0.98) 0.02 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.66 (0.53, 0.81) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 1.12 (1.06, 1.18) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.07 (1.00, 1.15) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 1.16 (0.95, 1.42) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.94 (0.75, 1.18) 0.6 "],["gh2-6.html", "8.3 GH2", " 8.3 GH2 Model summary Var Effect P (Intercept) 91.20 (72.55, 114.67) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.75 (0.70, 0.80) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.07 (0.85, 1.35) 0.54 Age_BMI_gp&gt;=35 yrs, obese 0.73 (0.55, 0.97) 0.03 StudySTOP 0.90 (0.83, 0.96) 0.003 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.19 (1.09, 1.30) 0.0001 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.96 (0.73, 1.27) 0.78 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.25 (0.90, 1.74) 0.18 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 2622.98 75.52 405.04 2478.64 2775.73 &lt;35 yrs, obese SCOPE 1965.30 72.81 896.88 1827.48 2113.52 &gt;=35 yrs, non-obese SCOPE 2819.58 332.88 2640.50 2236.89 3554.04 &gt;=35 yrs, obese SCOPE 1917.88 281.08 2453.00 1438.82 2556.43 &lt;35 yrs, non-obese STOP 2348.22 58.61 252.85 2235.59 2466.53 &lt;35 yrs, obese STOP 2092.72 66.91 552.19 1965.33 2228.37 &gt;=35 yrs, non-obese STOP 2424.72 195.42 2513.99 2070.26 2839.87 &gt;=35 yrs, obese STOP 2149.04 178.51 2529.28 1826.01 2529.21 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.75 (0.69, 0.82) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.07 (0.80, 1.45) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.43 (1.05, 1.95) 0.01 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.73 (0.50, 1.06) 0.1 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.98 (0.67, 1.43) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.68 (0.42, 1.10) 0.2 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.89 (0.83, 0.96) 0.0006 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 1.03 (0.84, 1.27) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.16 (0.94, 1.43) 0.3 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.92 (0.74, 1.13) 0.7 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 1.03 (0.83, 1.27) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.89 (0.66, 1.18) 0.7 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.90 (0.83, 0.96) 0.003 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.06 (0.97, 1.17) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.86 (0.65, 1.14) 0.3 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.12 (0.81, 1.56) 0.5 "],["mets-1.html", "9 MetS", " 9 MetS LME for duplicated or repeated measures. Characteristic No MetS (n=2052) MetS (n=309) Total (n=2361) P-value Prolactin: Median (IQ range) 96.9 (57.7-159.2) 110.6 (59.5-180.3) 98.3 (58.0-163.5) 0.03 HPL: Median (IQ range) 102.1 (54.0-176.4) 127.0 (55.5-173.8) 105.8 (54.0-176.2) 0.29 GH2: Median (IQ range) 2473.8 (1194.0-4183.9) 2715.7 (1498.0-4169.6) 2519.2 (1211.7-4183.1) 0.17 "],["prolactin-7.html", "9.1 Prolactin", " 9.1 Prolactin Model summary Var Effect P (Intercept) 13.69 (9.74, 19.25) &lt;0.0001 metab.C1MetS 0.93 (0.84, 1.04) 0.19 StudySTOP 1.00 (0.90, 1.10) 0.95 GA_samp 1.16 (1.14, 1.18) &lt;0.0001 metab.C1MetS:StudySTOP 1.12 (0.95, 1.31) 0.18 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 98.88 7.36 82.02 85.28 114.65 MetS SCOPE 92.33 7.86 139.51 78.03 109.25 No MetS STOP 98.58 7.08 71.46 85.43 113.76 MetS STOP 102.74 9.40 184.94 85.77 123.08 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.93 (0.84, 1.04) 0.2 MetS / No MetS Study: STOP 1.04 (0.92, 1.18) 0.5 STOP / SCOPE MetS: No MetS 1.00 (0.90, 1.10) 1.0 STOP / SCOPE MetS: MetS 1.11 (0.94, 1.32) 0.2 "],["hpl-7.html", "9.2 HPL", " 9.2 HPL Model summary Var Effect P (Intercept) 1.95 (1.63, 2.33) &lt;0.0001 metab.C1MetS 0.88 (0.83, 0.93) &lt;0.0001 StudySTOP 1.09 (1.03, 1.15) 0.002 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.95 (0.87, 1.04) 0.26 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 92.95 2.58 131.16 87.98 98.20 MetS SCOPE 81.93 2.94 346.90 76.35 87.92 No MetS STOP 101.53 2.63 100.07 96.44 106.88 MetS STOP 85.14 3.44 522.03 78.64 92.17 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.88 (0.83, 0.93) &lt;0.0001 MetS / No MetS Study: STOP 0.84 (0.78, 0.90) &lt;0.0001 STOP / SCOPE MetS: No MetS 1.09 (1.03, 1.15) 0.002 STOP / SCOPE MetS: MetS 1.04 (0.95, 1.14) 0.4 "],["gh2-7.html", "9.3 GH2", " 9.3 GH2 Model summary Var Effect P (Intercept) 89.01 (69.73, 113.63) &lt;0.0001 metab.C1MetS 0.87 (0.80, 0.94) 0.0006 StudySTOP 0.91 (0.84, 0.98) 0.01 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 metab.C1MetS:StudySTOP 1.13 (1.00, 1.27) 0.06 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 2490.45 72.23 383.70 2352.41 2636.59 MetS SCOPE 2165.59 94.02 1279.48 1988.79 2358.12 No MetS STOP 2264.98 56.60 233.99 2156.18 2379.28 MetS STOP 2217.76 109.81 1599.39 2012.50 2443.96 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.87 (0.80, 0.94) 0.0006 MetS / No MetS Study: STOP 0.98 (0.89, 1.07) 0.7 STOP / SCOPE MetS: No MetS 0.91 (0.84, 0.98) 0.01 STOP / SCOPE MetS: MetS 1.02 (0.90, 1.17) 0.7 "],["hormone-models.html", "10 Hormone Models", " 10 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 33 0 15wks 884 1244 "],["raw-plots.html", "10.1 Raw plots", " 10.1 Raw plots "],["scope-vs-stop.html", "10.2 SCOPE vs STOP", " 10.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Outcomes: Prolactin, hPL, GH2 (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Random intercepts for Study ID and Plate 10.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 35.621390 1 &lt;0.0001 *** Study 1.159630 1 0.3 ns GA_samp 55.874766 1 &lt;0.0001 *** Study:GA_samp 0.972037 1 0.3 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 109.17041 1 &lt;0.0001 *** Study 65.90714 1 &lt;0.0001 *** GA_samp 160.38601 1 &lt;0.0001 *** Study:GA_samp 74.84180 1 &lt;0.0001 *** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 416.58309 1 &lt;0.0001 *** Study 33.94750 1 &lt;0.0001 *** GA_samp 72.32611 1 &lt;0.0001 *** Study:GA_samp 32.10571 1 &lt;0.0001 *** 10.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 2.20 (1.48, 2.93) &lt;0.0001 StudySTOP 0.41 (-0.34, 1.16) 0.28 GA_samp 0.18 (0.13, 0.22) &lt;0.0001 StudySTOP:GA_samp -0.03 (-0.08, 0.02) 0.32 HPL Var Effect P (Intercept) 2.34 (1.90, 2.78) &lt;0.0001 StudySTOP -1.89 (-2.35, -1.43) &lt;0.0001 GA_samp 0.18 (0.15, 0.21) &lt;0.0001 StudySTOP:GA_samp 0.13 (0.10, 0.16) &lt;0.0001 GH2 Var Effect P (Intercept) 5.91 (5.34, 6.48) &lt;0.0001 StudySTOP -1.77 (-2.36, -1.16) &lt;0.0001 GA_samp 0.16 (0.12, 0.20) &lt;0.0001 StudySTOP:GA_samp 0.11 (0.07, 0.15) &lt;0.0001 10.2.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 10.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Prolactin Study GA_samp response SE df lower.CL upper.CL SCOPE 10 52.20298 7.642610 852.16020 39.16523 69.58089 STOP 10 61.26906 4.334108 67.45772 53.20206 70.55926 SCOPE 16 149.24211 10.586727 68.10219 129.54417 171.93522 STOP 16 150.63615 12.611752 131.30615 127.64415 177.76961 HPL Study GA_samp response SE df lower.CL upper.CL SCOPE 10 63.94582 5.2810638 1795.99829 54.38348 75.18953 STOP 10 36.84189 0.9514515 87.71519 34.99870 38.78215 SCOPE 16 190.64855 4.9736027 89.80336 181.01903 200.79033 STOP 16 245.48424 8.8185078 311.72152 228.73193 263.46349 GH2 Study GA_samp response SE df lower.CL upper.CL SCOPE 10 1806.5234 190.03309 1270.4841 1469.6639 2220.594 STOP 10 970.0657 23.01475 179.0626 925.6974 1016.561 SCOPE 16 4680.0856 112.45969 168.4486 4463.2572 4907.448 STOP 16 4994.8011 207.13235 1090.9490 4604.4739 5418.217 10.2.5 Comparisons Hormone Contrast Ratio of Geometric means (95% CI) P-value Prolactin STOP / SCOPE 1.17 (0.90, 1.52) 0.2 Prolactin STOP / SCOPE 1.01 (0.90, 1.13) 0.9 HPL STOP / SCOPE 0.58 (0.49, 0.68) &lt;0.0001 HPL STOP / SCOPE 1.29 (1.21, 1.37) &lt;0.0001 GH2 STOP / SCOPE 0.54 (0.44, 0.66) &lt;0.0001 GH2 STOP / SCOPE 1.07 (0.98, 1.16) 0.1 10.2.6 Plots for GA "],["session-info-4.html", "11 Session info", " 11 Session info Results generated on: 2022-10-23 14:55:44 Click for more details sessionInfo() ## R version 4.2.1 (2022-06-23) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.1 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils datasets ## [9] methods base ## ## other attached packages: ## [1] geepack_1.3.3 ggpubr_0.4.0 car_3.0-13 carData_3.0-5 ## [5] minpack.lm_1.2-2 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] plotly_4.10.0 investr_1.4.2 readxl_1.4.0 nlme_3.1-159 ## [13] lmerTest_3.1-3 lme4_1.1-29 Matrix_1.5-1 emmeans_1.7.3 ## [17] fontawesome_0.2.2 widgetframe_0.3.1 htmlwidgets_1.5.4 kableExtra_1.3.4 ## [21] knitr_1.39 rmarkdown_2.14 ggplot2_3.3.6 devtools_2.4.1 ## [25] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [29] bookdown_0.28 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-1 minqa_1.2.4 colorspace_2.0-3 ggsignif_0.6.3 ## [5] ellipsis_0.3.2 rprojroot_2.0.3 estimability_1.3 fs_1.5.2 ## [9] rstudioapi_0.13 farver_2.1.0 remotes_2.4.2 fansi_1.0.3 ## [13] mvtnorm_1.1-3 xml2_1.3.3 codetools_0.2-18 cachem_1.0.4 ## [17] pkgload_1.2.4 jsonlite_1.8.0 nloptr_2.0.1 pbkrtest_0.5.1 ## [21] broom_0.8.0 compiler_4.2.1 httr_1.4.4 backports_1.4.1 ## [25] assertthat_0.2.1 fastmap_1.1.0 lazyeval_0.2.2 cli_3.3.0 ## [29] htmltools_0.5.2 prettyunits_1.1.1 tools_4.2.1 coda_0.19-4 ## [33] gtable_0.3.0 glue_1.6.2 dplyr_1.0.9 Rcpp_1.0.8.3 ## [37] cellranger_1.1.0 jquerylib_0.1.4 vctrs_0.4.1 svglite_2.1.0 ## [41] crosstalk_1.2.0 xfun_0.30 stringr_1.4.0 ps_1.7.0 ## [45] brio_1.1.3 testthat_3.1.4 rvest_1.0.2 lifecycle_1.0.1 ## [49] rstatix_0.7.0 MASS_7.3-58 zoo_1.8-10 scales_1.2.0 ## [53] sandwich_3.0-1 yaml_2.3.5 memoise_2.0.0 sass_0.4.1 ## [57] stringi_1.7.6 highr_0.9 desc_1.4.1 boot_1.3-28 ## [61] pkgbuild_1.3.1 rlang_1.0.4 pkgconfig_2.0.3 systemfonts_1.0.4 ## [65] evaluate_0.15 lattice_0.20-45 purrr_0.3.4 labeling_0.4.2 ## [69] processx_3.5.3 tidyselect_1.1.2 R6_2.5.1 generics_0.1.3 ## [73] multcomp_1.4-19 DBI_1.1.2 mgcv_1.8-40 pillar_1.8.1 ## [77] withr_2.5.0 survival_3.4-0 abind_1.4-5 tibble_3.1.8 ## [81] crayon_1.5.1 utf8_1.2.2 data.table_1.14.2 callr_3.7.0 ## [85] digest_0.6.29 webshot_0.5.3 xtable_1.8-4 tidyr_1.2.0 ## [89] numDeriv_2016.8-1.1 munsell_0.5.0 viridisLite_0.4.0 bslib_0.3.1 ## [93] sessioninfo_1.2.2 "],["part-uncomplicated-pregnancies.html", "(PART*) Uncomplicated Pregnancies", " (PART*) Uncomplicated Pregnancies "],["descriptives-1.html", "12 Descriptives", " 12 Descriptives Descriptives on raw data. Tables in this section are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value PRL (pg/ml): Mean (SD) 183.6 (194.8) 107.0 (139.0) 138.0 (168.0) &lt;0.0001 hPL (mg/l): Mean (SD) 187.1 (56.7) 76.5 (50.1) 121.1 (75.8) &lt;0.0001 GH2 (pg/ml): Mean (SD) 4631.1 (1945.1) 1921.9 (1567.8) 3018.4 (2182.1) &lt;0.0001 "],["by-study-1.html", "12.1 By Study", " 12.1 By Study 12.1.1 Demographics Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 25.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 694 (97.6) 1285 (97.7) &gt;=35 13 (2.2) 17 (2.4) 30 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 25.3 (22.4-29.5) 25.2 (22.2-29.4) 0.27 Maternal BMI (category): N(%) 0.41 Missing 0 (0.0) 1 (0.1) 1 (0.1) &lt;20 64 (10.6) 55 (7.7) 119 (9.0) &gt;=20 to &lt;25 228 (37.7) 278 (39.1) 506 (38.5) &gt;=25 to &lt;30 176 (29.1) 212 (29.8) 388 (29.5) &gt;=30 to &lt;40 117 (19.4) 136 (19.1) 253 (19.2) &gt;=40 19 (3.1) 29 (4.1) 48 (3.7) SEI: Median (IQ range) 24.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-36.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Aboriginal 9 (1.5) 13 (1.8) 22 (1.7) African 3 (0.5) 11 (1.5) 14 (1.1) Caucasian 555 (91.9) 595 (83.7) 1150 (87.5) China and Japan 0 (0.0) 10 (1.4) 10 (0.8) Hispanic 0 (0.0) 2 (0.3) 2 (0.2) Indian 2 (0.3) 27 (3.8) 29 (2.2) Maori 3 (0.5) 0 (0.0) 3 (0.2) Middle-eastern 4 (0.7) 18 (2.5) 22 (1.7) Other 3 (0.5) 2 (0.3) 5 (0.4) Pacific Islander 0 (0.0) 3 (0.4) 3 (0.2) South East and Far East 25 (4.1) 30 (4.2) 55 (4.2) Smoking: N(%) 0.61 Missing 0 (0.0) 275 (38.7) 275 (20.9) No 476 (78.8) 337 (47.4) 813 (61.8) Yes 128 (21.2) 99 (13.9) 227 (17.3) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;800 335 (55.5) 134 (18.8) 469 (35.7) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;=400 66 (10.9) 7 (1.0) 73 (5.6) &gt;400 to &lt;800 269 (44.5) 127 (17.9) 396 (30.1) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 58 (9.6) 47 (6.6) 105 (8.0) 1-6x/week 222 (36.8) 203 (28.6) 425 (32.3) &gt;=1-&lt;3x/day 221 (36.6) 349 (49.1) 570 (43.3) &gt;=3x/day 103 (17.1) 101 (14.2) 204 (15.5) Leafy vege (1st trim): N(%) 0.52 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 60 (9.9) 73 (10.3) 133 (10.1) 1-2x/week 144 (23.8) 159 (22.4) 303 (23.0) 3-6x/week 220 (36.4) 235 (33.1) 455 (34.6) &gt;=1x/day 180 (29.8) 233 (32.8) 413 (31.4) Fast food (1st trim): N(%) 0.001 Missing 114 (18.9) 93 (13.1) 207 (15.7) Never 12 (2.0) 30 (4.2) 42 (3.2) &gt;0-&lt;2x/week 62 (10.3) 118 (16.6) 180 (13.7) &gt;=2-&lt;4x/week 249 (41.2) 261 (36.7) 510 (38.8) &gt;=4x/week 167 (27.6) 209 (29.4) 376 (28.6) Vigorous exercise: N(%) 0.72 Missing 3 (0.5) 5 (0.7) 8 (0.6) 2-3/wk 50 (8.3) 63 (8.9) 113 (8.6) 4-6/wk 7 (1.2) 12 (1.7) 19 (1.4) Daily 6 (1.0) 12 (1.7) 18 (1.4) More than once a day 0 (0.0) 1 (0.1) 1 (0.1) Never 390 (64.6) 439 (61.7) 829 (63.0) Once a week 148 (24.5) 179 (25.2) 327 (24.9) Moderate exercise: N(%) 0.17 Missing 3 (0.5) 7 (1.0) 10 (0.8) 2-3/wk 134 (22.2) 156 (21.9) 290 (22.1) 4-6/wk 36 (6.0) 49 (6.9) 85 (6.5) Daily 35 (5.8) 48 (6.8) 83 (6.3) More than once a day 2 (0.3) 12 (1.7) 14 (1.1) Never 248 (41.1) 266 (37.4) 514 (39.1) Once a week 146 (24.2) 173 (24.3) 319 (24.3) Recreational walking: N(%) 0.24 Missing 3 (0.5) 8 (1.1) 11 (0.8) 2-3/wk 161 (26.7) 170 (23.9) 331 (25.2) 4-6/wk 44 (7.3) 53 (7.5) 97 (7.4) Daily 52 (8.6) 83 (11.7) 135 (10.3) More than once a day 10 (1.7) 6 (0.8) 16 (1.2) Never 147 (24.3) 158 (22.2) 305 (23.2) Once a week 187 (31.0) 233 (32.8) 420 (31.9) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.5 (36.4-45.2) 39.2 (33.8-44.2) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 277.5 (219.0-355.0) 262.0 (206.0-339.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 155.9 (115.7-222.4) 150.5 (109.3-217.2) 0.0006 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 66.7 (24.7) 62.9 (24.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 670.7 (493.5-950.5) 634.4 (480.9-941.9) 0.05 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 61.0 (45.0-76.0) 59.3 (43.0-76.0) 0.02 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 199.0 (127.1-320.1) 156.1 (93.2-257.5) &lt;0.0001 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.6) 0.26 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.07 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.8 (9.7) 129.7 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 12.1.2 MetS Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 51 (7.2) 54 (4.1) No 525 (86.9) 624 (87.8) 1149 (87.4) Yes 76 (12.6) 36 (5.1) 112 (8.5) MetS: number of criteria: Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 81.0 (74.0-89.0) 83.0 (76.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 4.6 (0.8) 5.0 (0.9) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.1 (0.9-1.4) 1.2 (0.9-1.5) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.7 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.7) 2.4 (0.7) 2.7 (0.8) &lt;0.0001 Systolic BP (mmHg): Mean (SD) 107.8 (9.3) 113.9 (9.7) 111.0 (10.0) &lt;0.0001 diastolic BP (mmHg): Mean (SD) 63.4 (7.5) 69.4 (8.2) 66.6 (8.4) &lt;0.0001 Mean arterial pressure (mmHg): Mean (SD) 78.2 (7.1) 84.2 (7.7) 81.4 (8.0) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;80 cm 168 (27.8) 329 (46.3) 497 (37.8) &gt;=80 cm 436 (72.2) 371 (52.2) 807 (61.4) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 10 (1.4) 10 (0.8) &lt;1.7 mmol/L 468 (77.5) 627 (88.2) 1095 (83.3) &gt;=1.7 mmol/L 136 (22.5) 74 (10.4) 210 (16.0) MetS criteria: HDL: N(%) 0.003 Missing 0 (0.0) 10 (1.4) 10 (0.8) &lt;1.3 mmol/L 50 (8.3) 95 (13.4) 145 (11.0) &gt;=1.3 mmol/L 554 (91.7) 606 (85.2) 1160 (88.2) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 3 (0.5) 10 (1.4) 13 (1.0) &lt;5.6 mmol/L 341 (56.5) 648 (91.1) 989 (75.2) &gt;=5.6 mmol/L 260 (43.0) 53 (7.5) 313 (23.8) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130 mmHg 596 (98.7) 634 (89.2) 1230 (93.5) &gt;=130 mmHg 8 (1.3) 44 (6.2) 52 (4.0) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;85 mmHg 602 (99.7) 654 (92.0) 1256 (95.5) &gt;=85 mmHg 2 (0.3) 24 (3.4) 26 (2.0) MetS criteria: BP: Mean (SD) 0.0 (0.1) 0.1 (0.3) 0.1 (0.2) &lt;0.0001 CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 3.1 (1.3-6.0) 3.6 (1.7-6.9) &lt;0.0001 12.1.3 Outcomes Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 40.0 (39.1-40.9) 40.1 (39.3-40.9) 0.010 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3506.0 (3250.0-3786.0) 3526.0 (3270.0-3810.0) 0.03 Birthweight customised centile: Mean (SD) 54.2 (25.1) 53.3 (26.1) 53.7 (25.7) 0.52 Baby sex: N(%) 0.55 Missing 0 (0.0) 1 (0.1) 1 (0.1) Female 313 (51.8) 355 (49.9) 668 (50.8) Male 291 (48.2) 355 (49.9) 646 (49.1) Delivery mode: N(%) 0.15 Missing 0 (0.0) 0 (0.0) 0 (0.0) LSCS in labour 116 (19.2) 147 (20.7) 263 (20.0) Operative vaginal 103 (17.1) 147 (20.7) 250 (19.0) Pre-labour LSCS 24 (4.0) 35 (4.9) 59 (4.5) Unassisted vaginal 361 (59.8) 382 (53.7) 743 (56.5) "],["folate-vs-fa-supplement-1.html", "13 Folate vs FA supplement", " 13 Folate vs FA supplement 13.0.1 FA supp (3 categories) Characteristic None (n=171) &lt;800 (n=469) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 38.7 (32.2-44.2) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 254.5 (199.2-336.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 59.8 (23.4) 66.9 (25.0) 62.9 (24.5) 0.0004 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 151.4 (111.3-225.3) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 637.9 (482.6-1013.6) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.0008 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 57.0 (40.8-76.0) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=122) &lt;800 (n=335) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 37.8 (30.1-43.9) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 252.0 (196.8-327.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.005 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 59.0 (22.8) 65.1 (26.7) 58.8 (23.4) 0.0007 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 143.7 (107.5-210.1) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 618.7 (486.6-988.8) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.03 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 53.6 (38.6-75.0) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Click here for table within STOP Characteristic None (n=49) &lt;800 (n=134) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 39.8 (35.5-44.6) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.002 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 260.5 (205.0-347.2) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.06 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 62.3 (25.0) 67.6 (24.4) 67.4 (25.0) 0.04 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 171.1 (119.0-245.9) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.50 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 758.2 (480.3-1110.3) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.07 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 63.5 (49.2-79.8) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 13.0.2 FA supp (4 categories) Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 36.5 (29.7-42.0) 39.0 (32.7-44.4) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.8 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 255.0 (193.8-338.5) 254.5 (200.0-332.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 56.7 (21.6) 60.4 (23.7) 66.9 (25.0) 62.9 (24.5) 0.0009 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 141.7 (108.7-186.1) 152.4 (111.9-234.0) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 563.0 (487.9-894.8) 649.1 (483.2-1041.9) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.001 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 49.0 (35.7-69.0) 58.8 (42.1-76.4) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=122) &lt;=400 (n=66) &gt;400 to &lt;800 (n=269) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 35.6 (28.9-41.6) 38.4 (30.4-44.2) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 251.0 (192.5-338.0) 252.0 (198.0-318.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.01 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 55.3 (21.3) 59.9 (23.2) 65.1 (26.7) 58.8 (23.4) 0.001 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 131.6 (107.4-184.5) 146.9 (107.8-228.4) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 563.0 (507.4-920.2) 629.2 (483.2-997.7) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.06 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 47.1 (35.5-62.8) 55.6 (40.0-75.8) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Click here for table within STOP Characteristic None (n=49) &lt;=400 (n=7) &gt;400 to &lt;800 (n=127) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 42.1 (36.6-56.3) 39.8 (35.4-44.5) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.006 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.1 (1.1) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 261.0 (203.5-315.5) 260.0 (205.0-346.5) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.12 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 68.0 (23.3) 61.8 (25.3) 67.6 (24.4) 67.4 (25.0) 0.09 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 180.2 (165.0-201.9) 168.0 (116.3-248.2) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.52 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 550.8 (476.6-682.4) 805.2 (504.9-1155.7) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.08 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 76.0 (63.5-104.0) 63.0 (49.0-78.5) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 "],["folate.html", "13.1 Folate", " 13.1 Folate 13.1.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0918622 0.0940957 32.858714 &lt;0.0001 *** folate_cat2&lt;800 0.4044411 0.0532352 7.597252 &lt;0.0001 *** folate_cat2&gt;=800 0.4779058 0.0612912 7.797297 &lt;0.0001 *** StudySTOP 0.4876934 0.0824564 5.914563 &lt;0.0001 *** f1_age 0.0132802 0.0029572 4.490775 &lt;0.0001 *** BMI -0.0056414 0.0023590 -2.391397 0.02 * folate_cat2&lt;800:StudySTOP -0.3899550 0.0960217 -4.061112 &lt;0.0001 *** folate_cat2&gt;=800:StudySTOP -0.3603296 0.0943408 -3.819446 0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.50 (1.29, 1.74) &lt;0.0001 SCOPE: &gt;=800/None 1.61 (1.36, 1.91) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.08 (0.94, 1.23) 1 STOP: &lt;800/None 1.01 (0.81, 1.27) 1 STOP: &gt;=800/None 1.12 (0.92, 1.37) 0.9 STOP: &gt;=800/&lt;800 1.11 (0.97, 1.26) 0.3 None: STOP/SCOPE 1.63 (1.30, 2.05) &lt;0.0001 &lt;800: STOP/SCOPE 1.10 (0.96, 1.27) 0.5 &gt;=800: STOP/SCOPE 1.14 (1.00, 1.29) 0.05 P-value adjustment: bonferroni method for 9 tests 13.1.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0905284 0.0940717 32.852890 &lt;0.0001 *** folate_cat3&lt;=400 0.3173159 0.0767843 4.132562 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4255637 0.0548854 7.753682 &lt;0.0001 *** folate_cat3&gt;=800 0.4775237 0.0612737 7.793285 &lt;0.0001 *** StudySTOP 0.4873285 0.0824325 5.911846 &lt;0.0001 *** f1_age 0.0134131 0.0029575 4.535215 &lt;0.0001 *** BMI -0.0057020 0.0023587 -2.417392 0.02 * folate_cat3&lt;=400:StudySTOP -0.2254040 0.2062415 -1.092913 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4155745 0.0974396 -4.264946 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3600711 0.0943133 -3.817818 0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.37 (1.09, 1.72) 0.0006 SCOPE: &gt;400 to &lt;800/None 1.53 (1.30, 1.80) &lt;0.0001 SCOPE: &gt;=800/None 1.61 (1.34, 1.93) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.17 (0.94, 1.46) 0.5 SCOPE: &gt;=800/&gt;400 to &lt;800 1.05 (0.91, 1.22) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.90 (0.73, 1.10) 1 STOP: &lt;=400/None 1.10 (0.62, 1.93) 1 STOP: &gt;400 to &lt;800/None 1.01 (0.80, 1.28) 1 STOP: &gt;=800/None 1.12 (0.91, 1.39) 1 STOP: &gt;=800/&lt;=400 1.03 (0.60, 1.75) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.96, 1.28) 0.4 STOP: &lt;=400/&gt;400 to &lt;800 1.09 (0.63, 1.87) 1 None: STOP/SCOPE 1.63 (1.28, 2.08) &lt;0.0001 &lt;=400: STOP/SCOPE 1.30 (0.74, 2.28) 1 &gt;400 to &lt;800: STOP/SCOPE 1.07 (0.92, 1.26) 1 &gt;=800: STOP/SCOPE 1.14 (0.99, 1.30) 0.10 P-value adjustment: bonferroni method for 16 tests "],["b12.html", "13.2 B12", " 13.2 B12 13.2.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4221270 0.0745587 72.7228994 &lt;0.0001 *** folate_cat2&lt;800 0.1122967 0.0421820 2.6621912 0.008 ** folate_cat2&gt;=800 0.1217016 0.0485654 2.5059308 0.01 * StudySTOP 0.1714030 0.0653361 2.6234043 0.009 ** f1_age 0.0106478 0.0023432 4.5440955 &lt;0.0001 *** BMI -0.0098606 0.0018692 -5.2752170 &lt;0.0001 *** folate_cat2&lt;800:StudySTOP -0.1600879 0.0760849 -2.1040696 0.04 * folate_cat2&gt;=800:StudySTOP -0.0702722 0.0747530 -0.9400586 0.35 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.12 (1.00, 1.26) 0.07 SCOPE: &gt;=800/None 1.13 (0.99, 1.29) 0.1 SCOPE: &gt;=800/&lt;800 1.01 (0.91, 1.12) 1 STOP: &lt;800/None 0.95 (0.80, 1.14) 1 STOP: &gt;=800/None 1.05 (0.90, 1.23) 1 STOP: &gt;=800/&lt;800 1.10 (1.00, 1.23) 0.07 None: STOP/SCOPE 1.19 (0.99, 1.42) 0.08 &lt;800: STOP/SCOPE 1.01 (0.91, 1.13) 1 &gt;=800: STOP/SCOPE 1.11 (1.00, 1.22) 0.05 P-value adjustment: bonferroni method for 9 tests 13.2.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4221799 0.0746248 72.6592525 &lt;0.0001 *** folate_cat3&lt;=400 0.1116077 0.0609111 1.8323054 0.07 ns folate_cat3&gt;400 to &lt;800 0.1124641 0.0435392 2.5830535 0.010 ** folate_cat3&gt;=800 0.1216999 0.0486069 2.5037563 0.01 * StudySTOP 0.1713993 0.0653917 2.6211177 0.009 ** f1_age 0.0106483 0.0023461 4.5386395 &lt;0.0001 *** BMI -0.0098630 0.0018711 -5.2711581 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.1894511 0.1636063 -1.1579699 0.25 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1585432 0.0772964 -2.0511079 0.04 * folate_cat3&gt;=800:StudySTOP -0.0702675 0.0748164 -0.9391987 0.35 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.12 (0.93, 1.34) 1 SCOPE: &gt;400 to &lt;800/None 1.12 (0.98, 1.27) 0.2 SCOPE: &gt;=800/None 1.13 (0.98, 1.30) 0.2 SCOPE: &gt;=800/&lt;=400 1.01 (0.85, 1.20) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.01 (0.90, 1.14) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 1.00 (0.85, 1.17) 1 STOP: &lt;=400/None 0.93 (0.59, 1.45) 1 STOP: &gt;400 to &lt;800/None 0.95 (0.79, 1.15) 1 STOP: &gt;=800/None 1.05 (0.89, 1.25) 1 STOP: &gt;=800/&lt;=400 1.14 (0.75, 1.74) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.10 (0.98, 1.24) 0.2 STOP: &lt;=400/&gt;400 to &lt;800 0.97 (0.63, 1.49) 1 None: STOP/SCOPE 1.19 (0.98, 1.44) 0.1 &lt;=400: STOP/SCOPE 0.98 (0.63, 1.53) 1 &gt;400 to &lt;800: STOP/SCOPE 1.01 (0.89, 1.15) 1 &gt;=800: STOP/SCOPE 1.11 (0.99, 1.23) 0.09 P-value adjustment: bonferroni method for 16 tests "],["homocysteine.html", "13.3 Homocysteine", " 13.3 Homocysteine 13.3.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5756808 0.0444031 35.4858518 &lt;0.0001 *** folate_cat2&lt;800 -0.1151020 0.0251167 -4.5826830 &lt;0.0001 *** folate_cat2&gt;=800 -0.1623759 0.0289179 -5.6150683 &lt;0.0001 *** StudySTOP 0.0302406 0.0389037 0.7773193 0.44 ns f1_age 0.0005980 0.0013961 0.4283576 0.67 ns BMI 0.0002349 0.0011148 0.2106636 0.83 ns folate_cat2&lt;800:StudySTOP 0.1285288 0.0453036 2.8370549 0.005 ** folate_cat2&gt;=800:StudySTOP 0.0856836 0.0445148 1.9248354 0.05 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 0.89 (0.83, 0.96) &lt;0.0001 SCOPE: &gt;=800/None 0.85 (0.78, 0.92) &lt;0.0001 SCOPE: &gt;=800/&lt;800 0.95 (0.89, 1.02) 0.4 STOP: &lt;800/None 1.01 (0.91, 1.13) 1 STOP: &gt;=800/None 0.93 (0.84, 1.02) 0.2 STOP: &gt;=800/&lt;800 0.91 (0.86, 0.97) 0.0005 None: STOP/SCOPE 1.03 (0.93, 1.15) 1 &lt;800: STOP/SCOPE 1.17 (1.10, 1.25) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.06, 1.19) &lt;0.0001 P-value adjustment: bonferroni method for 9 tests 13.3.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5755699 0.0444379 35.4555061 &lt;0.0001 *** folate_cat3&lt;=400 -0.1268829 0.0362651 -3.4987635 0.0005 *** folate_cat3&gt;400 to &lt;800 -0.1122455 0.0259222 -4.3300917 &lt;0.0001 *** folate_cat3&gt;=800 -0.1624262 0.0289397 -5.6125727 &lt;0.0001 *** StudySTOP 0.0301903 0.0389329 0.7754434 0.44 ns f1_age 0.0006154 0.0013977 0.4402927 0.66 ns BMI 0.0002245 0.0011159 0.2012125 0.84 ns folate_cat3&lt;=400:StudySTOP 0.1173646 0.0974071 1.2048878 0.23 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.1269687 0.0460204 2.7589678 0.006 ** folate_cat3&gt;=800:StudySTOP 0.0857212 0.0445481 1.9242383 0.05 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 0.88 (0.79, 0.98) 0.008 SCOPE: &gt;400 to &lt;800/None 0.89 (0.83, 0.97) 0.0003 SCOPE: &gt;=800/None 0.85 (0.78, 0.93) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 0.97 (0.87, 1.07) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.95 (0.89, 1.02) 0.6 SCOPE: &lt;=400/&gt;400 to &lt;800 0.99 (0.90, 1.08) 1 STOP: &lt;=400/None 0.99 (0.76, 1.29) 1 STOP: &gt;400 to &lt;800/None 1.01 (0.91, 1.14) 1 STOP: &gt;=800/None 0.93 (0.84, 1.02) 0.4 STOP: &gt;=800/&lt;=400 0.94 (0.73, 1.20) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.91 (0.85, 0.98) 0.001 STOP: &lt;=400/&gt;400 to &lt;800 0.98 (0.75, 1.26) 1 None: STOP/SCOPE 1.03 (0.92, 1.16) 1 &lt;=400: STOP/SCOPE 1.16 (0.89, 1.51) 1 &gt;400 to &lt;800: STOP/SCOPE 1.17 (1.09, 1.26) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.05, 1.20) &lt;0.0001 P-value adjustment: bonferroni method for 16 tests "],["active-b12.html", "13.4 Active B12", " 13.4 Active B12 13.4.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6122690 0.1028613 35.117846 &lt;0.0001 *** folate_cat2&lt;800 0.1367106 0.0555196 2.462387 0.01 * folate_cat2&gt;=800 0.2164003 0.0633348 3.416767 0.0007 *** StudySTOP 0.4286753 0.0919347 4.662825 &lt;0.0001 *** f1_age 0.0076438 0.0033803 2.261274 0.02 * BMI 0.0029555 0.0026004 1.136572 0.26 ns folate_cat2&lt;800:StudySTOP -0.4092640 0.1100691 -3.718247 0.0002 *** folate_cat2&gt;=800:StudySTOP -0.3901251 0.1049792 -3.716212 0.0002 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.15 (0.98, 1.34) 0.1 SCOPE: &gt;=800/None 1.24 (1.04, 1.48) 0.006 SCOPE: &gt;=800/&lt;800 1.08 (0.94, 1.25) 1 STOP: &lt;800/None 0.76 (0.58, 0.99) 0.04 STOP: &gt;=800/None 0.84 (0.67, 1.06) 0.4 STOP: &gt;=800/&lt;800 1.10 (0.94, 1.30) 0.8 None: STOP/SCOPE 1.54 (1.19, 1.98) &lt;0.0001 &lt;800: STOP/SCOPE 1.02 (0.86, 1.21) 1 &gt;=800: STOP/SCOPE 1.04 (0.90, 1.20) 1 P-value adjustment: bonferroni method for 9 tests 13.4.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6107066 0.1029489 35.0727978 &lt;0.0001 *** folate_cat3&lt;=400 0.0765721 0.0837526 0.9142653 0.36 ns folate_cat3&gt;400 to &lt;800 0.1509771 0.0574959 2.6258750 0.009 ** folate_cat3&gt;=800 0.2164867 0.0633662 3.4164408 0.0007 *** StudySTOP 0.4288045 0.0919802 4.6619199 &lt;0.0001 *** f1_age 0.0076339 0.0033820 2.2571861 0.02 * BMI 0.0030216 0.0026033 1.1606941 0.25 ns folate_cat3&lt;=400:StudySTOP -0.2189817 0.2258022 -0.9697942 0.33 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4336678 0.1120755 -3.8694268 0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3903496 0.1050317 -3.7164949 0.0002 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.08 (0.84, 1.38) 1 SCOPE: &gt;400 to &lt;800/None 1.16 (0.98, 1.38) 0.1 SCOPE: &gt;=800/None 1.24 (1.03, 1.50) 0.01 SCOPE: &gt;=800/&lt;=400 1.15 (0.90, 1.47) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.07 (0.91, 1.26) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.93 (0.74, 1.17) 1 STOP: &lt;=400/None 0.87 (0.47, 1.62) 1 STOP: &gt;400 to &lt;800/None 0.75 (0.57, 1.00) 0.06 STOP: &gt;=800/None 0.84 (0.65, 1.08) 0.6 STOP: &gt;=800/&lt;=400 0.97 (0.54, 1.73) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.93, 1.33) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.15 (0.63, 2.09) 1 None: STOP/SCOPE 1.54 (1.17, 2.02) &lt;0.0001 &lt;=400: STOP/SCOPE 1.23 (0.67, 2.28) 1 &gt;400 to &lt;800: STOP/SCOPE 1.00 (0.82, 1.20) 1 &gt;=800: STOP/SCOPE 1.04 (0.89, 1.21) 1 P-value adjustment: bonferroni method for 16 tests "],["folateb12.html", "13.5 Folate:B12", " 13.5 Folate:B12 13.5.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5774904 0.1135284 40.3202170 &lt;0.0001 *** folate_cat2&lt;800 0.2921444 0.0642294 4.5484542 &lt;0.0001 *** folate_cat2&gt;=800 0.3562042 0.0739492 4.8168797 &lt;0.0001 *** StudySTOP 0.3162904 0.0994854 3.1792654 0.002 ** f1_age 0.0026324 0.0035680 0.7377927 0.46 ns BMI 0.0042192 0.0028462 1.4823900 0.14 ns folate_cat2&lt;800:StudySTOP -0.2298671 0.1158523 -1.9841398 0.05 * folate_cat2&gt;=800:StudySTOP -0.2900574 0.1138242 -2.5482928 0.01 * Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.34 (1.12, 1.60) &lt;0.0001 SCOPE: &gt;=800/None 1.43 (1.16, 1.75) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.07 (0.91, 1.26) 1 STOP: &lt;800/None 1.06 (0.81, 1.39) 1 STOP: &gt;=800/None 1.07 (0.84, 1.36) 1 STOP: &gt;=800/&lt;800 1.00 (0.86, 1.18) 1 None: STOP/SCOPE 1.37 (1.04, 1.81) 0.01 &lt;800: STOP/SCOPE 1.09 (0.92, 1.29) 1 &gt;=800: STOP/SCOPE 1.03 (0.88, 1.20) 1 P-value adjustment: bonferroni method for 9 tests 13.5.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5761038 0.1135359 40.3053372 &lt;0.0001 *** folate_cat3&lt;=400 0.2057082 0.0926716 2.2197548 0.03 * folate_cat3&gt;400 to &lt;800 0.3130996 0.0662416 4.7266319 &lt;0.0001 *** folate_cat3&gt;=800 0.3558238 0.0739518 4.8115659 &lt;0.0001 *** StudySTOP 0.3159292 0.0994885 3.1755350 0.002 ** f1_age 0.0027648 0.0035695 0.7745620 0.44 ns BMI 0.0041610 0.0028468 1.4616578 0.14 ns folate_cat3&lt;=400:StudySTOP -0.0359529 0.2489145 -0.1444386 0.89 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2570313 0.1176006 -2.1856289 0.03 * folate_cat3&gt;=800:StudySTOP -0.2898036 0.1138275 -2.5459896 0.01 * Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.23 (0.93, 1.62) 0.4 SCOPE: &gt;400 to &lt;800/None 1.37 (1.12, 1.66) &lt;0.0001 SCOPE: &gt;=800/None 1.43 (1.15, 1.78) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.16 (0.89, 1.51) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.04 (0.87, 1.25) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.90 (0.70, 1.15) 1 STOP: &lt;=400/None 1.19 (0.60, 2.35) 1 STOP: &gt;400 to &lt;800/None 1.06 (0.79, 1.41) 1 STOP: &gt;=800/None 1.07 (0.83, 1.38) 1 STOP: &gt;=800/&lt;=400 0.90 (0.47, 1.72) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.01 (0.85, 1.20) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.12 (0.58, 2.16) 1 None: STOP/SCOPE 1.37 (1.02, 1.84) 0.02 &lt;=400: STOP/SCOPE 1.32 (0.67, 2.60) 1 &gt;400 to &lt;800: STOP/SCOPE 1.06 (0.88, 1.28) 1 &gt;=800: STOP/SCOPE 1.03 (0.87, 1.21) 1 P-value adjustment: bonferroni method for 16 tests "],["folateactive-b12.html", "13.6 Folate:Active B12", " 13.6 Folate:Active B12 13.6.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5761805 0.1554473 42.3048944 &lt;0.0001 *** folate_cat2&lt;800 0.2297706 0.0839029 2.7385302 0.006 ** folate_cat2&gt;=800 0.2003714 0.0957136 2.0934487 0.04 * StudySTOP 0.0302250 0.1389345 0.2175484 0.83 ns f1_age 0.0001884 0.0051084 0.0368818 0.97 ns BMI -0.0097795 0.0039298 -2.4885510 0.01 * folate_cat2&lt;800:StudySTOP 0.0872974 0.1663398 0.5248135 0.60 ns folate_cat2&gt;=800:StudySTOP 0.0707165 0.1586479 0.4457452 0.66 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.26 (1.00, 1.59) 0.06 SCOPE: &gt;=800/None 1.22 (0.94, 1.59) 0.3 SCOPE: &gt;=800/&lt;800 0.97 (0.78, 1.21) 1 STOP: &lt;800/None 1.37 (0.92, 2.05) 0.2 STOP: &gt;=800/None 1.31 (0.92, 1.87) 0.3 STOP: &gt;=800/&lt;800 0.96 (0.75, 1.22) 1 None: STOP/SCOPE 1.03 (0.70, 1.52) 1 &lt;800: STOP/SCOPE 1.12 (0.87, 1.45) 1 &gt;=800: STOP/SCOPE 1.11 (0.89, 1.37) 1 P-value adjustment: bonferroni method for 9 tests 13.6.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5810099 0.1555581 42.3058016 &lt;0.0001 *** folate_cat3&lt;=400 0.1714131 0.1265520 1.3544877 0.18 ns folate_cat3&gt;400 to &lt;800 0.2435284 0.0868776 2.8031201 0.005 ** folate_cat3&gt;=800 0.2002737 0.0957477 2.0916821 0.04 * StudySTOP 0.0299622 0.1389842 0.2155798 0.83 ns f1_age 0.0001536 0.0051103 0.0300603 0.98 ns BMI -0.0099293 0.0039336 -2.5241999 0.01 * folate_cat3&lt;=400:StudySTOP -0.1628045 0.3411921 -0.4771638 0.63 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0977125 0.1693485 0.5769909 0.56 ns folate_cat3&gt;=800:StudySTOP 0.0712919 0.1587051 0.4492099 0.65 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.19 (0.82, 1.73) 1 SCOPE: &gt;400 to &lt;800/None 1.28 (0.99, 1.65) 0.08 SCOPE: &gt;=800/None 1.22 (0.92, 1.62) 0.6 SCOPE: &gt;=800/&lt;=400 1.03 (0.71, 1.49) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.96 (0.75, 1.22) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.93 (0.66, 1.32) 1 STOP: &lt;=400/None 1.01 (0.39, 2.58) 1 STOP: &gt;400 to &lt;800/None 1.41 (0.91, 2.17) 0.3 STOP: &gt;=800/None 1.31 (0.90, 1.91) 0.5 STOP: &gt;=800/&lt;=400 1.30 (0.54, 3.13) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.93 (0.71, 1.22) 1 STOP: &lt;=400/&gt;400 to &lt;800 0.72 (0.29, 1.77) 1 None: STOP/SCOPE 1.03 (0.68, 1.56) 1 &lt;=400: STOP/SCOPE 0.88 (0.35, 2.21) 1 &gt;400 to &lt;800: STOP/SCOPE 1.14 (0.85, 1.52) 1 &gt;=800: STOP/SCOPE 1.11 (0.88, 1.39) 1 P-value adjustment: bonferroni method for 16 tests "],["fa-supp-3-categories-9.html", "14 FA supp: 3 categories", " 14 FA supp: 3 categories Characteristic None (n=171) &lt;800 (n=469) &gt;=800 (n=588) Total (n=1228) P-value Prolactin: Median (IQ range) 115.0 (74.2-192.6) 119.8 (79.0-182.4) 78.4 (49.9-131.9) 99.3 (59.4-162.3) &lt;0.0001 HPL: Median (IQ range) 155.4 (96.8-202.7) 157.2 (91.0-200.9) 73.4 (45.9-136.3) 115.4 (56.9-180.1) &lt;0.0001 GH2: Median (IQ range) 3611.7 (2280.0-4989.5) 3504.6 (2295.8-4880.8) 1750.5 (979.0-3313.9) 2655.3 (1279.9-4214.9) &lt;0.0001 LME for duplicated or repeated measures shown on next page. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(hormone_var,function(x){ #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run))) return(mod)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- hormone_var mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-8.html", "14.1 Prolactin", " 14.1 Prolactin Model summary Var Effect P (Intercept) 8.08 (5.35, 12.21) &lt;0.0001 folate_cat2&lt;800 1.31 (1.16, 1.49) &lt;0.0001 folate_cat2&gt;=800 1.53 (1.31, 1.79) &lt;0.0001 StudySTOP 1.73 (1.37, 2.19) &lt;0.0001 GA_samp 1.18 (1.15, 1.21) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.93 (0.73, 1.20) 0.58 folate_cat2&gt;=800:StudySTOP 0.47 (0.37, 0.61) &lt;0.0001 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 71.87 6.95 139.81 59.37 87.01 &lt;800 SCOPE 94.46 8.42 102.16 79.16 112.72 &gt;=800 SCOPE 110.11 10.77 146.66 90.76 133.59 None STOP 124.23 15.37 334.82 97.39 158.46 &lt;800 STOP 152.23 14.11 119.25 126.71 182.89 &gt;=800 STOP 90.10 7.63 84.03 76.13 106.64 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.31 (1.13, 1.52) &lt;0.0001 &gt;=800 / None Study: SCOPE 1.53 (1.27, 1.84) &lt;0.0001 &gt;=800 / &lt;800 Study: SCOPE 1.17 (1.00, 1.37) 0.06 &lt;800 / None Study: STOP 1.23 (0.95, 1.58) 0.2 &gt;=800 / None Study: STOP 0.73 (0.57, 0.92) 0.005 &gt;=800 / &lt;800 Study: STOP 0.59 (0.52, 0.68) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): None 1.73 (1.37, 2.18) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.61 (1.38, 1.88) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.82 (0.70, 0.96) 0.02 "],["hpl-8.html", "14.2 HPL", " 14.2 HPL Model summary Var Effect P (Intercept) 1.73 (1.37, 2.19) &lt;0.0001 folate_cat2&lt;800 1.02 (0.95, 1.10) 0.56 folate_cat2&gt;=800 1.02 (0.93, 1.11) 0.67 StudySTOP 1.21 (1.07, 1.38) 0.003 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.96 (0.84, 1.10) 0.56 folate_cat2&gt;=800:StudySTOP 0.93 (0.81, 1.07) 0.33 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 90.73 3.87 430.87 83.43 98.67 &lt;800 SCOPE 92.79 3.26 219.96 86.59 99.44 &gt;=800 SCOPE 92.51 3.84 386.38 85.25 100.38 None STOP 110.03 6.22 767.33 98.48 122.94 &lt;800 STOP 108.07 4.16 304.34 100.18 116.58 &gt;=800 STOP 104.78 3.32 149.06 98.42 111.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.02 (0.93, 1.12) 0.8 &gt;=800 / None Study: SCOPE 1.02 (0.92, 1.13) 0.9 &gt;=800 / &lt;800 Study: SCOPE 1.00 (0.91, 1.09) 1.0 &lt;800 / None Study: STOP 0.98 (0.86, 1.13) 0.9 &gt;=800 / None Study: STOP 0.95 (0.84, 1.08) 0.6 &gt;=800 / &lt;800 Study: STOP 0.97 (0.90, 1.05) 0.6 STOP / SCOPE Folic acid supplement (μg): None 1.21 (1.07, 1.38) 0.003 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.16 (1.07, 1.27) 0.0008 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.13 (1.03, 1.24) 0.008 "],["gh2-8.html", "14.3 GH2", " 14.3 GH2 Model summary Var Effect P (Intercept) 85.03 (63.65, 113.22) &lt;0.0001 folate_cat2&lt;800 1.05 (0.96, 1.15) 0.31 folate_cat2&gt;=800 1.07 (0.96, 1.20) 0.21 StudySTOP 1.10 (0.93, 1.30) 0.25 GA_samp 1.28 (1.26, 1.31) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.83 (0.70, 1.00) 0.05 folate_cat2&gt;=800:StudySTOP 0.79 (0.66, 0.95) 0.01 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2354.20 114.41 601.70 2139.91 2589.95 &lt;800 SCOPE 2466.39 98.49 342.77 2280.07 2667.93 &gt;=800 SCOPE 2527.38 125.75 651.98 2292.14 2786.76 None STOP 2594.74 191.47 983.88 2244.95 2999.03 &lt;800 STOP 2268.91 101.76 491.96 2077.53 2477.93 &gt;=800 STOP 2211.34 77.35 216.79 2064.02 2369.18 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.05 (0.94, 1.17) 0.6 &gt;=800 / None Study: SCOPE 1.07 (0.94, 1.23) 0.4 &gt;=800 / &lt;800 Study: SCOPE 1.02 (0.91, 1.15) 0.9 &lt;800 / None Study: STOP 0.87 (0.73, 1.05) 0.2 &gt;=800 / None Study: STOP 0.85 (0.72, 1.01) 0.07 &gt;=800 / &lt;800 Study: STOP 0.97 (0.88, 1.08) 0.8 STOP / SCOPE Folic acid supplement (μg): None 1.10 (0.93, 1.30) 0.3 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.92 (0.83, 1.02) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.87 (0.78, 0.98) 0.02 "],["fa-supp-4-categories-9.html", "15 FA supp: 4 categories", " 15 FA supp: 4 categories Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Prolactin: Median (IQ range) 115.0 (74.2-192.6) 128.5 (97.9-199.9) 116.4 (74.9-178.1) 78.4 (49.9-131.9) 99.3 (59.4-162.3) &lt;0.0001 HPL: Median (IQ range) 155.4 (96.8-202.7) 175.7 (134.9-196.7) 154.1 (81.0-201.2) 73.4 (45.9-136.3) 115.4 (56.9-180.1) &lt;0.0001 GH2: Median (IQ range) 3611.7 (2280.0-4989.5) 4107.2 (3207.4-5667.6) 3336.6 (2114.3-4631.7) 1750.5 (979.0-3313.9) 2655.3 (1279.9-4214.9) &lt;0.0001 LME for duplicated or repeated measures. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-9.html", "15.1 Prolactin", " 15.1 Prolactin Model summary Var Effect P (Intercept) 7.87 (5.20, 11.92) &lt;0.0001 folate_cat3&lt;=400 1.24 (1.05, 1.46) 0.01 folate_cat3&gt;400 to &lt;800 1.36 (1.18, 1.56) &lt;0.0001 folate_cat3&gt;=800 1.54 (1.32, 1.81) &lt;0.0001 StudySTOP 1.75 (1.38, 2.21) &lt;0.0001 GA_samp 1.18 (1.15, 1.21) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.14 (0.66, 1.96) 0.65 folate_cat3&gt;400 to &lt;800:StudySTOP 0.90 (0.69, 1.16) 0.41 folate_cat3&gt;=800:StudySTOP 0.47 (0.36, 0.61) &lt;0.0001 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 71.12 6.89 141.07 58.72 86.14 &lt;=400 SCOPE 88.11 9.58 215.58 71.11 109.18 &gt;400 to &lt;800 SCOPE 96.52 8.81 112.27 80.55 115.65 &gt;=800 SCOPE 109.84 10.75 146.98 90.52 133.28 None STOP 124.42 15.42 336.04 97.51 158.76 &lt;=400 STOP 175.23 45.83 1035.17 104.88 292.76 &gt;400 to &lt;800 STOP 151.39 14.13 122.38 125.86 182.11 &gt;=800 STOP 90.05 7.63 84.06 76.08 106.58 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.24 (1.00, 1.54) 0.05 &gt;400 to &lt;800 / None Study: SCOPE 1.36 (1.14, 1.62) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.10 (0.89, 1.35) 0.7 &gt;=800 / None Study: SCOPE 1.54 (1.26, 1.89) &lt;0.0001 &gt;=800 / &lt;=400 Study: SCOPE 1.25 (0.99, 1.57) 0.07 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.14 (0.95, 1.37) 0.3 &lt;=400 / None Study: STOP 1.41 (0.71, 2.80) 0.6 &gt;400 to &lt;800 / None Study: STOP 1.22 (0.92, 1.61) 0.3 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.86 (0.45, 1.67) 0.9 &gt;=800 / None Study: STOP 0.72 (0.56, 0.94) 0.009 &gt;=800 / &lt;=400 Study: STOP 0.51 (0.27, 0.98) 0.04 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.59 (0.51, 0.69) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): None 1.75 (1.38, 2.21) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.99 (1.18, 3.35) 0.010 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.57 (1.33, 1.84) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.82 (0.70, 0.96) 0.02 "],["hpl-9.html", "15.2 HPL", " 15.2 HPL Model summary Var Effect P (Intercept) 1.72 (1.35, 2.18) &lt;0.0001 folate_cat3&lt;=400 1.04 (0.94, 1.15) 0.48 folate_cat3&gt;400 to &lt;800 1.02 (0.94, 1.10) 0.64 folate_cat3&gt;=800 1.02 (0.93, 1.11) 0.66 StudySTOP 1.22 (1.07, 1.38) 0.003 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.12 (0.84, 1.49) 0.46 folate_cat3&gt;400 to &lt;800:StudySTOP 0.96 (0.83, 1.10) 0.53 folate_cat3&gt;=800:StudySTOP 0.93 (0.81, 1.07) 0.33 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 90.59 3.87 428.87 83.29 98.53 &lt;=400 SCOPE 94.10 4.89 707.89 84.96 104.22 &gt;400 to &lt;800 SCOPE 92.30 3.40 258.19 85.84 99.24 &gt;=800 SCOPE 92.40 3.84 384.08 85.15 100.27 None STOP 110.09 6.22 763.59 98.54 123.01 &lt;=400 STOP 127.63 16.72 963.20 98.70 165.04 &gt;400 to &lt;800 STOP 107.24 4.19 315.34 99.31 115.80 &gt;=800 STOP 104.86 3.33 148.50 98.49 111.65 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.04 (0.90, 1.19) 0.9 &gt;400 to &lt;800 / None Study: SCOPE 1.02 (0.92, 1.13) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.98 (0.86, 1.11) 1.0 &gt;=800 / None Study: SCOPE 1.02 (0.91, 1.15) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.86, 1.13) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.91, 1.11) 1.0 &lt;=400 / None Study: STOP 1.16 (0.81, 1.65) 0.7 &gt;400 to &lt;800 / None Study: STOP 0.97 (0.84, 1.13) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.84 (0.60, 1.18) 0.5 &gt;=800 / None Study: STOP 0.95 (0.83, 1.09) 0.8 &gt;=800 / &lt;=400 Study: STOP 0.82 (0.59, 1.15) 0.4 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.98 (0.90, 1.07) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.22 (1.07, 1.38) 0.003 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.36 (1.03, 1.78) 0.03 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.16 (1.06, 1.27) 0.002 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.13 (1.04, 1.24) 0.007 "],["gh2-9.html", "15.3 GH2", " 15.3 GH2 Model summary Var Effect P (Intercept) 86.07 (64.37, 114.65) &lt;0.0001 folate_cat3&lt;=400 1.09 (0.96, 1.23) 0.18 folate_cat3&gt;400 to &lt;800 1.03 (0.94, 1.13) 0.55 folate_cat3&gt;=800 1.07 (0.96, 1.20) 0.23 StudySTOP 1.10 (0.93, 1.30) 0.28 GA_samp 1.28 (1.26, 1.31) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.67 (0.46, 1.00) 0.05 folate_cat3&gt;400 to &lt;800:StudySTOP 0.86 (0.71, 1.03) 0.10 folate_cat3&gt;=800:StudySTOP 0.80 (0.66, 0.96) 0.01 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2363.48 115.04 605.30 2148.02 2600.55 &lt;=400 SCOPE 2570.60 152.26 859.05 2288.47 2887.51 &gt;400 to &lt;800 SCOPE 2434.36 104.08 427.11 2238.15 2647.77 &gt;=800 SCOPE 2529.85 125.84 653.29 2294.43 2789.42 None STOP 2593.17 191.28 982.85 2243.71 2997.07 &lt;=400 STOP 1901.89 341.53 1034.53 1337.06 2705.32 &gt;400 to &lt;800 STOP 2291.52 104.37 512.97 2095.39 2506.01 &gt;=800 STOP 2212.89 77.39 217.63 2065.50 2370.80 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.09 (0.93, 1.28) 0.5 &gt;400 to &lt;800 / None Study: SCOPE 1.03 (0.91, 1.17) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.95 (0.81, 1.10) 0.8 &gt;=800 / None Study: SCOPE 1.07 (0.93, 1.24) 0.6 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.83, 1.16) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.04 (0.91, 1.18) 0.9 &lt;=400 / None Study: STOP 0.73 (0.45, 1.20) 0.4 &gt;400 to &lt;800 / None Study: STOP 0.88 (0.72, 1.08) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.20 (0.76, 1.92) 0.7 &gt;=800 / None Study: STOP 0.85 (0.71, 1.03) 0.1 &gt;=800 / &lt;=400 Study: STOP 1.16 (0.73, 1.84) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.97 (0.86, 1.08) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.10 (0.93, 1.30) 0.3 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.74 (0.51, 1.07) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.94 (0.84, 1.06) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.87 (0.78, 0.98) 0.02 "],["age-groups-1.html", "16 Age groups", " 16 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=1270) &gt;=35 yrs (n=45) Total (n=1315) P-value PRL (pg/ml): Median (IQ range) 98.4 (59.0-159.8) 77.5 (46.4-112.5) 97.4 (58.4-159.0) 0.04 hPL (mg/l): Median (IQ range) 110.3 (55.1-179.1) 83.2 (49.4-141.7) 108.4 (55.0-178.8) 0.15 GH2 (pg/ml): Median (IQ range) 2576.9 (1216.4-4157.2) 2139.1 (1438.4-3387.1) 2562.5 (1223.4-4147.5) 0.50 Within SCOPE Characteristic &lt;35 yrs (n=587) &gt;=35 yrs (n=17) Total (n=604) P-value PRL (pg/ml): Median (IQ range) 138.3 (95.2-212.0) 138.6 (77.6-193.3) 138.3 (95.0-212.0) 0.54 hPL (mg/l): Median (IQ range) 181.9 (148.4-218.5) 168.6 (119.1-208.4) 181.9 (148.1-218.4) 0.22 GH2 (pg/ml): Median (IQ range) 4183.7 (3302.5-5645.7) 3670.7 (3094.4-5332.9) 4181.4 (3301.5-5645.7) 0.46 Serum folate concentration (nM): Median (IQ range) 36.5 (28.3-43.0) 34.6 (32.1-42.2) 36.4 (28.5-43.0) 1.00 B12 concentration (pM): Median (IQ range) 248.0 (195.0-316.0) 255.0 (218.0-331.8) 248.0 (195.5-316.0) 0.69 Folate:B12 ratio: Median (IQ range) 143.0 (103.0-210.0) 133.8 (117.5-192.9) 142.6 (104.0-207.4) 0.93 Active B12 concentration (pM): Median (IQ range) 54.0 (42.5-72.0) 55.5 (48.0-78.8) 54.0 (43.0-72.0) 0.51 Folate:Active B12 ratio: Median (IQ range) 617.5 (462.2-951.7) 500.8 (390.1-718.5) 617.0 (458.5-931.9) 0.21 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.2 (3.9-4.6) 4.4 (3.8-5.0) 0.67 Within STOP Characteristic &lt;35 yrs (n=683) &gt;=35 yrs (n=28) Total (n=711) P-value PRL (pg/ml): Median (IQ range) 73.5 (48.7-117.3) 52.6 (38.2-90.3) 73.0 (48.4-115.1) 0.08 hPL (mg/l): Median (IQ range) 61.6 (41.9-96.3) 68.1 (39.3-83.4) 62.1 (41.7-95.8) 0.92 GH2 (pg/ml): Median (IQ range) 1429.6 (907.3-2427.3) 1626.4 (1075.3-2221.4) 1442.4 (914.3-2407.3) 0.59 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-44.9) 44.0 (41.2-97.7) 40.5 (36.4-45.2) 0.001 B12 concentration (pM): Median (IQ range) 277.5 (218.8-354.2) 283.5 (228.5-363.0) 277.5 (219.0-355.0) 0.81 Folate:B12 ratio: Median (IQ range) 155.5 (114.9-219.5) 172.7 (132.5-316.0) 155.9 (115.7-222.4) 0.06 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 57.0 (54.5-83.5) 63.0 (48.0-80.0) 0.82 Folate:Active B12 ratio: Median (IQ range) 670.5 (493.5-950.0) 747.4 (505.0-965.5) 670.7 (493.5-950.5) 0.86 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.8 (4.4-5.8) 4.8 (4.3-5.6) 0.40 Red cell folate (nmol/L): Median (IQ range) 1435.0 (1202.0-1760.0) 1592.0 (1443.5-1743.0) 1446.5 (1204.8-1755.5) 0.15 mod_ls &lt;- lapply(hormone_var,function(x){ #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) #mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID)&quot;)) #log mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run))) return(mod)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- hormone_var mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-10.html", "16.1 Prolactin", " 16.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 7.66 (5.15, 11.39) &lt;0.0001 Age_gp&gt;=35 yrs 1.11 (0.83, 1.50) 0.47 StudySTOP 1.22 (1.08, 1.38) 0.002 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.62 (0.42, 0.91) 0.01 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 86.78 7.28 88.55 73.45 102.53 &gt;=35 yrs SCOPE 96.75 16.56 908.01 69.14 135.37 &lt;35 yrs STOP 105.77 8.46 73.23 90.19 124.05 &gt;=35 yrs STOP 72.96 10.13 540.68 55.54 95.85 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.11 (0.83, 1.50) 0.5 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.69 (0.55, 0.87) 0.002 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.22 (1.08, 1.38) 0.002 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.75 (0.51, 1.12) 0.2 "],["hpl-10.html", "16.2 HPL", " 16.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.77 (1.43, 2.20) &lt;0.0001 Age_gp&gt;=35 yrs 0.92 (0.78, 1.10) 0.37 StudySTOP 1.15 (1.07, 1.23) &lt;0.0001 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.99 (0.80, 1.24) 0.95 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 89.33 2.84 156.07 83.90 95.11 &gt;=35 yrs SCOPE 82.50 7.65 1425.65 68.77 98.97 &lt;35 yrs STOP 102.50 2.95 106.07 96.82 108.52 &gt;=35 yrs STOP 94.03 6.68 1207.46 81.80 108.10 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.92 (0.77, 1.10) 0.4 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.92 (0.80, 1.05) 0.2 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.15 (1.07, 1.23) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.14 (0.91, 1.43) 0.3 "],["gh2-10.html", "16.3 GH2", " 16.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 79.80 (60.94, 104.37) &lt;0.0001 Age_gp&gt;=35 yrs 0.93 (0.75, 1.14) 0.47 StudySTOP 0.95 (0.87, 1.03) 0.21 GA_samp 1.29 (1.27, 1.32) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.00 (0.77, 1.31) 0.97 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 2353.61 83.83 243.97 2194.15 2524.67 &gt;=35 yrs SCOPE 2178.17 240.14 1399.10 1754.55 2704.06 &lt;35 yrs STOP 2233.65 69.65 149.77 2100.18 2375.60 &gt;=35 yrs STOP 2076.22 176.83 1403.87 1756.78 2453.75 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.93 (0.75, 1.14) 0.5 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.93 (0.79, 1.09) 0.4 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.95 (0.87, 1.03) 0.2 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.95 (0.73, 1.25) 0.7 "],["bmi-groups-1.html", "17 BMI groups", " 17 BMI groups Descriptives with univariate P-values. Characteristic Underweight (n=32) Normal (n=593) Overweight (n=388) Obese (n=301) Total (n=1314) P-value PRL (pg/ml): Median (IQ range) 103.1 (78.8-182.4) 103.7 (63.7-160.3) 102.6 (59.3-170.4) 80.2 (47.9-131.1) 97.4 (58.4-159.0) 0.0001 hPL (mg/l): Median (IQ range) 144.8 (88.1-242.9) 121.0 (61.0-195.4) 111.4 (55.2-166.3) 80.5 (44.0-144.9) 108.4 (55.0-178.8) &lt;0.0001 GH2 (pg/ml): Median (IQ range) 4064.4 (1547.5-5935.3) 2932.6 (1278.1-4766.7) 2566.6 (1230.8-3964.4) 2297.7 (1059.7-3434.7) 2562.5 (1223.4-4147.5) &lt;0.0001 Within SCOPE Characteristic Underweight (n=16) Normal (n=276) Overweight (n=176) Obese (n=136) Total (n=604) P-value PRL (pg/ml): Median (IQ range) 187.3 (146.2-325.0) 138.4 (98.2-205.6) 140.3 (103.0-223.1) 127.8 (81.5-193.8) 138.3 (95.0-212.0) 0.03 hPL (mg/l): Median (IQ range) 262.2 (219.0-278.0) 197.8 (170.3-230.0) 171.6 (148.7-206.9) 151.8 (129.6-180.5) 181.9 (148.1-218.4) &lt;0.0001 GH2 (pg/ml): Median (IQ range) 6152.5 (4620.1-6488.4) 4765.6 (3636.3-6406.5) 4007.6 (3212.7-5358.7) 3467.6 (2657.7-4382.7) 4181.4 (3301.5-5645.7) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 29.2 (24.9-36.1) 37.0 (29.7-43.8) 37.0 (29.7-41.2) 35.2 (24.8-43.0) 36.4 (28.5-43.0) 0.07 B12 concentration (pM): Median (IQ range) 288.0 (252.0-355.0) 256.0 (198.5-324.0) 248.5 (198.2-311.2) 227.0 (181.0-285.0) 248.0 (195.5-316.0) 0.005 Folate:B12 ratio: Median (IQ range) 105.6 (74.6-117.3) 142.5 (104.6-204.3) 144.2 (106.8-208.7) 143.0 (103.5-210.0) 142.6 (104.0-207.4) 0.24 Active B12 concentration (pM): Median (IQ range) 63.5 (53.5-78.0) 53.0 (41.0-72.0) 54.0 (43.0-70.2) 60.5 (43.8-72.2) 54.0 (43.0-72.0) 0.36 Folate:Active B12 ratio: Median (IQ range) 491.8 (337.4-589.7) 641.2 (465.6-1042.9) 638.0 (491.8-953.1) 537.6 (404.5-693.9) 617.0 (458.5-931.9) 0.009 Homocysteine concentration (μM): Median (IQ range) 4.5 (4.2-5.3) 4.4 (3.9-5.0) 4.2 (3.8-4.9) 4.4 (3.8-5.0) 4.4 (3.8-5.0) 0.24 Within STOP Characteristic Underweight (n=16) Normal (n=317) Overweight (n=212) Obese (n=165) Total (n=710) P-value PRL (pg/ml): Median (IQ range) 91.6 (47.1-99.5) 78.8 (53.3-120.7) 74.2 (49.6-118.7) 60.6 (38.9-99.1) 73.0 (48.4-115.1) 0.0006 hPL (mg/l): Median (IQ range) 90.3 (64.3-140.4) 67.3 (45.7-101.0) 61.0 (42.6-98.1) 50.4 (34.5-73.4) 62.1 (41.7-95.8) &lt;0.0001 GH2 (pg/ml): Median (IQ range) 1574.4 (1387.2-3511.4) 1453.5 (947.4-2440.2) 1521.1 (856.3-2407.9) 1303.5 (816.1-2356.9) 1442.4 (914.3-2407.3) 0.07 Serum folate concentration (nM): Median (IQ range) 35.0 (29.9-40.4) 40.8 (37.0-52.4) 40.4 (36.2-45.1) 40.5 (35.8-45.2) 40.5 (36.4-45.3) 0.008 B12 concentration (pM): Median (IQ range) 349.5 (240.0-494.2) 288.0 (227.0-369.0) 275.5 (213.2-338.8) 260.5 (217.2-333.0) 278.0 (219.0-355.0) 0.03 Folate:B12 ratio: Median (IQ range) 98.0 (68.5-159.2) 154.8 (114.8-227.6) 151.2 (120.5-215.2) 168.3 (118.0-233.7) 155.8 (115.6-222.5) 0.03 Active B12 concentration (pM): Median (IQ range) 50.0 (48.0-82.0) 63.0 (46.0-79.0) 63.0 (49.0-82.2) 62.0 (51.5-76.0) 63.0 (48.0-80.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 602.0 (490.9-735.8) 693.8 (534.1-990.9) 675.3 (461.4-944.2) 644.4 (517.4-898.6) 670.9 (493.7-951.1) 0.59 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.7-5.7) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 4.8 (4.3-5.6) 0.15 Red cell folate (nmol/L): Median (IQ range) 1305.5 (1058.0-1585.0) 1445.0 (1212.0-1744.5) 1469.0 (1208.5-1785.5) 1433.0 (1189.0-1737.0) 1446.5 (1204.8-1755.5) 0.55 "],["prolactin-11.html", "17.1 Prolactin", " 17.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 11.12 (6.47, 19.13) &lt;0.0001 BMI_gp3Normal 0.77 (0.54, 1.11) 0.16 BMI_gp3Overweight 0.84 (0.58, 1.21) 0.34 BMI_gp3Obese 0.63 (0.43, 0.91) 0.01 StudySTOP 0.83 (0.52, 1.33) 0.44 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.54 (0.96, 2.46) 0.08 BMI_gp3Overweight:StudySTOP 1.22 (0.76, 1.96) 0.42 BMI_gp3Obese:StudySTOP 1.32 (0.81, 2.14) 0.26 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 118.23 23.49 1134.37 80.06 174.59 Normal SCOPE 91.20 8.02 111.01 76.61 108.57 Overweight SCOPE 98.92 9.14 134.32 82.39 118.76 Obese SCOPE 73.97 7.33 173.81 60.84 89.95 Underweight STOP 98.04 16.51 864.82 70.45 136.45 Normal STOP 116.18 9.53 84.87 98.69 136.77 Overweight STOP 99.78 8.66 105.65 84.00 118.53 Obese STOP 81.05 7.59 138.85 67.36 97.53 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.77 (0.48, 1.24) 0.5 Overweight / Underweight Study: SCOPE 0.84 (0.52, 1.35) 0.8 Overweight / Normal Study: SCOPE 1.08 (0.93, 1.27) 0.6 Obese / Underweight Study: SCOPE 0.63 (0.38, 1.02) 0.07 Obese / Normal Study: SCOPE 0.81 (0.67, 0.98) 0.02 Obese / Overweight Study: SCOPE 0.75 (0.61, 0.91) 0.0009 Normal / Underweight Study: STOP 1.18 (0.80, 1.76) 0.7 Overweight / Underweight Study: STOP 1.02 (0.68, 1.52) 1.0 Overweight / Normal Study: STOP 0.86 (0.75, 0.99) 0.02 Obese / Underweight Study: STOP 0.83 (0.55, 1.25) 0.6 Obese / Normal Study: STOP 0.70 (0.59, 0.82) &lt;0.0001 Obese / Overweight Study: STOP 0.81 (0.69, 0.96) 0.009 STOP / SCOPE Maternal BMI: Underweight 0.83 (0.51, 1.34) 0.4 STOP / SCOPE Maternal BMI: Normal 1.27 (1.11, 1.46) 0.0005 STOP / SCOPE Maternal BMI: Overweight 1.01 (0.86, 1.19) 0.9 STOP / SCOPE Maternal BMI: Obese 1.10 (0.90, 1.33) 0.4 "],["hpl-11.html", "17.2 HPL", " 17.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.08 (1.55, 2.78) &lt;0.0001 BMI_gp3Normal 0.99 (0.81, 1.21) 0.92 BMI_gp3Overweight 0.93 (0.76, 1.14) 0.49 BMI_gp3Obese 0.79 (0.64, 0.96) 0.02 StudySTOP 1.36 (1.06, 1.76) 0.02 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.81 (0.63, 1.04) 0.10 BMI_gp3Overweight:StudySTOP 0.80 (0.62, 1.04) 0.09 BMI_gp3Obese:StudySTOP 0.78 (0.60, 1.02) 0.07 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 98.89 10.17 1364.56 80.83 120.99 Normal SCOPE 97.90 3.36 266.41 91.50 104.75 Overweight SCOPE 92.20 3.45 355.92 85.65 99.24 Obese SCOPE 77.78 3.12 441.55 71.88 84.16 Underweight STOP 134.85 11.30 1236.86 114.41 158.94 Normal STOP 107.77 3.21 161.05 101.61 114.30 Overweight STOP 100.71 3.33 231.08 94.36 107.48 Obese STOP 83.21 3.13 319.49 77.28 89.60 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.99 (0.76, 1.28) 1.0 Overweight / Underweight Study: SCOPE 0.93 (0.72, 1.21) 0.9 Overweight / Normal Study: SCOPE 0.94 (0.86, 1.03) 0.3 Obese / Underweight Study: SCOPE 0.79 (0.60, 1.03) 0.09 Obese / Normal Study: SCOPE 0.79 (0.72, 0.88) &lt;0.0001 Obese / Overweight Study: SCOPE 0.84 (0.76, 0.94) 0.0002 Normal / Underweight Study: STOP 0.80 (0.65, 0.99) 0.03 Overweight / Underweight Study: STOP 0.75 (0.60, 0.93) 0.003 Overweight / Normal Study: STOP 0.93 (0.87, 1.01) 0.10 Obese / Underweight Study: STOP 0.62 (0.50, 0.77) &lt;0.0001 Obese / Normal Study: STOP 0.77 (0.71, 0.84) &lt;0.0001 Obese / Overweight Study: STOP 0.83 (0.75, 0.90) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.36 (1.05, 1.76) 0.02 STOP / SCOPE Maternal BMI: Normal 1.10 (1.02, 1.19) 0.01 STOP / SCOPE Maternal BMI: Overweight 1.09 (1.00, 1.19) 0.05 STOP / SCOPE Maternal BMI: Obese 1.07 (0.97, 1.18) 0.2 "],["gh2-11.html", "17.3 GH2", " 17.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 88.29 (60.66, 128.33) &lt;0.0001 BMI_gp3Normal 1.08 (0.84, 1.39) 0.53 BMI_gp3Overweight 0.98 (0.76, 1.26) 0.88 BMI_gp3Obese 0.79 (0.61, 1.02) 0.07 StudySTOP 1.56 (1.12, 2.17) 0.009 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.53 (0.38, 0.74) 0.0002 BMI_gp3Overweight:StudySTOP 0.62 (0.44, 0.87) 0.005 BMI_gp3Obese:StudySTOP 0.66 (0.47, 0.93) 0.02 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 2439.73 319.01 1496.85 1887.78 3153.07 Normal SCOPE 2642.44 108.08 376.04 2438.25 2863.73 Overweight SCOPE 2392.24 107.72 503.51 2189.71 2613.51 Obese SCOPE 1928.84 96.05 683.19 1749.18 2126.95 Underweight STOP 3802.76 417.89 1449.44 3065.36 4717.54 Normal STOP 2175.06 75.57 225.06 2031.13 2329.18 Overweight STOP 2310.86 91.26 344.44 2138.17 2497.51 Obese STOP 1998.06 92.23 473.91 1824.81 2187.77 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.08 (0.78, 1.51) 0.9 Overweight / Underweight Study: SCOPE 0.98 (0.70, 1.37) 1.0 Overweight / Normal Study: SCOPE 0.91 (0.81, 1.01) 0.09 Obese / Underweight Study: SCOPE 0.79 (0.56, 1.11) 0.3 Obese / Normal Study: SCOPE 0.73 (0.64, 0.83) &lt;0.0001 Obese / Overweight Study: SCOPE 0.81 (0.70, 0.92) 0.0003 Normal / Underweight Study: STOP 0.57 (0.43, 0.76) &lt;0.0001 Overweight / Underweight Study: STOP 0.61 (0.46, 0.81) &lt;0.0001 Overweight / Normal Study: STOP 1.06 (0.96, 1.17) 0.4 Obese / Underweight Study: STOP 0.53 (0.39, 0.70) &lt;0.0001 Obese / Normal Study: STOP 0.92 (0.82, 1.03) 0.2 Obese / Overweight Study: STOP 0.86 (0.77, 0.97) 0.010 STOP / SCOPE Maternal BMI: Underweight 1.56 (1.12, 2.18) 0.009 STOP / SCOPE Maternal BMI: Normal 0.82 (0.75, 0.90) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.97 (0.87, 1.08) 0.5 STOP / SCOPE Maternal BMI: Obese 1.04 (0.91, 1.17) 0.6 "],["age-bmi-groups-1.html", "18 Age &amp; BMI groups", " 18 Age &amp; BMI groups Descriptives with univariate P-values. Characteristic &lt;35 yrs, non-obese (n=984) &lt;35 yrs, obese (n=285) &gt;=35 yrs, non-obese (n=29) &gt;=35 yrs, obese (n=16) Total (n=1314) P-value PRL (pg/ml): Median (IQ range) 103.8 (62.8-165.8) 81.4 (49.2-131.3) 79.3 (52.6-108.0) 47.7 (32.9-110.3) 97.4 (58.4-159.0) &lt;0.0001 hPL (mg/l): Median (IQ range) 121.4 (58.4-187.6) 80.5 (44.5-145.3) 83.3 (59.0-145.8) 83.1 (34.7-121.2) 108.4 (55.0-178.8) &lt;0.0001 GH2 (pg/ml): Median (IQ range) 2837.5 (1285.3-4455.5) 2314.5 (1044.0-3463.6) 2082.3 (1229.8-3670.7) 2297.7 (1586.8-3158.9) 2562.5 (1223.4-4147.5) 0.0009 Within SCOPE Characteristic &lt;35 yrs, non-obese (n=457) &lt;35 yrs, obese (n=130) &gt;=35 yrs, non-obese (n=11) &gt;=35 yrs, obese (n=6) Total (n=604) P-value PRL (pg/ml): Median (IQ range) 141.0 (102.5-218.2) 128.1 (82.0-194.1) 177.6 (85.6-202.7) 110.3 (59.7-166.9) 138.3 (95.0-212.0) 0.11 hPL (mg/l): Median (IQ range) 190.2 (157.7-224.2) 152.3 (130.2-179.8) 183.5 (142.3-214.3) 121.2 (112.9-200.3) 181.9 (148.1-218.4) &lt;0.0001 GH2 (pg/ml): Median (IQ range) 4446.1 (3460.8-6033.7) 3474.9 (2648.2-4354.8) 3828.7 (3428.9-4741.0) 3158.9 (2901.2-6138.8) 4181.4 (3301.5-5645.7) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.8 (29.2-43.0) 35.5 (24.8-43.2) 37.6 (33.9-43.0) 32.7 (31.3-36.9) 36.4 (28.5-43.0) 0.57 B12 concentration (pM): Median (IQ range) 252.5 (199.0-318.8) 227.0 (182.0-287.5) 289.0 (245.2-345.2) 227.5 (181.2-249.0) 248.0 (195.5-316.0) 0.02 Folate:B12 ratio: Median (IQ range) 142.8 (103.4-207.5) 143.0 (103.1-215.4) 124.3 (115.6-165.0) 153.9 (126.0-192.9) 142.6 (104.0-207.4) 0.97 Active B12 concentration (pM): Median (IQ range) 53.5 (42.0-72.0) 60.0 (43.5-71.0) 48.0 (48.0-53.5) 74.0 (52.0-93.0) 54.0 (43.0-72.0) 0.45 Folate:Active B12 ratio: Median (IQ range) 634.3 (471.2-1019.0) 546.7 (436.3-698.7) 685.4 (633.4-794.8) 400.0 (360.2-420.3) 617.0 (458.5-931.9) 0.01 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-5.0) 4.4 (3.8-5.0) 4.2 (3.9-4.5) 4.3 (3.9-4.6) 4.4 (3.8-5.0) 0.98 Within STOP Characteristic &lt;35 yrs, non-obese (n=527) &lt;35 yrs, obese (n=155) &gt;=35 yrs, non-obese (n=18) &gt;=35 yrs, obese (n=10) Total (n=710) P-value PRL (pg/ml): Median (IQ range) 76.5 (52.4-120.2) 61.8 (39.8-99.1) 72.9 (50.0-90.3) 41.2 (32.3-60.9) 73.0 (48.4-115.1) 0.0002 hPL (mg/l): Median (IQ range) 66.3 (44.5-100.9) 50.4 (34.5-71.7) 68.1 (49.4-83.4) 60.2 (33.9-90.7) 62.1 (41.7-95.8) &lt;0.0001 GH2 (pg/ml): Median (IQ range) 1495.4 (926.2-2468.5) 1205.8 (801.5-2356.9) 1598.9 (1072.2-2110.7) 1626.4 (1349.8-2437.7) 1442.4 (914.3-2407.3) 0.22 Serum folate concentration (nM): Median (IQ range) 40.4 (36.5-45.0) 40.0 (35.4-44.9) 44.5 (40.3-78.6) 43.6 (42.1-99.6) 40.5 (36.4-45.3) 0.007 B12 concentration (pM): Median (IQ range) 284.5 (221.5-361.2) 260.0 (218.0-330.0) 272.0 (239.0-363.0) 295.0 (205.0-363.0) 278.0 (219.0-355.0) 0.20 Folate:B12 ratio: Median (IQ range) 152.6 (114.8-219.0) 166.7 (116.5-224.1) 168.2 (127.9-316.8) 241.6 (144.4-313.7) 155.8 (115.6-222.5) 0.22 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-80.5) 62.0 (51.5-76.0) 68.0 (55.0-100.0) 56.0 (53.2-59.5) 63.0 (48.0-80.0) 0.72 Folate:Active B12 ratio: Median (IQ range) 691.9 (487.2-959.9) 630.9 (513.8-898.6) 527.9 (444.1-965.5) 756.4 (713.9-1092.8) 670.9 (493.7-951.1) 0.71 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.5) 4.9 (4.3-5.7) 4.8 (4.4-6.1) 4.9 (4.7-5.3) 4.8 (4.3-5.6) 0.68 Red cell folate (nmol/L): Median (IQ range) 1445.0 (1205.8-1760.5) 1388.0 (1182.0-1744.0) 1592.0 (1361.0-1751.0) 1592.5 (1529.2-1667.0) 1446.5 (1204.8-1755.5) 0.50 "],["prolactin-12.html", "18.1 Prolactin", " 18.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 8.71 (5.87, 12.93) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.74 (0.65, 0.85) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.78 (0.51, 1.20) 0.26 Age_BMI_gp&gt;=35 yrs, obese 1.17 (0.77, 1.77) 0.45 StudySTOP 1.17 (1.03, 1.33) 0.01 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.03 (0.86, 1.22) 0.78 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.86 (0.52, 1.42) 0.55 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.44 (0.24, 0.81) 0.009 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 94.58 8.01 94.97 79.94 111.91 &lt;35 yrs, obese SCOPE 70.18 6.99 176.28 57.65 85.43 &gt;=35 yrs, non-obese SCOPE 73.91 16.97 1338.68 47.11 115.96 &gt;=35 yrs, obese SCOPE 110.76 24.80 1271.71 71.39 171.84 &lt;35 yrs, non-obese STOP 110.78 8.85 75.66 94.49 129.90 &lt;35 yrs, obese STOP 84.33 7.96 142.12 69.98 101.62 &gt;=35 yrs, non-obese STOP 74.28 11.37 719.53 54.99 100.32 &gt;=35 yrs, obese STOP 57.46 13.86 1107.84 35.79 92.25 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.74 (0.62, 0.89) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 0.78 (0.45, 1.37) 0.7 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.05 (0.59, 1.88) 1.0 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.17 (0.68, 2.01) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.58 (0.92, 2.72) 0.1 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.50 (0.69, 3.25) 0.5 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.76 (0.65, 0.89) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.67 (0.47, 0.95) 0.02 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.88 (0.61, 1.27) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.52 (0.29, 0.94) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.68 (0.37, 1.24) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.77 (0.39, 1.53) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 1.17 (1.03, 1.33) 0.01 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.20 (0.99, 1.46) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 1.00 (0.60, 1.67) 1.0 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.52 (0.28, 0.96) 0.04 "],["hpl-12.html", "18.2 HPL", " 18.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.97 (1.59, 2.43) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.82 (0.76, 0.88) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.04 (0.82, 1.31) 0.77 Age_BMI_gp&gt;=35 yrs, obese 0.69 (0.54, 0.88) 0.003 StudySTOP 1.12 (1.04, 1.19) 0.002 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.96 (0.88, 1.06) 0.45 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.89 (0.67, 1.19) 0.43 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.02 (0.73, 1.43) 0.92 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 95.23 3.02 194.99 89.46 101.37 &lt;35 yrs, obese SCOPE 78.14 3.20 461.37 72.09 84.68 &gt;=35 yrs, non-obese SCOPE 98.66 12.16 1409.16 77.47 125.64 &gt;=35 yrs, obese SCOPE 65.88 8.39 1528.11 51.32 84.57 &lt;35 yrs, non-obese STOP 106.26 2.95 120.05 100.58 112.27 &lt;35 yrs, obese STOP 84.12 3.22 334.23 78.02 90.70 &gt;=35 yrs, non-obese STOP 98.24 7.94 1398.66 83.83 115.12 &gt;=35 yrs, obese STOP 74.88 9.04 1210.29 59.08 94.90 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.82 (0.75, 0.90) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.04 (0.76, 1.42) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.26 (0.92, 1.74) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.69 (0.50, 0.96) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.84 (0.61, 1.17) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.67 (0.43, 1.04) 0.09 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.79 (0.73, 0.86) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.92 (0.76, 1.13) 0.7 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.17 (0.95, 1.44) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.70 (0.52, 0.96) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.89 (0.65, 1.22) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.76 (0.53, 1.10) 0.2 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 1.12 (1.04, 1.20) 0.002 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.08 (0.97, 1.19) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 1.00 (0.75, 1.33) 1.0 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.14 (0.81, 1.60) 0.5 "],["gh2-12.html", "18.3 GH2", " 18.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 91.24 (69.54, 119.54) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.77 (0.70, 0.84) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.03 (0.76, 1.38) 0.86 Age_BMI_gp&gt;=35 yrs, obese 0.69 (0.52, 0.93) 0.01 StudySTOP 0.90 (0.82, 0.98) 0.01 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.15 (1.01, 1.30) 0.03 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.85 (0.60, 1.20) 0.35 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.31 (0.85, 2.03) 0.23 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 2533.51 94.24 286.27 2354.64 2725.96 &lt;35 yrs, obese SCOPE 1943.57 99.18 746.72 1758.29 2148.37 &gt;=35 yrs, non-obese SCOPE 2599.68 396.19 1498.10 1927.94 3505.47 &gt;=35 yrs, obese SCOPE 1756.60 263.55 1216.85 1308.68 2357.82 &lt;35 yrs, non-obese STOP 2271.67 72.04 168.56 2133.81 2418.44 &lt;35 yrs, obese STOP 1998.57 93.92 510.98 1822.31 2191.88 &gt;=35 yrs, non-obese STOP 1972.96 187.62 1337.42 1637.19 2377.60 &gt;=35 yrs, obese STOP 2063.04 350.99 1133.32 1477.54 2880.57 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.77 (0.68, 0.87) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.03 (0.70, 1.51) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.34 (0.90, 2.00) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.69 (0.47, 1.01) 0.06 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.90 (0.61, 1.33) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.68 (0.39, 1.16) 0.2 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.88 (0.79, 0.98) 0.02 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.87 (0.68, 1.10) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.99 (0.76, 1.28) 1.0 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.91 (0.59, 1.41) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 1.03 (0.66, 1.61) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.05 (0.64, 1.71) 1.0 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.90 (0.82, 0.98) 0.01 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.03 (0.90, 1.17) 0.7 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.76 (0.53, 1.08) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.17 (0.76, 1.83) 0.5 "],["mets-3.html", "19 MetS", " 19 MetS Descriptives with univariate P-values. Characteristic No MetS (n=1149) MetS (n=112) Total (n=1261) P-value PRL (pg/ml): Median (IQ range) 96.2 (57.8-152.7) 108.3 (65.6-181.2) 97.2 (58.4-157.0) 0.18 hPL (mg/l): Median (IQ range) 100.8 (54.2-178.8) 136.8 (64.0-175.8) 106.1 (54.6-178.8) 0.19 GH2 (pg/ml): Median (IQ range) 2482.1 (1176.7-4129.6) 3060.6 (1727.5-4463.5) 2532.9 (1208.3-4147.4) 0.07 Within SCOPE Characteristic No MetS (n=525) MetS (n=76) Total (n=601) P-value PRL (pg/ml): Median (IQ range) 135.5 (92.2-215.5) 157.2 (108.5-200.8) 137.8 (95.0-212.3) 0.32 hPL (mg/l): Median (IQ range) 183.5 (149.9-220.7) 167.7 (145.4-201.1) 181.9 (148.0-218.5) 0.04 GH2 (pg/ml): Median (IQ range) 4193.3 (3323.7-5669.0) 3960.5 (2926.6-5364.0) 4177.0 (3297.3-5643.2) 0.11 Serum folate concentration (nM): Median (IQ range) 36.8 (28.2-43.2) 35.2 (30.3-42.5) 36.5 (28.6-43.0) 0.76 B12 concentration (pM): Median (IQ range) 252.0 (198.2-320.5) 223.0 (173.5-291.5) 249.5 (196.0-316.0) 0.006 Folate:B12 ratio: Median (IQ range) 141.0 (101.6-203.1) 154.1 (118.2-216.4) 142.6 (104.3-208.3) 0.18 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 51.0 (43.5-68.0) 54.0 (42.8-72.0) 0.65 Folate:Active B12 ratio: Median (IQ range) 615.9 (456.2-973.2) 620.0 (505.1-746.5) 617.2 (461.4-935.8) 0.80 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.8-4.7) 4.4 (3.8-4.9) 0.44 Within STOP Characteristic No MetS (n=624) MetS (n=36) Total (n=660) P-value PRL (pg/ml): Median (IQ range) 73.6 (48.4-114.4) 60.5 (43.3-87.4) 72.6 (48.1-112.3) 0.05 hPL (mg/l): Median (IQ range) 60.7 (41.6-91.0) 50.6 (34.4-71.7) 60.3 (41.2-90.7) 0.07 GH2 (pg/ml): Median (IQ range) 1403.1 (906.9-2365.9) 1501.5 (844.5-2025.2) 1407.2 (900.4-2354.6) 0.70 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.1) 40.3 (37.2-45.0) 40.5 (36.3-45.1) 0.85 B12 concentration (pM): Median (IQ range) 279.5 (220.2-356.0) 247.0 (201.0-335.5) 278.0 (219.0-356.0) 0.13 Folate:B12 ratio: Median (IQ range) 153.6 (114.8-223.8) 172.4 (143.0-203.7) 155.4 (115.6-222.8) 0.27 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-81.0) 62.0 (56.0-74.0) 63.0 (49.0-81.0) 0.84 Folate:Active B12 ratio: Median (IQ range) 670.5 (487.1-941.9) 633.9 (493.7-726.8) 667.9 (488.1-936.8) 0.63 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.5) 4.8 (4.3-5.6) 0.91 Red cell folate (nmol/L): Median (IQ range) 1446.0 (1206.0-1751.0) 1469.5 (1207.5-1784.8) 1446.5 (1206.0-1753.8) 0.66 "],["prolactin-13.html", "19.1 Prolactin", " 19.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 8.21 (5.43, 12.42) &lt;0.0001 metab.C1MetS 0.79 (0.67, 0.93) 0.003 StudySTOP 1.16 (1.02, 1.32) 0.03 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 metab.C1MetS:StudySTOP 1.22 (0.94, 1.57) 0.13 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 90.40 7.71 93.70 76.32 107.08 MetS SCOPE 71.41 7.71 229.74 57.73 88.34 No MetS STOP 104.86 8.47 75.89 89.27 123.17 MetS STOP 100.82 12.53 374.19 78.96 128.72 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.79 (0.68, 0.92) 0.003 MetS / No MetS Study: STOP 0.96 (0.79, 1.17) 0.7 STOP / SCOPE MetS: No MetS 1.16 (1.02, 1.32) 0.03 STOP / SCOPE MetS: MetS 1.41 (1.09, 1.83) 0.010 "],["hpl-13.html", "19.2 HPL", " 19.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.00 (1.61, 2.47) &lt;0.0001 metab.C1MetS 0.84 (0.77, 0.92) &lt;0.0001 StudySTOP 1.11 (1.03, 1.18) 0.003 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 metab.C1MetS:StudySTOP 1.04 (0.91, 1.18) 0.61 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 92.83 2.97 156.98 87.15 98.89 MetS SCOPE 78.22 3.72 595.12 71.25 85.87 No MetS STOP 102.69 2.98 107.29 96.95 108.76 MetS STOP 89.56 5.22 901.79 79.89 100.40 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.84 (0.78, 0.92) &lt;0.0001 MetS / No MetS Study: STOP 0.87 (0.79, 0.97) 0.010 STOP / SCOPE MetS: No MetS 1.11 (1.03, 1.18) 0.003 STOP / SCOPE MetS: MetS 1.15 (1.00, 1.31) 0.05 "],["gh2-13.html", "19.3 GH2", " 19.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 92.28 (69.32, 122.56) &lt;0.0001 metab.C1MetS 0.85 (0.76, 0.95) 0.005 StudySTOP 0.89 (0.81, 0.97) 0.007 GA_samp 1.28 (1.26, 1.31) &lt;0.0001 metab.C1MetS:StudySTOP 1.51 (1.25, 1.82) &lt;0.0001 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 2449.36 91.73 257.59 2275.22 2636.82 MetS SCOPE 2084.57 125.44 953.28 1852.38 2345.87 No MetS STOP 2171.02 70.63 155.93 2035.90 2315.11 MetS STOP 2793.04 203.96 1147.85 2420.21 3223.31 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.85 (0.76, 0.95) 0.005 MetS / No MetS Study: STOP 1.29 (1.12, 1.47) 0.0003 STOP / SCOPE MetS: No MetS 0.89 (0.81, 0.97) 0.007 STOP / SCOPE MetS: MetS 1.34 (1.12, 1.60) 0.001 "],["hormone-models-1.html", "20 Hormone Models", " 20 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 22 0 15wks 465 684 "],["raw-plots-1.html", "20.1 Raw plots", " 20.1 Raw plots "],["scope-vs-stop-1.html", "20.2 SCOPE vs STOP", " 20.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Outcomes: Prolactin, hPL, GH2 (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Random intercepts for Study ID and Plate 20.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 43.925782 1 &lt;0.0001 *** Study 2.294907 1 0.1 ns GA_samp 28.349660 1 &lt;0.0001 *** Study:GA_samp 3.868145 1 0.05 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 51.84297 1 &lt;0.0001 *** Study 26.02829 1 &lt;0.0001 *** GA_samp 125.43159 1 &lt;0.0001 *** Study:GA_samp 31.38456 1 &lt;0.0001 *** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 397.95207 1 &lt;0.0001 *** Study 28.18342 1 &lt;0.0001 *** GA_samp 87.98624 1 &lt;0.0001 *** Study:GA_samp 26.73751 1 &lt;0.0001 *** 20.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 15.51 (6.83, 34.99) &lt;0.0001 StudySTOP 0.52 (0.22, 1.24) 0.13 GA_samp 1.15 (1.09, 1.21) &lt;0.0001 StudySTOP:GA_samp 1.06 (1.00, 1.12) 0.05 HPL Var Effect P (Intercept) 7.63 (4.37, 13.28) &lt;0.0001 StudySTOP 0.22 (0.13, 0.40) &lt;0.0001 GA_samp 1.23 (1.18, 1.27) &lt;0.0001 StudySTOP:GA_samp 1.12 (1.07, 1.16) &lt;0.0001 GH2 Var Effect P (Intercept) 298.46 (169.07, 523.09) &lt;0.0001 StudySTOP 0.20 (0.11, 0.36) &lt;0.0001 GA_samp 1.19 (1.15, 1.23) &lt;0.0001 StudySTOP:GA_samp 1.11 (1.07, 1.16) &lt;0.0001 20.2.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Prolactin Study GA_samp response SE df lower.CL upper.CL SCOPE 10 62.42250 10.29740 683.32279 45.15181 86.29926 STOP 10 57.25852 4.58971 73.04376 48.80457 67.17686 SCOPE 16 143.93327 11.51709 72.47439 122.71406 168.82163 STOP 16 185.47975 18.06864 155.79603 153.01252 224.83610 HPL Study GA_samp response SE df lower.CL upper.CL SCOPE 10 58.22444 6.026671 1236.8940 47.52402 71.33414 STOP 10 38.76192 1.135723 103.4258 36.57378 41.08097 SCOPE 16 197.12771 5.822063 104.3612 185.91437 209.01737 STOP 16 252.68532 10.650792 384.2696 232.58845 274.51866 GH2 Study GA_samp response SE df lower.CL upper.CL SCOPE 10 1672.1499 175.96481 812.0632 1360.0889 2055.811 STOP 10 960.8149 31.15735 146.3701 901.1702 1024.407 SCOPE 16 4702.3015 150.51703 135.7571 4413.8657 5009.586 STOP 16 5128.5026 261.59549 636.8486 4639.6977 5668.805 20.2.5 Comparisons Hormone Contrast GA_samp Ratio of Geometric means (95% CI) P-value Prolactin STOP / SCOPE 10 0.92 (0.68, 1.24) 0.6 Prolactin STOP / SCOPE 16 1.29 (1.12, 1.48) 0.0004 HPL STOP / SCOPE 10 0.67 (0.54, 0.81) &lt;0.0001 HPL STOP / SCOPE 16 1.28 (1.19, 1.38) &lt;0.0001 GH2 STOP / SCOPE 10 0.57 (0.47, 0.71) &lt;0.0001 GH2 STOP / SCOPE 16 1.09 (0.99, 1.20) 0.08 20.2.6 Barplots by Study Barplots in this section may be misleading due to involvement of Study by GA interaction. 20.2.7 Plots for GA "],["folate-1.html", "20.3 Folate", " 20.3 Folate 20.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 97.9452199 1 &lt;0.0001 *** Folate 0.0152388 1 0.9 ns Study 4.3492854 1 0.04 * GA_samp 235.0840728 1 &lt;0.0001 *** Folate:Study 0.0866349 1 0.8 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 25.9858346 1 &lt;0.0001 *** Folate 0.0805806 1 0.8 ns Study 15.2826136 1 &lt;0.0001 *** GA_samp 1848.4394416 1 &lt;0.0001 *** Folate:Study 1.3062064 1 0.3 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 1024.5898533 1 &lt;0.0001 *** Folate 0.2420749 1 0.6 ns Study 0.4567813 1 0.5 ns GA_samp 910.5912691 1 &lt;0.0001 *** Folate:Study 0.0978781 1 0.8 ns 20.3.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 7.63 (5.09, 11.43) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.51 StudySTOP 1.20 (1.06, 1.36) 0.004 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 HPL Var Effect P (Intercept) 1.80 (1.45, 2.24) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.28 StudySTOP 1.15 (1.08, 1.23) &lt;0.0001 GA_samp 1.35 (1.33, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 81.57 (61.96, 107.14) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.17 StudySTOP 0.95 (0.88, 1.04) 0.26 GA_samp 1.29 (1.27, 1.32) &lt;0.0001 20.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 86.47225 7.260587 89.61848 73.18599 102.1705 STOP 103.51561 8.264268 73.56567 88.29029 121.3665 HPL Study response SE df lower.CL upper.CL SCOPE 88.71237 2.832780 156.2917 83.28971 94.48808 STOP 102.02321 2.951504 106.2477 96.33637 108.04576 GH2 Study response SE df lower.CL upper.CL SCOPE 2341.224 83.84685 247.2776 2181.769 2512.333 STOP 2232.593 69.94768 151.4568 2098.584 2375.159 20.3.4 Comparisons Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin 40.2 / 39.2 SCOPE 1.00 (1.00, 1.00) 0.5 Prolactin 40.2 / 39.2 STOP 1.00 (1.00, 1.00) 0.5 HPL 40.2 / 39.2 SCOPE 1.00 (1.00, 1.00) 0.3 HPL 40.2 / 39.2 STOP 1.00 (1.00, 1.00) 0.3 GH2 40.2 / 39.2 SCOPE 1.00 (1.00, 1.00) 0.2 GH2 40.2 / 39.2 STOP 1.00 (1.00, 1.00) 0.2 20.3.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.3.6 Plots "],["b12-1.html", "20.4 B12", " 20.4 B12 20.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 87.5683359 1 &lt;0.0001 *** B12 1.6850267 1 0.2 ns Study 0.5366473 1 0.5 ns GA_samp 230.2619060 1 &lt;0.0001 *** B12:Study 0.5635606 1 0.5 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 22.1547433 1 &lt;0.0001 *** B12 0.5430725 1 0.5 ns Study 2.4940723 1 0.1 ns GA_samp 1862.9787394 1 &lt;0.0001 *** B12:Study 0.4077735 1 0.5 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 903.0588516 1 &lt;0.0001 *** B12 9.3399741 1 0.002 ** Study 0.3984172 1 0.5 ns GA_samp 899.2408356 1 &lt;0.0001 *** B12:Study 3.5521149 1 0.06 ns 20.4.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 7.00 (4.68, 10.45) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.0005 StudySTOP 1.17 (1.03, 1.32) 0.02 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 HPL Var Effect P (Intercept) 1.69 (1.36, 2.11) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.02 StudySTOP 1.14 (1.06, 1.22) 0.0002 GA_samp 1.35 (1.33, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 75.90 (57.71, 99.61) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.008 StudySTOP 0.93 (0.85, 1.01) 0.08 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 20.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 89.42647 7.548953 91.4814 75.62207 105.7508 STOP 104.21767 8.299126 72.7356 88.92243 122.1438 HPL Study response SE df lower.CL upper.CL SCOPE 89.49814 2.870782 163.4035 84.00532 95.35012 STOP 101.77840 2.906590 103.8503 96.17460 107.70871 GH2 Study response SE df lower.CL upper.CL SCOPE 2385.598 87.20514 272.5528 2219.948 2563.607 STOP 2215.478 68.24605 145.5489 2084.620 2354.549 20.4.4 Comparisons Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin 363 / 263 SCOPE 1.05 (1.02, 1.09) 0.0005 Prolactin 363 / 263 STOP 1.05 (1.02, 1.09) 0.0005 HPL 363 / 263 SCOPE 1.02 (1.00, 1.04) 0.03 HPL 363 / 263 STOP 1.02 (1.00, 1.04) 0.03 GH2 363 / 263 SCOPE 1.03 (1.01, 1.05) 0.008 GH2 363 / 263 STOP 1.03 (1.01, 1.05) 0.008 20.4.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.4.6 Plots "],["folateb12-1.html", "20.5 Folate:B12", " 20.5 Folate:B12 20.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 100.0080167 1 &lt;0.0001 *** folate_B12 0.2259167 1 0.6 ns Study 2.8661060 1 0.09 ns GA_samp 236.8454932 1 &lt;0.0001 *** folate_B12:Study 1.4525894 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 25.3238445 1 &lt;0.0001 *** folate_B12 0.4556808 1 0.5 ns Study 17.8480053 1 &lt;0.0001 *** GA_samp 1853.3803589 1 &lt;0.0001 *** folate_B12:Study 2.6095038 1 0.1 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 1060.9102654 1 &lt;0.0001 *** folate_B12 6.1997164 1 0.01 * Study 2.6855488 1 0.1 ns GA_samp 910.5159287 1 &lt;0.0001 *** folate_B12:Study 0.9374689 1 0.3 ns 20.5.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 7.60 (5.07, 11.37) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.41 StudySTOP 1.20 (1.06, 1.36) 0.004 GA_samp 1.20 (1.17, 1.23) &lt;0.0001 HPL Var Effect P (Intercept) 1.80 (1.44, 2.23) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.34 StudySTOP 1.15 (1.07, 1.23) &lt;0.0001 GA_samp 1.35 (1.33, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 85.04 (64.55, 111.82) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.004 StudySTOP 0.95 (0.87, 1.03) 0.19 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 20.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 86.69384 7.272874 89.19579 73.38337 102.4186 STOP 104.00590 8.283958 72.76797 88.73896 121.8994 HPL Study response SE df lower.CL upper.CL SCOPE 88.50099 2.818994 155.6775 83.10414 94.24832 STOP 101.61540 2.914976 103.3512 95.99584 107.56394 GH2 Study response SE df lower.CL upper.CL SCOPE 2336.511 83.71219 241.7348 2177.297 2507.367 STOP 2213.067 68.77356 143.1694 2081.215 2353.272 20.5.4 Comparisons Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin 247.65 / 147.65 SCOPE 1.01 (0.99, 1.03) 0.4 Prolactin 247.65 / 147.65 STOP 1.01 (0.99, 1.03) 0.4 HPL 247.65 / 147.65 SCOPE 0.99 (0.98, 1.01) 0.3 HPL 247.65 / 147.65 STOP 0.99 (0.98, 1.01) 0.3 GH2 247.65 / 147.65 SCOPE 0.98 (0.96, 0.99) 0.004 GH2 247.65 / 147.65 STOP 0.98 (0.96, 0.99) 0.004 20.5.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.5.6 Plots "],["active-b12-1.html", "20.6 Active B12", " 20.6 Active B12 20.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 81.0885246 1 &lt;0.0001 *** Active.B12 1.9362240 1 0.2 ns Study 0.1186125 1 0.7 ns GA_samp 68.3522277 1 &lt;0.0001 *** Active.B12:Study 0.5665036 1 0.5 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 6.8906165 1 0.009 ** Active.B12 0.4689859 1 0.5 ns Study 2.6893900 1 0.1 ns GA_samp 948.5896535 1 &lt;0.0001 *** Active.B12:Study 0.2691582 1 0.6 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 643.3147544 1 &lt;0.0001 *** Active.B12 0.2044897 1 0.7 ns Study 0.0283550 1 0.9 ns GA_samp 406.5139428 1 &lt;0.0001 *** Active.B12:Study 6.6605343 1 0.010 * 20.6.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 14.91 (8.56, 25.94) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.20 StudySTOP 0.95 (0.80, 1.14) 0.60 GA_samp 1.15 (1.11, 1.18) &lt;0.0001 HPL Var Effect P (Intercept) 1.53 (1.11, 2.12) 0.01 Active.B12 1.00 (1.00, 1.00) 0.66 StudySTOP 1.21 (1.09, 1.33) 0.0002 GA_samp 1.36 (1.33, 1.39) &lt;0.0001 GH2 Var Effect P (Intercept) 145.05 (79.20, 259.01) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.65 StudySTOP 1.02 (0.81, 1.29) 0.87 GA_samp 1.24 (1.20, 1.29) &lt;0.0001 Active.B12:StudySTOP 1.00 (0.99, 1.00) 0.01 20.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 101.05622 9.586270 108.69119 83.73525 121.9601 STOP 96.45014 8.704284 89.81199 80.61871 115.3905 HPL Study response SE df lower.CL upper.CL SCOPE 89.91191 3.532595 223.3336 83.2131 97.14998 STOP 108.59836 3.890979 160.0248 101.1796 116.56105 GH2 Study response SE df lower.CL upper.CL SCOPE 2709.620 152.7366 167.0869 2424.251 3028.581 STOP 2071.438 106.5236 121.4940 1870.935 2293.429 20.6.4 Comparisons Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin 70 / 60 SCOPE 1.01 (0.99, 1.04) 0.2 Prolactin 70 / 60 STOP 1.01 (0.99, 1.04) 0.2 HPL 70 / 60 SCOPE 1.00 (0.99, 1.01) 0.7 HPL 70 / 60 STOP 1.00 (0.99, 1.01) 0.7 GH2 70 / 60 SCOPE 1.01 (0.98, 1.03) 0.7 GH2 70 / 60 STOP 0.96 (0.94, 0.98) 0.0004 20.6.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.6.6 Plots "],["folateactive-b12-1.html", "20.7 Folate:Active B12", " 20.7 Folate:Active B12 20.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 99.311486 1 &lt;0.0001 *** folate_Active.B12 1.717764 1 0.2 ns Study 3.725170 1 0.05 ns GA_samp 73.726659 1 &lt;0.0001 *** folate_Active.B12:Study 9.876351 1 0.002 ** HPL Chisq Df Pr(&gt;Chisq) (Intercept) 7.1512364 1 0.007 ** folate_Active.B12 0.1439516 1 0.7 ns Study 19.1151470 1 &lt;0.0001 *** GA_samp 944.2450570 1 &lt;0.0001 *** folate_Active.B12:Study 5.3292207 1 0.02 * GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 739.198664 1 &lt;0.0001 *** folate_Active.B12 2.021081 1 0.2 ns Study 31.239203 1 &lt;0.0001 *** GA_samp 431.794015 1 &lt;0.0001 *** folate_Active.B12:Study 14.181671 1 0.0002 *** 20.7.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 15.72 (9.15, 26.99) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.19 StudySTOP 0.82 (0.67, 1.00) 0.05 GA_samp 1.15 (1.12, 1.19) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.002 HPL Var Effect P (Intercept) 1.53 (1.12, 2.10) 0.008 folate_Active.B12 1.00 (1.00, 1.00) 0.70 StudySTOP 1.30 (1.15, 1.46) &lt;0.0001 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.02 GH2 Var Effect P (Intercept) 139.55 (85.84, 220.80) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.16 StudySTOP 0.68 (0.57, 0.80) &lt;0.0001 GA_samp 1.25 (1.22, 1.29) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.0002 20.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 98.79645 9.315941 108.81049 81.95496 119.0988 STOP 98.14411 8.811187 90.17274 82.11180 117.3067 HPL Study response SE df lower.CL upper.CL SCOPE 90.21142 3.536942 220.5997 83.50339 97.45831 STOP 108.08577 3.871530 158.9142 100.70368 116.00901 GH2 Study response SE df lower.CL upper.CL SCOPE 2632.506 147.7525 153.8660 2356.220 2941.188 STOP 2100.775 109.5991 118.5319 1894.583 2329.407 20.7.4 Comparisons Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin 1146.67 / 646.67 SCOPE 0.97 (0.92, 1.02) 0.2 Prolactin 1146.67 / 646.67 STOP 1.08 (1.03, 1.12) 0.0010 HPL 1146.67 / 646.67 SCOPE 1.01 (0.98, 1.03) 0.7 HPL 1146.67 / 646.67 STOP 0.96 (0.94, 0.99) 0.003 GH2 1146.67 / 646.67 SCOPE 0.97 (0.93, 1.01) 0.2 GH2 1146.67 / 646.67 STOP 1.07 (1.04, 1.10) &lt;0.0001 20.7.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.7.6 Plots "],["homocysteine-1.html", "20.8 Homocysteine", " 20.8 Homocysteine 20.8.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 125.3817898 1 &lt;0.0001 *** Homocysteine 16.7568641 1 &lt;0.0001 *** Study 0.0000116 1 1.0 ns GA_samp 204.6330010 1 &lt;0.0001 *** Homocysteine:Study 1.3763087 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 27.2942732 1 &lt;0.0001 *** Homocysteine 1.1123156 1 0.3 ns Study 2.9680415 1 0.08 ns GA_samp 1745.4536124 1 &lt;0.0001 *** Homocysteine:Study 0.0369578 1 0.8 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 781.6172821 1 &lt;0.0001 *** Homocysteine 1.8478023 1 0.2 ns Study 0.9616043 1 0.3 ns GA_samp 868.5579552 1 &lt;0.0001 *** Homocysteine:Study 0.2831789 1 0.6 ns 20.8.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 13.03 (8.35, 20.32) &lt;0.0001 Homocysteine 0.93 (0.90, 0.96) &lt;0.0001 StudySTOP 1.18 (1.05, 1.34) 0.007 GA_samp 1.19 (1.16, 1.22) &lt;0.0001 HPL Var Effect P (Intercept) 1.97 (1.55, 2.52) &lt;0.0001 Homocysteine 0.98 (0.97, 1.00) 0.06 StudySTOP 1.14 (1.07, 1.22) &lt;0.0001 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 88.47 (64.84, 120.48) &lt;0.0001 Homocysteine 0.98 (0.96, 1.01) 0.13 StudySTOP 0.95 (0.87, 1.03) 0.19 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 20.8.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 85.73296 7.201441 88.64057 72.55354 101.3064 STOP 101.50046 8.123273 73.32961 86.53700 119.0513 HPL Study response SE df lower.CL upper.CL SCOPE 88.34759 2.815314 156.6176 82.95811 94.08722 STOP 101.09987 2.915804 105.9930 95.48117 107.04921 GH2 Study response SE df lower.CL upper.CL SCOPE 2330.375 83.49930 245.0260 2171.577 2500.786 STOP 2206.583 69.07053 149.1232 2074.235 2347.376 20.8.4 Comparisons Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin 5.6 / 4.6 SCOPE 0.93 (0.90, 0.96) &lt;0.0001 Prolactin 5.6 / 4.6 STOP 0.93 (0.90, 0.96) &lt;0.0001 HPL 5.6 / 4.6 SCOPE 0.98 (0.97, 1.00) 0.06 HPL 5.6 / 4.6 STOP 0.98 (0.97, 1.00) 0.06 GH2 5.6 / 4.6 SCOPE 0.98 (0.96, 1.00) 0.1 GH2 5.6 / 4.6 STOP 0.98 (0.96, 1.00) 0.1 20.8.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.8.6 Plots "],["red-cell-folate.html", "20.9 Red cell folate", " 20.9 Red cell folate 20.9.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 43.579702 1 &lt;0.0001 *** ns(rcfolate, 3) 6.490333 3 0.09 ns GA_samp 62.051227 1 &lt;0.0001 *** HPL Chisq Df Pr(&gt;Chisq) (Intercept) 10.764745 1 0.001 ** ns(rcfolate, 3) 1.788481 3 0.6 ns GA_samp 1009.677783 1 &lt;0.0001 *** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 122.286420 1 &lt;0.0001 *** ns(rcfolate, 3) 6.463033 3 0.09 ns GA_samp 552.258833 1 &lt;0.0001 *** 20.9.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 19.66 (8.13, 47.51) &lt;0.0001 ns(rcfolate, 3)1 0.77 (0.46, 1.28) 0.31 ns(rcfolate, 3)2 0.70 (0.13, 3.71) 0.68 ns(rcfolate, 3)3 1.03 (0.81, 1.30) 0.83 GA_samp 1.14 (1.11, 1.18) &lt;0.0001 HPL Var Effect P (Intercept) 2.25 (1.39, 3.66) 0.001 ns(rcfolate, 3)1 0.88 (0.66, 1.17) 0.37 ns(rcfolate, 3)2 0.84 (0.33, 2.11) 0.71 ns(rcfolate, 3)3 0.95 (0.83, 1.08) 0.42 GA_samp 1.35 (1.32, 1.37) &lt;0.0001 GH2 Var Effect P (Intercept) 40.70 (21.14, 78.49) &lt;0.0001 ns(rcfolate, 3)1 0.92 (0.63, 1.36) 0.68 ns(rcfolate, 3)2 1.45 (0.41, 5.06) 0.57 ns(rcfolate, 3)3 0.90 (0.75, 1.07) 0.23 GA_samp 1.35 (1.32, 1.39) &lt;0.0001 20.9.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 20.9.4 Plots "],["session-info-5.html", "21 Session info", " 21 Session info Results generated on: 2022-10-23 15:05:51 Click for more details sessionInfo() ## R version 4.2.1 (2022-06-23) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.1 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils datasets ## [9] methods base ## ## other attached packages: ## [1] geepack_1.3.3 ggpubr_0.4.0 car_3.0-13 carData_3.0-5 ## [5] minpack.lm_1.2-2 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] plotly_4.10.0 investr_1.4.2 readxl_1.4.0 nlme_3.1-159 ## [13] lmerTest_3.1-3 lme4_1.1-29 Matrix_1.5-1 emmeans_1.7.3 ## [17] fontawesome_0.2.2 widgetframe_0.3.1 htmlwidgets_1.5.4 kableExtra_1.3.4 ## [21] knitr_1.39 rmarkdown_2.14 ggplot2_3.3.6 devtools_2.4.1 ## [25] usethis_2.1.5 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [29] bookdown_0.28 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-1 minqa_1.2.4 colorspace_2.0-3 ggsignif_0.6.3 ## [5] ellipsis_0.3.2 rprojroot_2.0.3 estimability_1.3 fs_1.5.2 ## [9] rstudioapi_0.13 farver_2.1.0 remotes_2.4.2 fansi_1.0.3 ## [13] mvtnorm_1.1-3 xml2_1.3.3 codetools_0.2-18 cachem_1.0.4 ## [17] pkgload_1.2.4 jsonlite_1.8.0 nloptr_2.0.1 pbkrtest_0.5.1 ## [21] broom_0.8.0 compiler_4.2.1 httr_1.4.4 backports_1.4.1 ## [25] assertthat_0.2.1 fastmap_1.1.0 lazyeval_0.2.2 cli_3.3.0 ## [29] htmltools_0.5.2 prettyunits_1.1.1 tools_4.2.1 coda_0.19-4 ## [33] gtable_0.3.0 glue_1.6.2 dplyr_1.0.9 Rcpp_1.0.8.3 ## [37] cellranger_1.1.0 jquerylib_0.1.4 vctrs_0.4.1 svglite_2.1.0 ## [41] crosstalk_1.2.0 xfun_0.30 stringr_1.4.0 ps_1.7.0 ## [45] brio_1.1.3 testthat_3.1.4 rvest_1.0.2 lifecycle_1.0.1 ## [49] rstatix_0.7.0 MASS_7.3-58 zoo_1.8-10 scales_1.2.0 ## [53] sandwich_3.0-1 yaml_2.3.5 memoise_2.0.0 sass_0.4.1 ## [57] stringi_1.7.6 highr_0.9 desc_1.4.1 boot_1.3-28 ## [61] pkgbuild_1.3.1 rlang_1.0.4 pkgconfig_2.0.3 systemfonts_1.0.4 ## [65] evaluate_0.15 lattice_0.20-45 purrr_0.3.4 labeling_0.4.2 ## [69] processx_3.5.3 tidyselect_1.1.2 R6_2.5.1 generics_0.1.3 ## [73] multcomp_1.4-19 DBI_1.1.2 mgcv_1.8-40 pillar_1.8.1 ## [77] withr_2.5.0 survival_3.4-0 abind_1.4-5 tibble_3.1.8 ## [81] crayon_1.5.1 utf8_1.2.2 data.table_1.14.2 callr_3.7.0 ## [85] digest_0.6.29 webshot_0.5.3 xtable_1.8-4 tidyr_1.2.0 ## [89] numDeriv_2016.8-1.1 munsell_0.5.0 viridisLite_0.4.0 bslib_0.3.1 ## [93] sessioninfo_1.2.2 "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
